<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP6330028B2 - 
  Designer cells for enantioselective reduction of ketones and their use in the efficient preparation of enantioenriched alcohols
 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP6330028B2/en">
    
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Designer cells for enantioselective reduction of ketones and their use in the efficient preparation of enantioenriched alcohols
 
     ">
    <meta name="DC.date" content="2014-04-17" scheme="dateSubmitted">
    <meta name="DC.description" content="">
    <meta name="citation_patent_application_number" content="JP:2016508291A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/bb/f6/a6/7476c5e0a6681e/JP6330028B2.pdf">
    <meta name="citation_patent_number" content="JP:6330028:B2">
    <meta name="DC.date" content="2018-05-23" scheme="issue">
    <meta name="DC.contributor" content="ゴータム スリヴァスタヴァ" scheme="inventor">
    <meta name="DC.contributor" content="ゴータム スリヴァスタヴァ" scheme="inventor">
    <meta name="DC.contributor" content="スニート カウル" scheme="inventor">
    <meta name="DC.contributor" content="スニート カウル" scheme="inventor">
    <meta name="DC.contributor" content="ラヴィンダー シン ジョリー" scheme="inventor">
    <meta name="DC.contributor" content="ラヴィンダー  シン ジョリー" scheme="inventor">
    <meta name="DC.contributor" content="カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ" scheme="assignee">
    <meta name="DC.contributor" content="カウンシル  オブ  サイエンティフィック  アンド  インダストリアル  リサーチ" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Designer cells for enantioselective reduction of ketones and their use in the efficient preparation of enantioenriched alcohols
 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"></section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/00"><a id="link" href="#" class="style-scope state-modifier">C12P7/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of oxygen-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12P7/62"><a id="link" href="#" class="style-scope state-modifier">C12P7/62</a></state-modifier>
                  <span class="description style-scope classification-tree">Carboxylic acid esters</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0004"><a id="link" href="#" class="style-scope state-modifier">C12N9/0004</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0006"><a id="link" href="#" class="style-scope state-modifier">C12N9/0006</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P13/00"><a id="link" href="#" class="style-scope state-modifier">C12P13/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of nitrogen-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P13/008"><a id="link" href="#" class="style-scope state-modifier">C12P13/008</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of nitrogen-containing organic compounds containing a N-O bond, e.g. nitro (-NO2), nitroso (-NO)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P41/00"><a id="link" href="#" class="style-scope state-modifier">C12P41/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P41/002"><a id="link" href="#" class="style-scope state-modifier">C12P41/002</a></state-modifier>
                  <span class="description style-scope classification-tree">Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/00"><a id="link" href="#" class="style-scope state-modifier">C12P7/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of oxygen-containing organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/02"><a id="link" href="#" class="style-scope state-modifier">C12P7/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of oxygen-containing organic compounds containing a hydroxy group</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P7/22"><a id="link" href="#" class="style-scope state-modifier">C12P7/22</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y"><a id="link" href="#" class="style-scope state-modifier">C12Y</a></state-modifier>
                  <span class="description style-scope classification-tree">ENZYMES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y101/00"><a id="link" href="#" class="style-scope state-modifier">C12Y101/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases acting on the CH-OH group of donors (1.1)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y101/01"><a id="link" href="#" class="style-scope state-modifier">C12Y101/01</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y101/01184"><a id="link" href="#" class="style-scope state-modifier">C12Y101/01184</a></state-modifier>
                  <span class="description style-scope classification-tree">Carbonyl reductase (NADPH) (1.1.1.184)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y"><a id="link" href="#" class="style-scope state-modifier">C12Y</a></state-modifier>
                  <span class="description style-scope classification-tree">ENZYMES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y101/00"><a id="link" href="#" class="style-scope state-modifier">C12Y101/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases acting on the CH-OH group of donors (1.1)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Y101/01"><a id="link" href="#" class="style-scope state-modifier">C12Y101/01</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12Y101/01047"><a id="link" href="#" class="style-scope state-modifier">C12Y101/01047</a></state-modifier>
                  <span class="description style-scope classification-tree">Glucose 1-dehydrogenase (1.1.1.47)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 6 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Organic Chemistry"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Organic Chemistry
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP6330028B2</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published granted patent (Second level)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/bb/f6/a6/7476c5e0a6681e/JP6330028B2.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;seq&quot;,&quot;cell&quot;,&quot;crs&quot;,&quot;designer&quot;,&quot;polypeptide&quot;]" data-before="20130417"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP6330028B2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6330028B2/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ゴータム スリヴァスタヴァ"><a id="link" href="#" class="style-scope state-modifier">ゴータム スリヴァスタヴァ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ゴータム スリヴァスタヴァ"><a id="link" href="#" class="style-scope state-modifier">ゴータム スリヴァスタヴァ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="スニート カウル"><a id="link" href="#" class="style-scope state-modifier">スニート カウル</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="スニート カウル"><a id="link" href="#" class="style-scope state-modifier">スニート カウル</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ラヴィンダー シン ジョリー"><a id="link" href="#" class="style-scope state-modifier">ラヴィンダー シン ジョリー</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ラヴィンダー  シン ジョリー"><a id="link" href="#" class="style-scope state-modifier">ラヴィンダー  シン ジョリー</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2014</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR101876172B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1020157025390A</div>
                <div class="style-scope application-timeline">Filing date: 2014-04-17</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP6330028B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2016508291A</div>
                <div class="style-scope application-timeline">Filing date: 2014-04-17</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2986724B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP14734917.9A</div>
                <div class="style-scope application-timeline">Filing date: 2014-04-17</div>
                <div class="style-scope application-timeline">Legal status: Not-in-force</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US9790524B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/785,286</div>
                <div class="style-scope application-timeline">Filing date: 2014-04-17</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN105358687B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201480022301.2A</div>
                <div class="style-scope application-timeline">Filing date: 2014-04-17</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2014170917A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/IN2014/000247</div>
                <div class="style-scope application-timeline">Filing date: 2014-04-17</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2016508291A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2014-04-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ, カウンシル  オブ  サイエンティフィック  アンド  インダストリアル  リサーチ</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2016-05-30</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2016515399A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2016515399A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2016-11-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2016515399A5/ja"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2016515399A5</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2018-05-23</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2018-05-23</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP6330028B2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP6330028B2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Expired - Fee Related</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2034-04-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (11)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (6)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=6330028B2&amp;KC=B2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/6330028/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP6330028B2">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES136911816" lang="EN" load-source="google" class="style-scope patent-text">
  <technical-field class="style-scope patent-text">
    <p num="0001" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、全細胞生物触媒及びエナンチオ濃縮アルコールの効率的製造における前記の使用に関する。より具体的には、本発明は“デザイナー細胞”と本明細書で称する全細胞生物触媒の開発に関し、前記細胞は、種々のケトンのそれらの高鏡像体過剰アルコールへの不整還元のために極めて強化された変換速度を有する。特に、本発明はデザイナー細胞の開発に関し、前記細胞は下記式1で表されるエチル4-クロロ-3-オキソブチレートの効率的変換のために極めて強化された変換速度を有し、99.9％を超える鏡像体過剰で下記式2で表されるエチル(S)-4-クロロ-3-ヒドロキシブチレートを生成する（後者は、ヒドロキシメチルグルタリル-CoA（HMG-CoA）レダクターゼ阻害剤の製造のためにキラル構築ブロック及び中間体として有用である）：
</span>
&nbsp;&nbsp;The present invention relates to the use as described above in whole cell biocatalysis and efficient production of enantioenriched alcohols. More specifically, the present invention relates to the development of whole cell biocatalysts referred to herein as "designer cells", said cells being highly suitable for the asymmetric reduction of various ketones to their high enantiomeric excess alcohol. Has enhanced conversion speed. In particular, the present invention relates to the development of designer cells, said cells having an extremely enhanced conversion rate for efficient conversion of ethyl 4-chloro-3-oxobutyrate represented by the following formula 1, 99.9% Produces an ethyl (S) -4-chloro-3-hydroxybutyrate represented by the following formula 2 with an enantiomeric excess of&gt; (the latter is the preparation of a hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor Useful as chiral building blocks and intermediates):
</span>
    </p>
    <p num="0002" class="style-scope patent-text">
      <chemistry id="" num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
  </technical-field>
  <background-art class="style-scope patent-text">
    <p num="0003" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  従来技術では、種々の供給源から単離した野生型全細胞生物触媒を使用して、工業的に重要な光学活性アルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）を調製する方法例が記載されている。前記種々の供給源は、例えばゲオトリチュム・カンジズム（Geotrichum candidum）（Sundby, E.et al.Journal of Molecular Catalysis B: Enzymatic 2003, 21, 63-66）、カンジダ・パラプシロシス（Candida parapsilosis）（Kaliaperumal, T.et al.Journal of Industrial Microbiology &amp; Biotechnology 2010, 37, 159-165）、カンジダ・マグノリアエ（Candida magnoliae）（Yasohara, Y.et al.Applied Microbiology and Biotechnology 1999, 51, 847-851）、シリンドロカルポン・スクレロチゲヌム（Cylindrocarpon sclerotigenum）（Saratani, Y.et al.Bioscience, Biotechnology, and Biochemistry 2001, 65, 1676-1679）、クルベロミセス・ラクチス（Kluveromyces lactis）（Yamamoto, H., et al.Bioscience, Biotechnology, and Biochemistry 2002, 66, 1775-1778）、クルベロミセス・アエスツアリイ（Kluyveromyces aestuarii）（Yamamoto, H.et al.Bioscience, Biotechnology, and Biochemistry 2004, 68, 638-649）、アウレオバシジウム・プルーランス（Aureobasidium pullulans）（He, J.Y.et al.Process Biochemistry 2006, 41, 244-249）、ピキア・スチピチス（Pichia stipitis）（Ye, Q.et al.Biotechnology Letters 2009, 31, 537-542）、及びストレプトミセス・コエリコロル（Streptomyces coelicolor）（Wang, L.J.et al.Bioresource Technology 2011, 102, 7023-7028）である。さらにまた、野生型全細胞生物触媒を使用するエチル(S)-4-クロロ-3-ヒドロキシブチレートの製造方法が、米国特許99/5891685号；米国特許97/5700670号；米国特許96/5559030号；米国特許95/5413921号；米国特許90/4933282号；及び米国特許号87/4710468に開示されている。カルボニル基を対応するアルコールに還元する野生型微生物の使用を記述した方法はあるが、これらの方法は欠点（例えば低効率、低基質濃度、低光学純度など）を有する。したがって、工業的に重要な光学活性アルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）を野生型の天然の全細胞生物触媒を用いて合成することは実際的ではない。
</span>
&nbsp;&nbsp;The prior art uses optically active alcohols (including ethyl (S) -4-chloro-3-hydroxybutyrate) of industrial importance using wild-type whole cell biocatalysts isolated from various sources. An exemplary method of preparation is described. The various sources are, for example, Geotrichum candidum (Sundby, E. et al. Journal of Molecular Catalysis B: Enzymatic 2003, 21, 63-66), Candida parapsilosis (Kaliaperumal, T .et al. Journal of Industrial Microbiology &amp; Biotechnology 2010, 37, 159-165), Candida magnoliae (Yasohara, Y. et al. Applied Microbiology and Biotechnology 1999, 51, 847-851), Cylindro. Carpon sclerotimenum (Cylindrocarpon sclerotigenum) (Saratani, Y. et al. Bioscience, Biotechnology, and Biochemistry 2001, 65, 1676-1679), Kluveromyces lactis (Yamamoto, H., et al. Bioscience, Biotechnology , and Biochemistry 2002, 66, 1775-1778), Kluyveromyces aestuarii (Yamamoto, H. et al. Bioscience, Biotechnology, and Biochemistry 2004, 68, 638-649), Aureobasi. Process Biochemistry 2006, 41, 244-249), Pichia stipitis (Ye, Q. et al. Biotechnology Letters 2009, 31, 537-542). Aureobasidium pullulans (He, JY et al. Process Biochemistry 2006, 41, 244-249); And Streptomyces coelicolor (Wang, LJet al. Bioresource Technology 2011, 102, 7023-7028). Furthermore, a method for producing ethyl (S) -4-chloro-3-hydroxybutyrate using a wild type whole cell biocatalyst is disclosed in U.S. Patent 99/5891685; U.S. Patent 97/5700670; U.S. Patent 96/5559030. U.S. Patent No. 95/5413921; U.S. Patent No. 90/4933282; and U.S. Patent No. 87/4710468. Although there are methods which describe the use of wild type microorganisms to reduce the carbonyl group to the corresponding alcohol, these methods have drawbacks (eg low efficiency, low substrate concentration, low optical purity etc). Therefore, it is not practical to synthesize an industrially important optically active alcohol (including ethyl (S) -4-chloro-3-hydroxybutyrate) using a wild type natural whole cell biocatalyst.
</span>
    </p>
    <p num="0004" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらにまた、工業的に重要な光学活性アルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）の光学純度を改善する公知の方法は、手を加えられていない例えば以下の供給源から精製された酵素の使用を含む：カンジダ・マグノリアエ（Wada, M.et al.Bioscience, Biotechnology, and Biochemistry 1998, 62, 280-285）、スポロボロミセス・サルモニコロル（Sporobolomyces salmonicolor）（Kita, K.et al.Journal of Molecular Catalysis B: Enzymatic 1999, 6, 305-313）、クルベロミセス・ラクチス（Yamamoto, H.et al.Bioscience, Biotechnology, and Biochemistry 2002, 66, 1775-1778）、クルベロミセス・アエスツアリイ（Yamamoto, H.et al.Bioscience, Biotechnology, and Biochemistry 2004, 68, 638-649）、ピキア・スチピチス（Ye, Q., et al.Bioresource Technology 2009, 100, 6022-6027）、及びストレプトミセス・コエリコロル（Wang, L.J.et al.Bioresource Technology 2011, 102, 7023-7028）。
</span>
&nbsp;&nbsp;Furthermore, known methods for improving the optical purity of industrially important optically active alcohols (including ethyl (S) -4-chloro-3-hydroxybutyrate) have not been tampered with, for example: Including the use of enzymes purified from sources: Candida magnoliae (Wada, M. et al. Bioscience, Biotechnology, and Biochemistry 1998, 62, 280-285), Sporobolomyces salmonicolor (Kita, K. et al. Journal of Molecular Catalysis B: Enzymatic 1999, 6, 305-313), Kleberomyces lactis (Yamamoto, H. et al. Bioscience, Biotechnology, and Biochemistry 2002, 66, 1775-1778), Kleberomyces aestuarii (Yamamoto, H. et al. Bioscience, Biotechnology, and Biochemistry 2004, 68, 638-649), Pichia stipitis (Ye, Q., et al. Bioresource Technology 2009, 100, 6022-6027), and Streptomyces. Koerikorol (Wang, LJet al. Bio resource Technology 2011, 102, 7023-7028).
</span>
    </p>
    <p num="0005" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  カルボニルレダクターゼ活性を有する精製酵素又は形質転換体がケトン（エチル-4-クロロ-3-オキソブチレートを含む）のカルボニル基を還元するとき、前記は、工業的に重要な光学活性アルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）の調製に補酵素、ニコチンアミドアデニンジヌクレオチド還元型（NADH）又はニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を要求する。反応が進行するにつれて、補酵素はニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）又はニコチンアミドアデニンジヌクレオチドリン酸（NADP）に変換される。補因子再生系が存在しない場合、理論量の増量補因子が要求される。しかしながら、反応が補因子再生系の存在下で行われるとき、増量される補酵素の量は大幅に削減される。補因子再生系は典型的には、その基質の存在下でニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）又はニコチンアミドアデニンジヌクレオチドリン酸（NADP）をニコチンアミドアデニンジヌクレオチド還元型（NADH）又はニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）に変換する酵素から成る。補酵素再生能力は、精製酵素の使用によって達成されるか（Yasohara, Y.et al.Bioscience, Biotechnology, and Biochemistry 2000, 64, 1430-1436；Kaluzna, I.A.et al.Journal of the American Chemical Society 2004, 126, 12827-12832；Zhu, D.et al.The Journal of Organic Chemistry 2006, 71, 4202-4205；Ye, Q.et al.Biotechnology Letters 2009, 31, 537-542）、又はその細胞質で補酵素再生能力を有する形質転換体を使用することによって達成され得る（Xu, Z.et al.Applied Microbiology and Biotechnology 2006, 70, 40-46；Zhang, J.et al.Chemical Communications 2006, 398-400）。
</span>
&nbsp;&nbsp;When a purified enzyme or transformant having carbonyl reductase activity reduces the carbonyl group of a ketone (including ethyl-4-chloro-3-oxobutyrate), it is an industrially important optically active alcohol (ethyl ( The preparation of S) (including 4-chloro-3-hydroxybutyrate) requires coenzyme, nicotinamide adenine dinucleotide reduced form (NADH) or nicotinamide adenine dinucleotide phosphate reduced form (NADPH). As the reaction proceeds, the coenzyme is converted to nicotinamide adenine dinucleotide phosphate reduced form (NADPH) or nicotinamide adenine dinucleotide phosphate (NADP). In the absence of a cofactor regeneration system, a theoretical amount of increasing cofactor is required. However, when the reaction is carried out in the presence of a cofactor regeneration system, the amount of coenzyme that is increased is greatly reduced. Cofactor regeneration systems are typically nicotinamide adenine dinucleotide phosphate reduced (NADPH) or nicotinamide adenine dinucleotide phosphate (NADP) in the presence of its substrate nicotinamide adenine dinucleotide reduced (NADH) Alternatively, it comprises an enzyme that converts nicotinamide adenine dinucleotide phosphate into a reduced form (NADPH). Can coenzyme regenerating ability be achieved by the use of purified enzymes (Yasohara, Y. et al. Bioscience, Biotechnology, and Biochemistry 2000, 64, 1430-1436; Kaluzna, IA et al. Journal of the American Chemical Society 2004 , 126, 12827-12832; Zhu, D. et al. The Journal of Organic Chemistry 2006, 71, 4202-4205; Ye, Q. et al. Biotechnology Letters 2009, 31, 537-542), or It can be achieved by using transformants having the ability to regenerate enzymes (Xu, Z. et al. Applied Microbiology and Biotechnology 2006, 70, 40-46; Zhang, J. et al. Chemical Communications 2006, 398-400 ).
</span>
    </p>
    <p num="0006" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  複数の方法（例えば遺伝子シャッフリングを用いるin vitro遺伝子進化）を利用して、エチル-4-クロロ-3-オキソブチレートを不整還元するケトレダクターゼの活性が約13倍改善され、さらに基質としてグルコースを用い補因子（ニコチンアミドアデニンジヌクレオチドリン酸（NADP）又はニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH））をリサイクルするグルコースデヒドロゲナーゼの能力が対応する野生型酵素と比較して約7倍改善された（Steve K.Ma et al.Green Chemistry 2010, 12, 81-86米国特許10/0028972号；米国特許10/7816111号）。<br class="style-scope patent-text">
  しかしながら、単離酵素の使用は追加の工程（例えば酵素の単離、精製及び安定化）を要求し、前記は、コストの追加をもたらし、さらに光学活性アルコールの製造の全プロセスの経済的魅力を損なう。そのうえ、基質及び／又は生成物による酵素の阻害が時に生じ得る。2つの酵素（1つはカルボニル化合物の還元用及び他方は補因子リサイクリング用）を2つの基質（各酵素について1つの基質）と一緒に使用することは当該反応において全体の複雑な消長動態をもたらす。総合すれば、これらの要因は、鏡像体的に濃縮されたアルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）の調製で全細胞を使用する場合と比べて単離酵素の使用の価値を低下させる。
</span>The activity of ketoreductase, which asymmetrically reduces ethyl-4-chloro-3-oxobutyrate, is improved by about 13 times using multiple methods (eg, in vitro gene evolution using gene shuffling), and glucose as a substrate The ability of glucose dehydrogenase to recycle cofactors (nicotinamide adenine dinucleotide phosphate (NADP) or nicotinamide adenine dinucleotide phosphate reduced form (NADPH)) is improved by about 7 times compared to the corresponding wild-type enzyme (Steve K. Ma et al. Green Chemistry 2010, 12, 81-86 U.S. Patent No. 10/0028972; U.S. Patent No. 10/7816111). <br class="style-scope patent-text"> However, the use of isolated enzymes requires additional steps (e.g. enzyme isolation, purification and stabilization), which results in additional costs and additionally the economic attractiveness of the whole process of producing optically active alcohols. Lose. Moreover, inhibition of the enzyme by the substrate and / or product may sometimes occur. Using two enzymes (one for reduction of carbonyl compounds and the other for cofactor recycling) together with two substrates (one substrate for each enzyme) results in an overall complex kinetics of the reaction. Bring. Taken together, these factors are the isolated enzyme compared to using whole cells in the preparation of enantiomerically enriched alcohols (including ethyl (S) -4-chloro-3-hydroxybutyrate) Reduce the value of use.</span>
    </p>
    <p num="0007" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  野生型株に付随する低効率の問題を克服するために、カルボニルレダクターゼ活性をコードする遺伝子を推論し、宿主細胞で過剰発現させることができる。鏡像体濃縮アルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）を製造するために、全細胞生物触媒の更なる効率改善が、同じ宿主細胞の細胞質でカルボニルレダクターゼ及び補酵素再生能力の両方を共同発現させることによって達成される（Kizaki, N.et al.Applied Microbiology and Biotechnology 2001, 55, 590-595, Kataoka, M.et al.Enzyme and Microbial Technology 2006, 38, 944-951; Ye, Q.et al.Bioresource Technology 2010, 101, 6761-6767）。<br class="style-scope patent-text">
  しかしながら、カルボニルレダクターゼ能力が存在する形質転換体又はカルボニルレダクターゼ及び補酵素再生能力の両方が細胞の細胞質に存在する形質転換体のいずれかを使用する方法では、複数の欠点（例えば形質膜によって強制される障壁による基質取り込み及び生成物流出における低効率、全プロセスの複雑な消長動態）に悩まされる。<br class="style-scope patent-text">
  結果として、光学的に純粋なエチル(S)-4-クロロ-3-ヒドロキシブチレート及び他の光学的に濃縮されたアルコールを製造する現行方法は、欠点（例えば低効率、低生産性など）を抱え、したがって前記は製造コストの上昇を生じる。
</span>To overcome the low efficiency problems associated with wild type strains, the gene encoding the carbonyl reductase activity can be inferred and overexpressed in host cells. Further efficiency improvement of whole cell biocatalyst to produce enantiomerically enriched alcohol (including ethyl (S) -4-chloro-3-hydroxybutyrate), carbonyl reductase and coenzyme in the cytoplasm of the same host cell Achieved by co-expressing both regenerating ability (Kizaki, N. et al. Applied Microbiology and Biotechnology 2001, 55, 590-595, Kataoka, M. et al. Enzyme and Microbial Technology 2006, 38, 944- 951; Ye, Q. et al. Bioresource Technology 2010, 101, 6761-6767). <br class="style-scope patent-text"> However, methods that use either transformants in which there is a carbonylreductase capacity or transformants in which both the carbonylreductase and the coenzyme regenerating capacity are in the cytoplasm of the cell result in several drawbacks (eg forced by the plasma membrane) Low efficiency in substrate uptake and product efflux by complex barriers, complex dynamics of the whole process). <br class="style-scope patent-text"> As a result, current methods for producing optically pure ethyl (S) -4-chloro-3-hydroxybutyrate and other optically concentrated alcohols suffer from disadvantages (eg, low efficiency, low productivity, etc.) The above causes an increase in manufacturing costs.</span>
    </p>
    <p num="0008" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  タンパク質（酵素を含む）を細胞の表面で発現させる技術は周知であり（Lee, S.Y.et al.Trends in Biotechnology 2003, 21, 45-52）、広範囲のバイオテクノロジー及び工業における応用で用いられている。前記応用は、例えばバイオ変換のための全細胞生物触媒（Shimazu, M.et al.Protein.Biotechnology Progress 2001, 17, 76-80；Shimazu, M.et al.Biotechnology and Bioengineering 2001, 76, 318-324）、有害な化学物質及び重金属を除去するバイオ吸着材（Bae, W.et al.Biotechnology and Bioengineering 2000, 70, 518-524；Bae, W.et al.J Inorg Biochem 2002, 88, 223-227；Sousa, C.et al.J.Bacteriol.1998, 180, 2280-2284；Xu, Z.et al.Appl Environ Microbiol 1999, 65, 5142-5147）、ヒト抗体ライブラリーのスクリーニング（Chao, G.et al.Nat.Protocols 2006, 1, 755-768）、変異の検出（Aoki, T.et al.Analytical Biochemistry 2002, 300, 103-106）、酵素、受容体又は他のシグナル感受性成分を固着させることによるバイオセンサーの開発（Dhillon, J.K.et al.Letters in Applied Microbiology 1999, 28, 350-354; Shibasaki, S.et al.Applied Microbiology and Biotechnology 2001, 57, 702-707; Shibasaki, S.S.et al.Applied Microbiology and Biotechnology 2001, 57, 528-533）である。
</span>
&nbsp;&nbsp;Techniques for expressing proteins (including enzymes) on the surface of cells are well known (Lee, SY et al. Trends in Biotechnology 2003, 21, 45-52) and are used in a wide range of biotechnological and industrial applications . Said applications are for example whole cell biocatalysts for bioconversion (Shimazu, M. et al. Protein. Biotechnology Progress 2001, 17, 76-80; Shimazu, M. et al. Biotechnology and Bioengineering 2001, 76, 318- 324), biosorbents that remove harmful chemicals and heavy metals (Bae, W. et al. Biotechnology and Bioengineering 2000, 70, 518-524; Bae, W. et al. J Inorg Biochem 2002, 88, 223- Sousa, C. et al. J. Bacteriol. 1998, 180, 2280-2284; Xu, Z. et al. Appl Environ Microbiol 1999, 65, 5142-5147), screening of human antibody library (Chao, G .. et al. Nat. Protocols 2006, 1, 755-768), detection of mutations (Aoki, T. et al. Analytical Biochemistry 2002, 300, 103-106), anchoring enzymes, receptors or other signal sensitive components Development of biosensors by making them (Dhillon, JK et al. Letters in Applied Microbiology 1999, 28, 350-354; Shibasaki, S. et al. Applied Microbiology and Biotechnology 2001, 57, 702-707; Shibasaki, SSet al .Applied Microbiology and Biotechnology 2001, 57, 528-533).
</span>
    </p>
    <p num="0009" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  もっと最近では、標的タンパク質（デヒドロゲナーゼを含むがカルボニルレダクターゼ及びグルコースデヒドロゲナーゼを含まない）の同時ディスプレーのための方法が米国特許11/7897366号に開示された。通常では、標的ペプチド又はタンパク質（パッセンジャータンパク質）に融合させた細胞表面タンパク質又はそれらの切端形（担体タンパク質）が、表面でのタンパク質のディスプレーに用いられる。グラム陰性（大腸菌（Escherichia coli））、グラム陽性（枯草菌（Bacillus subtilis）、ブドウ球菌属（Staphylococcus）株）細菌及び酵母（サッカロミセス・セレビシアエ（Saccharomyces cerevisiae）、ピキア・パストリス（Pichia pastoris））が、表面での異種タンパク質発現のディスプレーのために開発されている。グラム陽性細菌の細胞壁の硬質構造は当該細菌を適切な宿主とするが、しかしながらグラム陰性大腸菌は最も人気があり、細胞表面ディスプレーのために大いに開発されてきた。大腸菌の必須タンパク質（例えばLamB、FhuA並びにポリンOmpA、OmpC及びOmpX（前記は外膜に構造的な硬さを与える））が、細胞外ループに短いアミノ酸配列（60アミノ酸まで）を挿入し細胞表面でディスプレーするために重点的に用いられている。外膜リポタンパク質は小さな脂質改変アミノ末端によって膜に固着される。最初のリポタンパク質系細胞表面ディスプレーはLpp-OmpAキメラであり、前記は20アミノ酸シグナル配列及び成熟大腸菌リポタンパク質の最初の9つのN-末端残基から成り、大腸菌外膜タンパク質A（OmpA）の残基46−159がパッセンジャータンパク質のN-末端に融合された。
</span>
&nbsp;&nbsp;More recently, methods for the simultaneous display of target proteins (including dehydrogenase but not carbonyl reductase and glucose dehydrogenase) have been disclosed in US Patent No. 11/7897366. Usually, cell surface proteins fused to target peptides or proteins (passenger proteins) or their truncated forms (carrier proteins) are used for display of proteins on the surface. Gram-negative (Escherichia coli), Gram-positive (B. subtilis, Bacillus subtilis, Staphylococcal strain) Bacteria and yeast (Saccharomyces cerevisiae, Pichia pastoris), but not It has been developed for the display of heterologous protein expression on the surface. The rigid structure of the cell wall of Gram positive bacteria makes the bacteria an appropriate host, however Gram negative E. coli is the most popular and has been greatly developed for cell surface display. Essential proteins of E. coli (eg, LamB, FhuA and porins OmpA, OmpC and OmpX, which confer structural rigidity to the outer membrane) insert short amino acid sequences (up to 60 amino acids) into the extracellular loop and the cell surface Are used intensively for display. Outer membrane lipoproteins are anchored to the membrane by small lipid-modified amino termini. The first lipoprotein-based cell surface display is the Lpp-OmpA chimera, which consists of a 20 amino acid signal sequence and the first nine N-terminal residues of the mature E. coli lipoprotein, leaving the E. coli outer membrane protein A (OmpA) remaining Groups 46-159 were fused to the N-terminus of the passenger protein.
</span>
    </p>
  </background-art>
  
  <summary-of-invention class="style-scope patent-text">
    <p num="0010" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、細胞の表面でCRSポリペプチドを発現する大腸菌を提供し、前記細胞は、エチル-4-クロロ-3-オキソブチレートからエチル-4-クロロ-3-ヒドロキシブチレートへの還元のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較してCRSポリペプチドの単位質量当たり250倍から300倍強化された変換速度を有する。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチドを発現する組換え大腸菌株は、種々のケト化合物の不整還元のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較してCRSポリペプチドの単位質量当たり50倍から275倍強化された変換速度を有する。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチドを発現する組換え大腸菌株は、種々のケト化合物の還元のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較して単位細胞質量当たり約3倍から26倍強化された変換速度を有する。<br class="style-scope patent-text">
  別の特徴では、本発明は、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株の提供を目的とし、前記は、大腸菌細胞の細胞質でCRS及びGDHを同時に発現する大腸菌株と比較して、CRSポリペプチドの単位質量当たりのエチル-4-クロロ-3-オキソブチレートからエチル-4-クロロ-3-ヒドロキシブチレートに還元する変換速度は250倍から300倍強化され、さらにGDHポリペプチドの単位質量当たりのグルコースをグルコネートに酸化する能力は200倍から250倍強化される。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株は、種々のケトンの還元のために細胞の細胞質でCRSポリペプチド及びGDHポリペプチドを同時に発現する従来技術の対応する大腸菌株と比較して、CRSタンパク質の単位質量当たりの変換速度は約50倍から270倍強化される。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株は、種々のケト化合物の還元のために細胞の細胞質でCRSポリペプチド及びGDHポリペプチドを同時に発現する従来技術の対応する大腸菌株と比較して、単位細胞質量当たりの変換速度は約3倍から24倍強化される。
</span>The present invention provides E. coli expressing CRS polypeptide on the surface of cells, said cells comprising the reduction of ethyl-4-chloro-3-oxobutyrate to ethyl-4-chloro-3-hydroxybutyrate. Therefore, it has a 250-fold to 300-fold enhanced conversion rate per unit mass of CRS polypeptide as compared to the corresponding E. coli strain of the prior art expressing CRS in the cytoplasm of cells. <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain that expresses a CRS polypeptide on the surface of the cell is compared to a corresponding E. coli strain that expresses CRS in the cytoplasm of the cell for asymmetric reduction of various keto compounds. It has a 50- to 275-fold enhanced conversion rate per unit mass of CRS polypeptide. <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain that expresses a CRS polypeptide on the surface of the cell has a unit compared to the corresponding E. coli strain that expresses CRS in the cytoplasm of the cell for reduction of various keto compounds. It has an enhanced conversion rate of about 3 to 26 times per cell mass. <br class="style-scope patent-text"> In another aspect, the present invention aims to provide a recombinant E. coli strain that simultaneously expresses CRS polypeptide and GDH polypeptide on the surface of cells, said E. coli coexpressing CRS and GDH in the cytoplasm of E. coli cells. The conversion rate from ethyl-4-chloro-3-oxobutyrate to ethyl-4-chloro-3-hydroxybutyrate per unit mass of CRS polypeptide is enhanced 250-fold to 300-fold compared to the strain Furthermore, the ability to oxidize glucose per unit mass of GDH polypeptide to gluconate is enhanced by a factor of 200 to 250. <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain that co-expresses CRS and GDH polypeptides on the surface of cells is conventionally used to co-express CRS and GDH polypeptides in the cell cytoplasm for reduction of various ketones. The conversion rate per unit mass of CRS protein is enhanced by about 50-fold to 270-fold as compared to the corresponding E. coli strain of the technology. <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain co-expressing a CRS polypeptide and a GDH polypeptide on the surface of a cell co-expresses a CRS polypeptide and a GDH polypeptide in the cytoplasm of the cell for reduction of various keto compounds. The conversion rate per unit cell mass is enhanced approximately 3 to 24 times compared to the corresponding E. coli strain of the prior art.</span>
    </p>
    <p num="0011" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施態様では、種々のケトンは式3で表される脂肪族化合物であり、式中R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>はH、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、さらにR<sub class="style-scope patent-text">3</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、XはCl又はBrであり、さらにnは1−4であり、mは1−8である。<br class="style-scope patent-text">
  より好ましい実施態様では、R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>は(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">7</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はClであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCF<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>は(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CHであり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>である。<br class="style-scope patent-text">
  別の実施態様では、種々のケトンは一般式4で表される芳香族化合物であり、式中R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、さらにR<sub class="style-scope patent-text">6</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、nは1から5である。<br class="style-scope patent-text">
  ある実施態様では、大腸菌は、大腸菌BL21(DE3)、大腸菌C41(DE3)、又は大腸菌C43(DE3)から選択される。
</span>In certain embodiments, the various ketones are aliphatic compounds represented by Formula 3, wherein R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">2</sub> is H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , further R <sub class="style-scope patent-text">3</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X is Cl or Br, and n is 1-4 and m is 1-8. <br class="style-scope patent-text"> In a more preferred embodiment, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H and further R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">2</sub> is H, Further, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H, and R <sub class="style-scope patent-text">3</sub> is (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">7</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> R <sub class="style-scope patent-text">2</sub> is Cl and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CF <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , Or R <sub class="style-scope patent-text">1</sub> is (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, R <sub class="style-scope patent-text">2</sub> is H, and further R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> . <br class="style-scope patent-text"> In another embodiment, the various ketones are aromatic compounds represented by general formula 4 wherein R <sub class="style-scope patent-text">1</sub> = R <sub class="style-scope patent-text">2</sub> 3R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br , I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , further R <sub class="style-scope patent-text">6</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and n is 1 to 5. <br class="style-scope patent-text"> In one embodiment, the E. coli is selected from E. coli BL21 (DE3), E. coli C41 (DE3), or E. coli C43 (DE3).</span>
    </p>
    <p num="0012" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  好ましい実施態様では、補因子としてニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を用いるエチル-4-クロロ-3-オキソブチレートからエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換の速度は、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する大腸菌株BL21(DE3)を、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する大腸菌株C41(DE3)に取り替えると1.3倍高い。<br class="style-scope patent-text">
  別の好ましい実施態様では、補因子としてニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を用いるエチル-4-クロロ-3-オキソブチレートからエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換の速度は、細胞の表面でCRSポリペプチドのみを発現し補因子リサイクリングのために外部GDHの添加を必要とする大腸菌株BL21(DE3)と比較して、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する大腸菌株C41(DE3)で約1.6倍高い。<br class="style-scope patent-text">
  具体的な実施態様では、本発明は、工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートを高い生産性及び少なくとも150gl<sup class="style-scope patent-text">-1</sup>の生成物蓄積とともに約100％の鏡像体過剰で生産する製造方法を提供する。
</span>In a preferred embodiment, ethyl-4-chloro-3-oxobutyrate to ethyl (S) -4-chloro-3-hydroxybutyrate using nicotinamide adenine dinucleotide phosphate reduced form (NADPH) as a cofactor The rate of conversion is as follows: E. coli strain BL21 (DE3) co-expressing CRS polypeptide and GDH polypeptide on the surface of the cell, and E. coli strain C41 (DE3) co-expressing CRS polypeptide and GDH polypeptide on the surface of the cell When replaced, it is 1.3 times higher. <br class="style-scope patent-text"> In another preferred embodiment, ethyl (S) -4-chloro-3-hydroxybutyrate from ethyl-4-chloro-3-oxobutyrate using nicotinamide adenine dinucleotide phosphate reduced form (NADPH) as a cofactor The rate of conversion to CRS poly (CRS) on the surface of the cell compared to E. coli strain BL21 (DE3), which expresses only CRS polypeptide on the surface of the cell and requires the addition of external GDH for cofactor recycling. About 1.6 fold higher in E. coli strain C41 (DE3) co-expressing peptide and GDH polypeptide. <br class="style-scope patent-text"> In a specific embodiment, the present invention provides about 100% enantiomers of industrially important ethyl (S) -4-chloro-3-hydroxybutyrate with high productivity and product accumulation of at least 150 gl <sup class="style-scope patent-text">-1.</sup> To provide a manufacturing method to produce in excess.</span>
    </p>
  </summary-of-invention>
  
  <description-of-drawings class="style-scope patent-text">
    <p num="0013" class="style-scope patent-text">
      <figref num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">基質として適切な化合物の例である。</span>Examples of compounds suitable as substrates are:</span>
      </figref>
      <figref num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">生成物として適切な化合物の例である。</span>It is an example of a compound suitable as a product.</span>
      </figref>
      <figref num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">配列番号:1、3、5又は7に対応する“CRSポリペプチド”構築物の模式図である。配列は、（i）成熟大腸菌リポタンパク質（Lpp）の最初の9つのN-末端残基と連結されたN-末端20アミノ酸のシグナル配列、（ii）大腸菌外膜タンパク質A（OmpA）の残基46−159（前記はそのC末端に融合されるパッセンジャータンパク質を膜を通過して輸送すると期待される）、及び（iii）CRSの完全配列（ここでCRSは、カンジダ・マグノリアエの野生型カルボニルレダクターゼ（配列番号:13）又は改変カルボニルレダクターゼ（配列番号:15、17又は19（前記はいくつかのアミノ酸置換を有することで配列番号:13と異なる））である）から成る。最初の29アミノ酸残基（シグナル＋Lppペプチド）はGly-Ileリンカーを介して114アミノ酸のOmpA残基と連結され、前記リンカーは続いてGly-Ile-Pro-Glyを介してCRSのN-末端に貼付される。</span>FIG. 1 is a schematic representation of a “CRS polypeptide” construct corresponding to SEQ ID NO: 1, 3, 5 or 7. The sequence is (i) a signal sequence of N-terminal 20 amino acids linked to the first nine N-terminal residues of mature E. coli lipoprotein (Lpp), (ii) residues of E. coli outer membrane protein A (OmpA) 46-159 (which is expected to transport the passenger protein fused to its C-terminus across the membrane), and (iii) the complete sequence of CRS (where CRS is the wild-type carbonyl of Candida magnoliae) Reductase (SEQ ID NO: 13) or modified carbonyl reductase (SEQ ID NO: 15, 17 or 19 (which differs from SEQ ID NO: 13 by having several amino acid substitutions)). The first 29 amino acid residues (signal + Lpp peptide) are linked to the 114 amino acid OmpA residue via the Gly-Ile linker, which is subsequently linked to the N-terminus of CRS via Gly-Ile-Pro-Gly It is attached.</span>
      </figref>
      <figref num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">配列番号:9又は11に対応する“GDHポリペプチド”構築物の模式図である。配列は、（i）成熟大腸菌リポタンパク質（Lpp）の最初の9つのN-末端残基と連結されたN-末端20アミノ酸のシグナル配列、（ii）大腸菌外膜タンパク質A（OmpA）の残基46−159（前記はそのC末端に融合されるパッセンジャータンパク質を膜を通過して輸送すると期待される）、及び（iii）GDHの完全配列（ここでGDHはバシルス・メガテリウム（Bacillus megaterium）の野生型グルコースデヒドロゲナーゼ（配列番号:21）又は改変グルコースデヒドロゲナーゼ（配列番号:23（前記はいくつかのアミノ酸置換を有することで配列番号:21と異なる））である）から成る。最初の29アミノ酸残基（シグナル＋Lppペプチド）はGly-Ileリンカーを介して114アミノ酸のOmpA残基と連結され、前記リンカーは続いてGly-Ile-Pro-Glyを介してGDHのN-末端に貼付される。</span>FIG. 12 is a schematic representation of a “GDH polypeptide” construct corresponding to SEQ ID NO: 9 or 11. The sequence is (i) a signal sequence of N-terminal 20 amino acids linked to the first nine N-terminal residues of mature E. coli lipoprotein (Lpp), (ii) residues of E. coli outer membrane protein A (OmpA) 46-159 (which are expected to transport the passenger protein fused to its C-terminus across the membrane), and (iii) the complete sequence of GDH (where GDH is the wild type of Bacillus megaterium) Type glucose dehydrogenase (SEQ ID NO: 21) or modified glucose dehydrogenase (SEQ ID NO: 23 (which differs from SEQ ID NO: 21 by having several amino acid substitutions)). The first 29 amino acid residues (signal + Lpp peptide) are linked to the 114 amino acid OmpA residue via the Gly-Ile linker, which is subsequently linked to the N-terminus of GDH via Gly-Ile-Pro-Gly It is attached.</span>
      </figref>
      <figref num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">組換えベクターpET23(a)-omp-CRSに関する方法及び構造である。</span>Methods and structures for the recombinant vector pET23 (a) -omp-CRS.</span>
      </figref>
      <figref num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">組換えベクターpETDuet1-omp-CRS, omp-GDHに関する方法及び構造である。</span>Methods and structures for the recombinant vector pETDuet1-omp-CRS, omp-GDH.</span>
      </figref>
      <figref num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">大腸菌細胞の表面でCRSを発現する‘デザイナー全細胞生物触媒’の透過型電子顕微鏡写真である。細胞をウサギ抗CRSポリクローナル抗体で続いてナノゴールド標識ヤギ抗ウサギIgG（全分子）二次抗体でプローブ精査した。矢印は金粒子を指す。図7aは、大腸菌BL21(DE3)+pET23(a)（すなわち陰性コントロール（金標識を全く示さない））のTEMである。図7bは、大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRSを発現する（強烈な金標識を示す））のTEMを示す。</span>FIG. 7 is a transmission electron micrograph of 'designer whole cell biocatalyst' expressing CRS on the surface of E. coli cells. Cells were probed with rabbit anti-CRS polyclonal antibody followed by nanogold labeled goat anti-rabbit IgG (whole molecule) secondary antibody. Arrows point to gold particles. FIG. 7a is a TEM of E. coli BL21 (DE3) + pET23 (a) (ie a negative control (showing no gold label)). FIG. 7 b shows a TEM of E. coli BL21 (DE3) + pET23 (a) -omp-CRS (expressing CRS (showing intense gold label)).</span>
      </figref>
    </p>
  </description-of-drawings>
  <description-of-embodiments class="style-scope patent-text">
    <p num="0014" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は種々の改変及び／又は代替プロセス及び／又は組成物に鋭敏ではあるが、その具体的な実施態様は絵図/図及び表における実例によって示されてあり、さらに下記に詳細に記載されるであろう。しかしながら、本発明を特定のプロセス及び／又は開示組成物に限定しようとするものではないことは理解されるべきであり、反対に、本発明は、添付の特許請求の範囲によって定義される本発明の趣旨及び範囲内に含まれる全ての改変、等価物及び代替物をカバーしようとするものである。<br class="style-scope patent-text">
  グラフ、図、表及びプロトコルは、適切な場合には絵図での通常的な表現によって表されているが、それらは、本明細書の記載が役立つ当業者には容易に明瞭となる詳細な開示を不明確にしないように、本発明の実施態様の理解に適切な具体的詳細を単に示す。<br class="style-scope patent-text">
  以下の記載は単に典型的な実施態様であり、本発明の範囲、応用性又は構成をいかなる態様においても制限しようとするものではない。そうではなく、以下の記載は本発明の典型的な実施態様を実行する便利な例示を提供する。記載した実施態様に対する多様な変更を記載した成分の機能及び配置において本発明の範囲から逸脱することなく実施できる。<br class="style-scope patent-text">
  “comprises”、“comprising”という用語又は前記用語の任意の他の変型は非排他的包含をカバーし、したがって、“comprises...a”に続く1つ以上のプロセス又は組成物又は系又は方法は、それ以上の拘束を受けずに他のプロセス、サブプロセス、組成物、サブ組成物、マイナーな若しくはメジャーな組成物又は他の成分又は他の構造物、又は追加のプロセス若しくは組成物、又は追加の成分、又は追加の特色、又は追加の特徴、又は追加の属性を排除しない。
</span>Although the present invention is sensitive to various modifications and / or alternatives, processes and / or compositions, specific embodiments thereof are illustrated by the illustrations in the drawings / figures and tables and are described in more detail below. Will. However, it should be understood that the present invention is not intended to be limited to the particular process and / or disclosed compositions, and conversely, the present invention is defined by the appended claims. It is intended to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. <br class="style-scope patent-text"> Although the graphs, figures, tables and protocols are, where appropriate, represented by the usual expressions in the drawings, they are detailed disclosures that will be readily apparent to those of ordinary skill in the art to which the present description relates. In order not to obscure the above, we merely present specific details that are appropriate for understanding the embodiments of the present invention. <br class="style-scope patent-text"> The following description is merely exemplary embodiments and is not intended to limit the scope, applicability or configuration of the present invention in any manner. Rather, the following description provides a convenient illustration of practicing the exemplary embodiments of the present invention. Various modifications to the described embodiments can be made in the function and arrangement of the described components without departing from the scope of the present invention. <br class="style-scope patent-text"> The term "comprises", the term "comprises" or any other variations of the term cover non-exclusive inclusion and thus, one or more processes or compositions or systems or methods following "comprises ... a" May be, without further limitation, other processes, subprocesses, compositions, subcompositions, minor or major compositions or other components or other structures, or additional processes or compositions, or It does not exclude additional components or additional features or additional features or additional attributes.</span>
    </p>
    <p num="0015" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">定義</u> <br class="style-scope patent-text">
  本発明の目的のために、下記用語はそこで特定される意味を有するであろう。<br class="style-scope patent-text">
  “CRSポリペプチド”は、図3に模式的に示されるアミノ酸配列を指す。<br class="style-scope patent-text">
  “GDHポリペプチド”は、図4に模式的に示される配列を指す。<br class="style-scope patent-text">
  “カルボニルレダクターゼ”及び“CRS”は互換的に用いられ、ケトン及びニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を対応するアルコール及びニコチンアミドアデニンジヌクレオチドリン酸（NADP）に変換するポリペプチドを指す。<br class="style-scope patent-text">
  “グルコースデヒドロゲナーゼ”及び“GDH”は互換的に用いられ、グルコース及びニコチンアミドアデニンジヌクレオチドリン酸（NADP）をグルコネート及びニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）に変換するポリペプチドを指す。<br class="style-scope patent-text">
  本記述では、“デザイナー細胞”という用語は本明細書では大腸菌の組換え株を指し、前記は、還元剤として還元ニコチンアミドアデニンジヌクレオチドリン酸（NADPH）の触媒量を用い、ニコチンアミドアデニンジヌクレオチドリン酸（NADP）のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）への酸化のための外部補因子リサイクリング系の存在下又は非存在下で種々のケトンの不整還元を触媒して鏡像体濃縮アルコールを生成する。
</span> <u class="style-scope patent-text">Definitions For</u> the purposes of the present invention, the following terms will have the meaning specified there. <br class="style-scope patent-text"> "CRS polypeptide" refers to the amino acid sequence schematically shown in FIG. <br class="style-scope patent-text"> "GDH polypeptide" refers to the sequence schematically shown in FIG. <br class="style-scope patent-text"> "Carbonyl reductase" and "CRS" are used interchangeably to convert ketone and nicotinamide adenine dinucleotide phosphate reduced form (NADPH) to the corresponding alcohol and nicotinamide adenine dinucleotide phosphate (NADP) Point to. <br class="style-scope patent-text"> "Glucose dehydrogenase" and "GDH" are used interchangeably and refer to polypeptides that convert glucose and nicotinamide adenine dinucleotide phosphate (NADP) to gluconate and nicotinamide adenine dinucleotide phosphate reduced form (NADPH). <br class="style-scope patent-text"> As used herein, the term "designer cell" refers herein to a recombinant strain of E. coli, which uses a catalytic amount of reduced nicotinamide adenine dinucleotide phosphate (NADPH) as a reducing agent, Enantiomers of various ketones catalyze the asymmetric reduction in the presence or absence of an external cofactor recycling system for the oxidation of nucleotide phosphate (NADP) to nicotinamide adenine dinucleotide phosphate reduced form (NADPH) Produces concentrated alcohol.</span>
    </p>
    <p num="0016" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらにまた、“補因子リサイクリング系”は、本明細書では使用済み補因子を反応前の状態に戻すために反応に添加される試薬一式を指す。例えば、CRSによるケトンからアルコールへの変換では、補因子ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）はニコチンアミドアデニンジヌクレオチドリン酸（NADP）（使用済み補因子）に変換される。試薬、GDH及びグルコースの反応への添加は、ニコチンアミドアデニンジヌクレオチドリン酸（NADP）からニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の再生をもたらすであろう。<br class="style-scope patent-text">
  さらにまた、“CRSポリペプチド”という用語は図3に模式的に示されるアミノ酸配列を指し、前記図では、CRSは、カンジダ・マグノリアエの野生型カルボニルレダクターゼ配列番号:13又はいくつかのアミノ酸置換を有することによって配列番号:13とは異なる改変カルボニルレダクターゼ、例えば配列番号:15（P14A、S42N、A194V、I275V）又は配列番号:17（P14A、S42N、V147A、A194V、E234G）又は配列番号:19（E9G、P14A、N20S、S42N、T190A、A194V、E234G）である。<br class="style-scope patent-text">
  さらにまた、GDHポリペプチドは図4に模式的に示される配列を指し、前記図では、GDHは、バシルス・メガテリウムの野生型グルコースデヒドロゲナーゼ配列番号:21又はいくつかのアミノ酸置換を有することによって配列番号:21とは異なる改変グルコースデヒドロゲナーゼ、例えば配列番号:23（S16T、E170K、P194T、A197K、E222D、S237C）である。
</span>Furthermore, "cofactor recycling system" refers herein to the set of reagents added to the reaction to bring spent cofactor back to its pre-reaction state. For example, in the conversion of ketones to alcohols by CRS, the cofactor nicotinamide adenine dinucleotide phosphate reduced form (NADPH) is converted to nicotinamide adenine dinucleotide phosphate (NADP) (used cofactor). The addition of reagents, GDH and glucose to the reaction will result in the regeneration of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) from nicotinamide adenine dinucleotide phosphate (NADP). <br class="style-scope patent-text"> Furthermore, the term "CRS polypeptide" refers to the amino acid sequence shown schematically in Figure 3, in which CRS is Candida magnoliae wild type carbonyl reductase SEQ ID NO: 13 or some amino acid substitution A modified carbonyl reductase which differs from SEQ ID NO: 13 by having, for example SEQ ID NO: 15 (P14A, S42N, A194V, I275V) or SEQ ID NO: 17 (P14A, S42N, V147A, A194V, E234G) or SEQ ID NO: 19 (E9G, P14A, N20S, S42N, T190A, A194V, E234G). <br class="style-scope patent-text"> Furthermore, the GDH polypeptide refers to the sequence shown schematically in Figure 4, in which GDH has the wild-type glucose dehydrogenase SEQ ID NO: 21 of Bacillus megaterium or SEQ ID NO by having several amino acid substitutions. A modified glucose dehydrogenase different from 21:21, for example SEQ ID NO: 23 (S16T, E170K, P194T, A197K, E222D, S237C).</span>
    </p>
    <p num="0017" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書で用いられるように、“カルボニルレダクターゼ”及び“CRS”という用語は互換的に用いられ、ケトン及びニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を対応するアルコール及びニコチンアミドアデニンジヌクレオチドリン酸（NADP）に変換するポリペプチドを指す。さらにまた、“グルコースデヒドロゲナーゼ”及び“GDH”という用語は互換的に用いられ、グルコース及びニコチンアミドアデニンジヌクレオチドリン酸（NADP）をグルコネート及びニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）に変換するポリペプチドを指す。<br class="style-scope patent-text">
  本発明は、“デザイナー細胞”と本明細書で称する全細胞生物触媒を提供する。前記は、種々のケトンのそれらの高鏡像体過剰アルコールへのエナンチオ選択性変換のために極めて強化された変換速度を有する。特に本発明はデザイナー細胞の開発に関し、前記細胞は、式1によって表されるエチル4-クロロ-3-オキソブチレートを効率的に変換して、99.9％を超える鏡像体過剰で式2によって表されるエチル(S)-4-クロロ-3-ヒドロキシブチレートを生成するために極めて強化された変換速度を有する（エチル(S)-4-クロロ-3-ヒドロキシブチレートはヒドロキシメチルグルタリル-CoA（HMG-CoA）レダクターゼ阻害剤の製造のためにキラル構築ブロック及び中間体として有用である）。
</span>As used herein, the terms "carbonyl reductase" and "CRS" are used interchangeably to refer to ketone and nicotinamide adenine dinucleotide phosphate reduced form (NADPH) corresponding alcohol and nicotinamide adenine dinucleotide Refers to a polypeptide that converts to phosphate (NADP). Furthermore, the terms "glucose dehydrogenase" and "GDH" are used interchangeably to convert glucose and nicotinamide adenine dinucleotide phosphate (NADP) to gluconate and nicotinamide adenine dinucleotide phosphate reduced form (NADPH) Refers to a polypeptide. <br class="style-scope patent-text"> The present invention provides whole cell biocatalysts referred to herein as "designer cells". The foregoing has a very enhanced conversion rate due to the enantioselective conversion of various ketones to their high enantiomeric excess alcohols. In particular, the present invention relates to the development of designer cells, said cells efficiently converting ethyl 4-chloro-3-oxobutyrate represented by formula 1 Ethyl (S) -4-chloro-3-hydroxybutyrate (ethyl (S) -4-chloro-3-hydroxybutyrate has a very enhanced conversion rate to produce ethyl (S) -4-chloro-3-hydroxybutyrate Useful as chiral building blocks and intermediates for the preparation of CoA (HMG-CoA) reductase inhibitors).</span>
    </p>
    <p num="0018" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、カルボニルレダクターゼポリペプチド（CRS）の細胞表面での発現を提供する。さらにまた、本発明は、カルボニルレダクターゼポリペプチド（CRS）及びグルコースデヒドロゲナーゼ（GDH）の細胞表面での共同発現もまた提供する。したがって、本発明は細胞質でカルボニルレダクターゼを発現する全細胞系の既存の欠点を克服し、カルボニルレダクターゼポリペプチド（CRS）は細胞の表面に固着され、エチル-4-クロロ-3-オキソブチレートを工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートに変換するために同じ細胞宿主の細胞質で発現されるカルボニルレダクターゼと比較して、CRSポリペプチドの単位質量当たり予想を超える驚異の強化変換速度を示す。同様に、本発明はまた細胞質でCRS及びGDH酵素を共同発現する全細胞系の既存の欠点を克服し、共同発現は予想を超える驚異の強化発現を示す。さらにまた、そのような態様で発現される酵素は、純粋な固定化酵素に類似する態様を示し、それによって該酵素のコスト集約的な単離、精製及び安定化の要請を不要にすると期待される。さらにまた、消長動態は、細胞質膜を通過する基質の取り込み及び生成物の流出がこの場合には不要であるという事実のためにはるかに単純であることが予想される。
</span>
&nbsp;&nbsp;The present invention provides cell surface expression of carbonyl reductase polypeptide (CRS). Furthermore, the present invention also provides co-expression on the cell surface of carbonyl reductase polypeptide (CRS) and glucose dehydrogenase (GDH). Thus, the present invention overcomes the existing shortcomings of whole cell lines that express carbonyl reductase in the cytoplasm, the carbonyl reductase polypeptide (CRS) is anchored to the surface of the cell, and ethyl-4-chloro-3-oxobutyrate The expected per unit mass of CRS polypeptide is exceeded compared to carbonyl reductase expressed in the cytoplasm of the same cellular host to convert to industrially important ethyl (S) -4-chloro-3-hydroxybutyrate Demonstrate amazing transformation rates. Similarly, the present invention also overcomes the existing shortcomings of all cell lines that co-express CRS and GDH enzymes in the cytoplasm, with co-expression showing surprising enhanced expression beyond expectations. Furthermore, enzymes expressed in such an aspect are expected to exhibit aspects similar to pure immobilized enzymes, thereby obviating the need for cost intensive isolation, purification and stabilization of the enzymes. Ru. Furthermore, it is expected that the kinetics of uptake will be much simpler due to the fact that uptake of substrate across the cytoplasmic membrane and efflux of product is unnecessary in this case.
</span>
    </p>
    <p num="0019" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  驚くべきことに、本発明は、デザイナー細胞の効率性はCRS及びグルコースデヒドロゲナーゼ（GDH）活性の双方が同じ宿主で共同発現される場合に一層改善され得るという仮説により機能し、これは多分、そのような生物触媒とともに、補因子（ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）/ニコチンアミドアデニンジヌクレオチドリン酸（NADP））は溶液中に完全に遊離されるのではなく、むしろ該補因子は細胞の表面で非常に近接して配置されるCRSとGDHとの間を水路で運ばれるためであろう。<br class="style-scope patent-text">
  したがって、本発明は、酵素カルボニルレダクターゼ及び補酵素再生系（例えばグルコースデヒドロゲナーゼ）が細胞の表面で一緒に共同発現される設計された形質転換体を提供し、前記形質転換体は、細胞の表面でCRSのみを発現しエチル(S)-4-クロロ-3-オキソブタノエートからエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換に補酵素リサイクリング系のためのGDHの外部添加を必要とする形質転換体と比較して、効率が数倍改善される。<br class="style-scope patent-text">
  本発明は、高生産性及び少なくとも150gl<sup class="style-scope patent-text">-1</sup>の生成物蓄積を示す、工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートの約100％鏡像体過剰の製造方法を提供する。<br class="style-scope patent-text">
  本発明はまた、種々のケトンの不整還元を触媒して鏡像体濃縮アルコールを製造する、大腸菌の組換え株である‘デザイナー細胞’を提供し、前記は、還元剤として還元ニコチンアミドアデニンジヌクレオチドリン酸（NADPH）の触媒量を、ニコチンアミドアデニンジヌクレオチドリン酸（NADP）からニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）への酸化のための補因子リサイクリング系の添加下又は非添加下で用いる。カンジダ・マグノリアエの当該株はAKU4643であり、バシルス・メガテリウムはDSM2894である。
</span>Surprisingly, the present invention works by the hypothesis that the efficiency of designer cells can be further improved when both CRS and glucose dehydrogenase (GDH) activity are coexpressed in the same host, which is probably due to its Cofactors (nicotinamide adenine dinucleotide phosphate reduced form (NADPH) / nicotinamide adenine dinucleotide phosphate (NADP)) along with such biocatalysts are not completely released in solution, but rather the cofactor It may be because it is transported in a water channel between CRS and GDH which are placed in close proximity on the surface of the cell. <br class="style-scope patent-text"> Thus, the present invention provides engineered transformants in which the enzyme carbonyl reductase and coenzyme regeneration system (eg glucose dehydrogenase) are coexpressed together on the surface of the cell, said transformant being on the surface of the cell. External to GDH for Coenzyme Recycling System Expressing CRS Only and Converting Ethyl (S) -4-Chloro-3-oxobutanoate to Ethyl (S) -4-Chloro-3-hydroxybutyrate Efficiency is improved several fold compared to transformants that require addition. <br class="style-scope patent-text"> The present invention provides a process for the production of about 100% enantiomeric excess of industrially important ethyl (S) -4-chloro-3-hydroxybutyrate exhibiting high productivity and product accumulation of at least 150 gl <sup class="style-scope patent-text">-1.</sup> Do. <br class="style-scope patent-text"> The present invention also provides a 'designer cell', a recombinant strain of E. coli, which catalyzes the asymmetric reduction of various ketones to produce enantiomerically enriched alcohols, which comprises reducing nicotinamide adenine dinucleotide as a reducing agent A catalytic amount of phosphoric acid (NADPH), with or without addition of a cofactor recycling system, for oxidation of nicotinamide adenine dinucleotide phosphate (NADP) to nicotinamide adenine dinucleotide phosphate reduced form (NADPH) Used below. The strain of Candida magnoliae is AKU 4643 and Bacillus megaterium is DSM 2894.</span>
    </p>
    <p num="0020" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、配列番号:1、3、5又は7に対応する“CRS”ポリペプチド構築物を含むデザイナー細胞を提供する。本発明に記載するデザイナー細胞は、（a）成熟大腸菌リポタンパク質（Lpp）の最初の9つのN-末端残基に連結されたN-末端20アミノ酸シグナル配列；（b）大腸菌外膜タンパク質A（OmpA）の残基46−159（前記はそのC-末端に融合されたパッセンジャータンパク質を当該膜を通過して輸送すると期待される）；及び（c）CRSの全配列を有し、ここで、CRSは、カンジダ・マグノリアエの野生型カルボニルレダクターゼ、配列番号:13又は改変カルボニルレダクターゼ、配列番号:15、17又は19（いくつかのアミノ酸置換を有することによって配列番号:13と異なる）である。最初の29アミノ酸残基のシグナル＋LppペプチドはGly-Ileリンカーを介して114アミノ酸のOmpA残基に連結され、前記は続いてCRSのN-末端にGly-Ile-Pro-Glyを介して貼り付けられた（図3）。いくつかのアミノ酸置換を有することによって配列番号:13と異なる改変カルボニルレダクターゼは、例えば配列番号:15（P14A、S42N、A194V、I275V）又は配列番号:17（P14A、S42N、V147A、A194V、E234G）又は配列番号:19（E9G、P14A、N20S、S42N、T190A、A194V、E234G）である。
</span>
&nbsp;&nbsp;The present invention provides a designer cell comprising a "CRS" polypeptide construct corresponding to SEQ ID NO: 1, 3, 5 or 7. The designer cell described in the present invention comprises (a) an N-terminal 20 amino acid signal sequence linked to the first nine N-terminal residues of mature E. coli lipoprotein (Lpp); (b) E. coli outer membrane protein A ( Residues 46-159 of OmpA), which are expected to transport the passenger protein fused to its C-terminus across the membrane; and (c) have the full sequence of CRS, where CRS is Candida magnoliae wild type carbonyl reductase, SEQ ID NO: 13 or modified carbonyl reductase, SEQ ID NO: 15, 17 or 19 (different from SEQ ID NO: 13 by having some amino acid substitutions). The first 29 amino acid residue signal + Lpp peptide is linked to the 114 amino acid OmpA residue via the Gly-Ile linker, which is subsequently attached via the Gly-Ile-Pro-Gly to the N-terminus of CRS It was done (Figure 3). Modified carbonyl reductases which differ from SEQ ID NO: 13 by having several amino acid substitutions are for example SEQ ID NO: 15 (P14A, S42N, A194V, I275V) or SEQ ID NO: 17 (P14A, S42N, V147A, A194V, E234G) Or SEQ ID NO: 19 (E9G, P14A, N20S, S42N, T190A, A194V, E234G).
</span>
    </p>
    <p num="0021" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、配列番号:9又は11に対応する“GDH”ポリペプチド構築物を含むデザイナー細胞を提供する。本発明に記載するデザイナー細胞は、（a）成熟大腸菌リポタンパク質（Lpp）の最初の9つのN-末端残基に連結されたN-末端20アミノ酸シグナル配列；（b）大腸菌外膜タンパク質A（OmpA）の残基46−159（前記はそのC-末端に融合されたパッセンジャータンパク質を当該膜を通過して輸送すると期待される）；及び（c）GDHの全配列を有し、ここで、GDHは、バシルス・メガテリウムの野生型グルコースデヒドロゲナーゼ（GDH）、配列番号:21又は改変カルボニルレダクターゼ、配列番号:23（前記はいくつかのアミノ酸置換を有することによって配列番号:21と異なる）である。最初の29アミノ酸残基のシグナル＋LppペプチドはGly-Ileリンカーを介して114アミノ酸のOmpA残基と連結され、前記リンカーは続いてGly-Ile-Pro-Glyを介してCRSのN-末端に貼付された（図3）。いくつかのアミノ酸置換を有することによって配列番号:21と異なる改変グルコースデヒドロゲナーゼは、例えば配列番号:23（S16T、E170K、P194T、A197K、E222D、S237C）である。<br class="style-scope patent-text">
  本発明はまた、使用済み補因子をその反応前の状態に戻すために反応に添加される補因子リサイクリング系（本明細書では一式の試薬を指す）を提供する。例えば、デザイナー細胞によるケトンからアルコールへの変換で、補因子ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）はニコチンアミドアデニンジヌクレオチドリン酸（NADP）（使用済み補因子）に変換される。試薬、GDH及びグルコースの反応への添加は、ニコチンアミドアデニンジヌクレオチドリン酸（NADP）からニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の再生をもたらすであろう。
</span>The invention also provides a designer cell comprising a "GDH" polypeptide construct corresponding to SEQ ID NO: 9 or 11. The designer cell described in the present invention comprises (a) an N-terminal 20 amino acid signal sequence linked to the first nine N-terminal residues of mature E. coli lipoprotein (Lpp); (b) E. coli outer membrane protein A ( Residues 46-159 of OmpA), which are expected to transport the passenger protein fused to its C-terminus across the membrane; and (c) have the full sequence of GDH, where GDH is the wild type glucose dehydrogenase (GDH) of Bacillus megaterium, SEQ ID NO: 21 or a modified carbonyl reductase, SEQ ID NO: 23 (which differs from SEQ ID NO: 21 by having several amino acid substitutions). The first 29 amino acid residue signal + Lpp peptide is linked to the 114 amino acid OmpA residue via the Gly-Ile linker, which is subsequently attached to the N-terminus of CRS via Gly-Ile-Pro-Gly Was done (Figure 3). A modified glucose dehydrogenase which differs from SEQ ID NO: 21 by having several amino acid substitutions is, for example, SEQ ID NO: 23 (S16T, E170K, P194T, A197K, E222D, S237C). <br class="style-scope patent-text"> The present invention also provides a cofactor recycling system (herein referred to as a set of reagents) which is added to the reaction to bring spent cofactor back to its pre-reaction state. For example, cofactor nicotinamide adenine dinucleotide phosphate reduced form (NADPH) is converted to nicotinamide adenine dinucleotide phosphate (NADP) (used cofactor) upon conversion of ketone to alcohol by designer cells. The addition of reagents, GDH and glucose to the reaction will result in the regeneration of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) from nicotinamide adenine dinucleotide phosphate (NADP).</span>
    </p>
    <p num="0022" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に提示する発明は多数の特徴を有する。ある特徴では、本発明は、細胞の表面でCRSポリペプチドを発現する組換え大腸菌株の構築を目的とし、前記組換え大腸菌は、エチル-4-クロロ-3-オキソブチレートのエチル-4-クロロ-3-ヒドロキシブチレートへの還元のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較して、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定したときCRSポリペプチドの単位質量当たり250倍から300倍強化された変換速度を有する。CRSの相対的な量は免疫ブロットによって決定した（実施例7）。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチドを発現する組換え大腸菌株は、種々のケト化合物の変換のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較して、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定したときCRSタンパク質の単位質量当たり約50倍から275倍強化された変換速度を有する。相対的なCRSタンパク質含有量は免疫ブロットによって決定した（実施例7）。
</span>The invention presented herein has a number of features. In one aspect, the present invention is directed to the construction of a recombinant E. coli strain expressing CRS polypeptide on the surface of cells, said recombinant E. coli comprising ethyl-4-ethyl of ethyl-4-chloro-3-oxobutyrate. By reducing the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) as compared to the corresponding E. coli strain of the prior art expressing CRS in the cytoplasm of cells for reduction to chloro-3-hydroxybutyrate. It has a 250- to 300-fold enhanced conversion rate per unit mass of CRS polypeptide as measured. The relative amount of CRS was determined by immunoblot (Example 7). <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain that expresses a CRS polypeptide on the surface of the cell is compared to the corresponding E. coli strain of the prior art that expresses CRS in the cytoplasm of the cell for conversion of various keto compounds, It has an enhanced conversion rate of about 50 to 275 times per unit mass of CRS protein as measured by a decrease in the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH). Relative CRS protein content was determined by immunoblot (Example 7).</span>
    </p>
    <p num="0023" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施態様では、ケトンは下記式3によって表される脂肪族化合物である：
</span>
&nbsp;&nbsp;In one embodiment, the ketone is an aliphatic compound represented by the following Formula 3:
</span>
    </p>
    <p num="0024" class="style-scope patent-text">
      <chemistry id="" num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0025" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>はH、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、XはCl又はBrであり、nは1−4であり、さらにmは1−8である。<br class="style-scope patent-text">
  好ましい実施態様では、R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>は(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">7</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はClであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCF<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>は(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CHであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>である。
</span>In the formula, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">2</sub> is H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> <sub class="style-scope patent-text">3</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X is Cl or Br, n is 1-4, and m is 1-8. <br class="style-scope patent-text"> In a preferred embodiment, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> Is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">7</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is Cl and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CF <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, R <sub class="style-scope patent-text">2</sub> is H, and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> .</span>
    </p>
    <p num="0026" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施態様では、ケトンは下記式4で表される芳香族化合物である:
</span>
&nbsp;&nbsp;In another embodiment, the ketone is an aromatic compound represented by Formula 4 below:
</span>
    </p>
    <p num="0027" class="style-scope patent-text">
      <chemistry id="" num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0028" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。<br class="style-scope patent-text">
  本明細書で記述するように、CRS活性の比較に用いられる従来技術の大腸菌は、カンジダ・マグノリアエの野生型カルボニルレダクターゼ配列番号:13又は改変カルボニルレダクターゼポリペプチド配列番号:15、配列番号:17又は配列番号:19を細胞質で発現する大腸菌株を指す。これらの大腸菌株は米国特許2010/0028972で開示される技術を用いて構築された。
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5; <br class="style-scope patent-text"> As described herein, prior art E. coli used for comparison of CRS activity can be Candida magnoliae wild type carbonyl reductase SEQ ID NO: 13 or modified carbonyl reductase polypeptide SEQ ID NO: 15, SEQ ID NO: 17 Or, it refers to an E. coli strain that expresses SEQ ID NO: 19 in the cytoplasm. These E. coli strains were constructed using the technology disclosed in US Patent 2010/0028972.</span>
    </p>
    <p num="0029" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の特徴では、本発明は、細胞の表面でCRSポリペプチドを発現する組換え大腸菌株の構築を目的とし、前記は、エチル-4-クロロ-3-オキソブチレートのエチル-4-クロロ-3-ヒドロキシブチレートへの還元のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較して、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定したとき単位細胞質量当たり15倍から26倍強化された変換速度を有する。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチドを発現する組換え大腸菌株は、種々のケト化合物の還元のために細胞の細胞質でCRSを発現する従来技術の対応する大腸菌株と比較して、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定したとき単位細胞質量当たり約3倍から26倍強化された変換速度を有する。<br class="style-scope patent-text">
  ある実施態様では、ケトンは式3で表される脂肪族化合物であり、式中R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>はH、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、さらにR<sub class="style-scope patent-text">3</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、XはCl又はBrであり、さらにnは1−4であり、mは1−8である。<br class="style-scope patent-text">
  より好ましい実施態様では、R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>は(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">7</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はClであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCF<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>は(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CHであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>である。<br class="style-scope patent-text">
  別の実施態様では、ケトンは一般式4で表される芳香族化合物であり、式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。
</span>In another aspect, the present invention is directed to the construction of a recombinant E. coli strain expressing CRS polypeptide on the surface of cells, which comprises: ethyl-4-chloro-ethyl-4-chloro-3-oxobutyrate Measured by a decrease in the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) as compared to the corresponding E. coli strain of the prior art expressing CRS in the cytoplasm of cells for reduction to 3-hydroxybutyrate When having a conversion rate of 15 to 26 times enhanced per unit cell mass. <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain that expresses a CRS polypeptide on the surface of the cell is compared to the corresponding E. coli strain of the prior art that expresses CRS in the cytoplasm of the cell for reduction of various keto compounds, It has an enhanced conversion rate of about 3-fold to 26-fold per unit cell mass, as measured by a decrease in the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH). <br class="style-scope patent-text"> In one embodiment, the ketone is an aliphatic compound represented by Formula 3, wherein R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">2</sub> is H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and further R <sub class="style-scope patent-text">3</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X is Cl or Br and further n is It is 1-4 and m is 1-8. <br class="style-scope patent-text"> In a more preferred embodiment, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">7</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is Cl, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CF <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH wherein R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> . <br class="style-scope patent-text"> In another embodiment, the ketone is an aromatic compound represented by the general formula 4 wherein R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub> = alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5.</span>
    </p>
    <p num="0030" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  なお別の特徴では、本発明は、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株の構築を目的とし、前記は、大腸菌細胞の細胞質でCRS及びGDHを同時に発現する大腸菌株と比較して、CRSポリペプチドの単位質量当たりのエチル-4-クロロ-3-オキソブチレートからエチル-4-クロロ-3-ヒドロキシブチレートに還元する変換速度は250倍から300倍強化され、さらにGDHポリペプチドの単位質量当たりのグルコースをグルコネートに酸化する能力は200倍から250倍強化される。CRS活性は、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定した。相対的なCRSポリペプチドの量は免疫ブロットによって決定した（実施例7）。GDH活性及び相対的なGDHポリペプチド量は実施例11に記載するように決定した。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株は、種々のケト化合物の還元のために細胞の細胞質でCRSポリペプチド及びGDHポリペプチドを同時に発現する従来技術の対応する大腸菌株と比較して、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定したときCRSタンパク質の単位質量当たり約50倍から270倍強化された変換速度を有する。相対的なCRSたんぱく質含有量は免疫ブロットによって決定した（実施例7）。<br class="style-scope patent-text">
  ある実施態様では、ケトンは式3で表される脂肪族化合物であり、式中R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>はH、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、さらにR<sub class="style-scope patent-text">3</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり（式中nは1−8である）、XはCl又はBrであり、nは1−4であり、さらにmは1−8である。<br class="style-scope patent-text">
  より好ましい実施態様では、R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>は(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">7</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はClであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCF<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>は(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CHであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>である。<br class="style-scope patent-text">
  別の実施態様では、ケトンは一般式4で表される芳香族化合物であり、式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。
</span>In yet another aspect, the present invention is directed to the construction of a recombinant E. coli strain that simultaneously expresses CRS and GDH polypeptides on the surface of cells, which simultaneously expresses CRS and GDH in the cytoplasm of E. coli cells. The 250 to 300-fold enhancement of the conversion rate from ethyl-4-chloro-3-oxobutyrate to ethyl-4-chloro-3-hydroxybutyrate per unit mass of CRS polypeptide compared to E. coli strains Furthermore, the ability to oxidize glucose per unit mass of GDH polypeptide to gluconate is enhanced 200-fold to 250-fold. CRS activity was measured by the decrease in absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH). The relative amount of CRS polypeptide was determined by immunoblot (Example 7). GDH activity and relative GDH polypeptide amounts were determined as described in Example 11. <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain co-expressing a CRS polypeptide and a GDH polypeptide on the surface of a cell co-expresses a CRS polypeptide and a GDH polypeptide in the cytoplasm of the cell for reduction of various keto compounds. An approximately 50-fold to 270-fold enhanced conversion rate per unit mass of CRS protein as measured by a decrease in the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) compared to the corresponding E. coli strain of the prior art Have. Relative CRS protein content was determined by immunoblot (Example 7). <br class="style-scope patent-text"> In one embodiment, the ketone is an aliphatic compound represented by Formula 3, wherein R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">2</sub> is H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , further R <sub class="style-scope patent-text">3</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , wherein n is 1-8, X is Cl or Br, n is 1-4, and m is 1-8. <br class="style-scope patent-text"> In a more preferred embodiment, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">7</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is Cl, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CF <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH wherein R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> . <br class="style-scope patent-text"> In another embodiment, the ketone is an aromatic compound represented by the general formula 4 wherein R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub> = alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5.</span>
    </p>
    <p num="0031" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に記述するように、CRS及びGDH活性の比較に用いられる従来技術の大腸菌は、カンジダ・マグノリアエの野生型カルボニルレダクターゼ配列番号:13及びバシルス・メガテリウムの野生型グルコースデヒドロゲナーゼ配列番号:21を細胞質で共同発現する大腸菌株に該当する。これらの大腸菌株は以下の文献に開示された技術を用いて構築された（Kizaki, N.et al.Applied Microbiology and Biotechnology 2001, 55, 590-595）。さらにまた、前記は、配列番号:15、配列番号:17又は配列番号:19から選択される変種カルボニルレダクターゼ、及び配列番号:21配列番号:23から選択される変種グルコースデヒドロゲナーゼを細胞質で共同発現する大腸菌株に該当する。これらの大腸菌株は、ペプチド配列、これらペプチド配列をコードする対応ヌクレオチド配列及び発現ベクターに関して以下の文献に開示された情報に基づいて構築された：Applied and Microbial Technology, 55:5590-595(2001)；米国特許2010/0028972及び米国特許2010/7816111。
</span>
&nbsp;&nbsp;As described herein, prior art E. coli used for comparison of CRS and GDH activities are Candida magnoliae wild type carbonyl reductase SEQ ID NO: 13 and Bacillus megaterium wild type glucose dehydrogenase SEQ ID NO: 21 Corresponds to the E. coli strain co-expressing in the cytoplasm. These E. coli strains were constructed using the techniques disclosed in the following literature (Kizaki, N. et al. Applied Microbiology and Biotechnology 2001, 55, 590-595). Furthermore, it co-expresses cytoplasmically a variant carbonyl reductase selected from SEQ ID NO: 15, SEQ ID NO: 17 or SEQ ID NO: 19 and a variant glucose dehydrogenase selected from SEQ ID NO: 21 SEQ ID NO: 23 It corresponds to E. coli strain. These E. coli strains were constructed based on the peptide sequences, the corresponding nucleotide sequences encoding these peptide sequences and the information disclosed in the following document regarding expression vectors: Applied and Microbial Technology, 55: 5590-595 (2001) U.S. Patent 2010/0028972 and U.S. Patent 2010/7816111.
</span>
    </p>
    <p num="0032" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の特徴では、本発明は、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株の構築を目的とし、前記は、大腸菌細胞の細胞質でCRS及びGDHを同時に発現する大腸菌株と比較して、エチル-4-クロロ-3-オキソブチレートからエチル-4-クロロ-3-ヒドロキシブチレートへの還元について単位細胞質量当たり11倍倍から24倍強化された活性、及びグルコースからグルコネートへの酸化について単位細胞質量当たり9倍から31倍強化された活性を有する。CRS活性は、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定した。GDH活性は、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定した（実施例11）。<br class="style-scope patent-text">
  ある実施態様では、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する組換え大腸菌株は、種々のケト化合物の還元のために細胞の細胞質でCRSポリペプチド及びGDHポリペプチドを同時に発現する従来技術の対応する大腸菌株と比較して、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収の低下によって測定したとき単位細胞質量当たり約3倍から24倍強化された変換速度を有する。<br class="style-scope patent-text">
  ある実施態様では、ケトンは式3で表される脂肪族化合物であり、式中R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>はH、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、さらにR<sub class="style-scope patent-text">3</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり（式中nは1−8である）、XはCl又はBrであり、nは1−4であり、さらにmは1−8である。<br class="style-scope patent-text">
  より好ましい実施態様では、R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>は(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">7</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はClであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCF<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>は(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CHであり、R<sub class="style-scope patent-text">2</sub>はHであり、R<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>である。<br class="style-scope patent-text">
  別の実施態様では、ケトンは一般式4で表される芳香族化合物であり、式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。
</span>In another aspect, the present invention is directed to the construction of a recombinant E. coli strain that simultaneously expresses CRS and GDH polypeptides on the surface of cells, which simultaneously expresses CRS and GDH in the cytoplasm of E. coli cells. An 11-fold to 24-fold enhanced activity per unit cell mass for the reduction of ethyl-4-chloro-3-oxobutyrate to ethyl-4-chloro-3-hydroxybutyrate as compared to the strain, and glucose To 9-fold to 31-fold enhanced activity per unit cell mass for oxidation to gluconate. CRS activity was measured by the decrease in absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH). GDH activity was measured by the reduction of the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) (Example 11). <br class="style-scope patent-text"> In one embodiment, a recombinant E. coli strain co-expressing a CRS polypeptide and a GDH polypeptide on the surface of a cell co-expresses a CRS polypeptide and a GDH polypeptide in the cytoplasm of the cell for reduction of various keto compounds. It has an approximately 3- to 24-fold enhanced conversion rate per unit cell mass as measured by a reduction in the absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) as compared to the corresponding E. coli strain of the prior art. <br class="style-scope patent-text"> In one embodiment, the ketone is an aliphatic compound represented by Formula 3, wherein R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">2</sub> is H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , further R <sub class="style-scope patent-text">3</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , wherein n is 1-8, X is Cl or Br, n is 1-4, and m is 1-8. <br class="style-scope patent-text"> In a more preferred embodiment, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">7</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is Cl, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CF <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is H, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH wherein R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> . <br class="style-scope patent-text"> In another embodiment, the ketone is an aromatic compound represented by the general formula 4 wherein R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub> = alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5.</span>
    </p>
    <p num="0033" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  したがって、本発明の目的は、配列リストの配列番号:1、3、5又は7から選択され配列リストの配列番号:1、3、5又は7のアミノ酸配列に1つ又はいくつかのアミノ酸の欠失、置換又は付加を含む、形質転換体の表面で発現されるアミノ酸配列を有し、カルボニルレダクターゼ活性を有するデザイナー細胞を提供することである。<br class="style-scope patent-text">
  上記ポリペプチドをコードする本発明のDNAは、配列リストの配列番号:2、4、6又は8から選択されるヌクレオチド配列を有する。<br class="style-scope patent-text">
  上記ポリペプチドをコードする本発明のプラスミドはpET23(a)-omp-CRSである。<br class="style-scope patent-text">
  本記載中では、アミノ酸配列は奇数を割り当てられている。具体的なアミノ酸をコードするヌクレオチド配列は直ぐ次の偶数を割り当てられている。例えば、配列番号:1のアミノ酸については、対応するコードヌクレオチド配列は配列番号:2の配列を割り当てられている。<br class="style-scope patent-text">
  形質転換体を作製するために本発明にしたがって用いられる細胞は、大腸菌BL21(DE3)、大腸菌C41(DE3)又は大腸菌C43(DE3)から選択される。<br class="style-scope patent-text">
  本発明にしたがって用いられる形質転換細胞は、上記プラスミドpET23(a)-omp-CRSで形質転換される細胞の形質転換体である。<br class="style-scope patent-text">
  好ましい実施態様では、形質転換細胞は大腸菌BL21(DE3)+pET23(a)-omp-CRSである。<br class="style-scope patent-text">
  より好ましい実施態様では、形質転換細胞は大腸菌C41(DE3)+pET23(a)-omp-CRSである。
</span>Thus, the object of the present invention is to select from the sequence list SEQ ID NO: 1, 3, 5 or 7 and lack one or several amino acids in the amino acid sequence of the sequence list SEQ ID NO: 1, 3, 5 or 7 It is to provide a designer cell having an amino acid sequence expressed on the surface of a transformant, including deletion, substitution or addition, and having carbonyl reductase activity. <br class="style-scope patent-text"> The DNA of the present invention encoding the above polypeptide has a nucleotide sequence selected from SEQ ID NO: 2, 4, 6 or 8 in the Sequence Listing. <br class="style-scope patent-text"> The plasmid of the present invention encoding the above polypeptide is pET23 (a) -omp-CRS. <br class="style-scope patent-text"> In the present description, the amino acid sequences are assigned odd numbers. The nucleotide sequence encoding a specific amino acid is assigned the next even number. For example, for the amino acids of SEQ ID NO: 1, the corresponding coding nucleotide sequence is assigned the sequence of SEQ ID NO: 2. <br class="style-scope patent-text"> The cells used according to the present invention to produce transformants are selected from E. coli BL21 (DE3), E. coli C41 (DE3) or E. coli C43 (DE3). <br class="style-scope patent-text"> The transformant used in accordance with the present invention is a transformant of a cell transformed with the plasmid pET23 (a) -omp-CRS. <br class="style-scope patent-text"> In a preferred embodiment, the transformed cell is E. coli BL21 (DE3) + pET23 (a) -omp-CRS. <br class="style-scope patent-text"> In a more preferred embodiment, the transformed cell is E. coli C41 (DE3) + pET23 (a) -omp-CRS.</span>
    </p>
    <p num="0034" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  好ましい実施態様では、デザイナー細胞は、配列リストの配列番号:1のアミノ酸配列に1つ又はいくつかのアミノ酸の欠失、置換又は付加を含む、形質転換体の表面で発現される配列リストの配列番号:1のアミノ酸配列を有し、カルボニルレダクターゼ活性を有する。<br class="style-scope patent-text">
  上記ポリペプチドのDNAは配列番号:2のヌクレオチド配列を有する。<br class="style-scope patent-text">
  上記ポリペプチドをコードする本発明のプラスミドはpET23(a)-omp-CRSである。<br class="style-scope patent-text">
  形質転換体を作製するために本発明にしたがって用いられる細胞は、大腸菌BL21(DE3)、大腸菌C41(DE3)又は大腸菌C43(DE3)から選択される。<br class="style-scope patent-text">
  本発明にしたがって用いられる形質転換細胞は、上記プラスミドpET23(a)-omp-CRSで形質転換される細胞の形質転換体である。<br class="style-scope patent-text">
  好ましい実施態様では、形質転換細胞は大腸菌BL21(DE3)+pET23(a)-omp-CRSである。<br class="style-scope patent-text">
  より好ましい実施態様では、形質転換細胞は大腸菌C41(DE3)+pET23(a)-omp-CRSである。
</span>In a preferred embodiment, the designer cell is a sequence list sequence expressed on the surface of a transformant, which comprises a deletion, substitution or addition of one or several amino acids in the amino acid sequence of SEQ ID NO: 1 in the sequence list It has the amino acid sequence of No. 1 and has carbonyl reductase activity. <br class="style-scope patent-text"> The DNA of the above polypeptide has the nucleotide sequence of SEQ ID NO: 2. <br class="style-scope patent-text"> The plasmid of the present invention encoding the above polypeptide is pET23 (a) -omp-CRS. <br class="style-scope patent-text"> The cells used according to the present invention to produce transformants are selected from E. coli BL21 (DE3), E. coli C41 (DE3) or E. coli C43 (DE3). <br class="style-scope patent-text"> The transformant used in accordance with the present invention is a transformant of a cell transformed with the plasmid pET23 (a) -omp-CRS. <br class="style-scope patent-text"> In a preferred embodiment, the transformed cell is E. coli BL21 (DE3) + pET23 (a) -omp-CRS. <br class="style-scope patent-text"> In a more preferred embodiment, the transformed cell is E. coli C41 (DE3) + pET23 (a) -omp-CRS.</span>
    </p>
    <p num="0035" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  工業的に重要で光学的に純粋なアルコール（エチル(S)-4-クロロ-3-ヒドロキシブチレートを含む）を製造するために基質（エチル-4-クロロ-3-オキソブチレートを含む）のカルボニル基を不整還元する、本発明の形質転換体は補酵素ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を要求する。反応が進行するにつれて、補酵素は酸化型ニコチンアミドアデニンジヌクレオチドリン酸（NADP）に変換される。酸化型から還元型への変換は、補酵素再生能力を有する別の酵素（例えばグルコースデヒドロゲナーゼ）を必要とする。<br class="style-scope patent-text">
  ある実施態様では、グルコースデヒドロゲナーゼはバシルス・メガテリウムから誘導される。<br class="style-scope patent-text">
  本発明の別の目的は、形質転換体の表面で2つのポリペプチド（一方はCRS活性を有し、他方はGDH活性を有する）を共同発現するデザイナー細胞を提供することである。前記CRS活性を有するポリペプチドは、配列リストの配列番号:1、3、5又は7のアミノ酸配列に1つ又はいくつかのアミノ酸の欠失、置換又は付加を含む、配列リストの配列番号:1、3、5又は7から選択されるアミノ酸配列を有し、前記は効率的にエチル(S)-4-クロロ-3-ヒドロキシブチレートを還元し、さらに他方のポリペプチドは、配列リストの配列番号:9又は11のアミノ酸配列に1つ又はいくつかのアミノ酸の欠失、置換又は付加を含む、配列リストの配列番号:9又は11から選択されるアミノ酸配列を有し、光学的に純粋なエチル(S)-4-クロロ-3-ヒドロキシブチレートの製造のために補酵素再生活性を有する。
</span>Substrates (including ethyl-4-chloro-3-oxobutyrate) to produce industrially important optically pure alcohols (including ethyl (S) -4-chloro-3-hydroxybutyrate) The transformant of the present invention, which asymmetrically reduces the carbonyl group of (1), requires coenzyme nicotinamide adenine dinucleotide phosphate reduced form (NADPH). As the reaction proceeds, the coenzyme is converted to oxidized nicotinamide adenine dinucleotide phosphate (NADP). Conversion from the oxidized form to the reduced form requires another enzyme (eg, glucose dehydrogenase) with coenzyme regenerating ability. <br class="style-scope patent-text"> In one embodiment, glucose dehydrogenase is derived from Bacillus megaterium. <br class="style-scope patent-text"> Another object of the present invention is to provide a designer cell which co-expresses two polypeptides (one having CRS activity and the other having GDH activity) on the surface of a transformant. The polypeptide having the CRS activity comprises the deletion, substitution or addition of one or several amino acids in the amino acid sequence of SEQ ID NO: 1, 3, 5 or 7 in SEQ ID NO: 1, , 3, 5 or 7, which efficiently reduces ethyl (S) -4-chloro-3-hydroxybutyrate, and the other polypeptide has the sequence of the sequence listing Optically pure, having an amino acid sequence selected from SEQ ID NO: 9 or 11 in the Sequence Listing, including deletion, substitution or addition of one or several amino acids in the amino acid sequence of No. 9 or 11 It has coenzyme regenerating activity for the production of ethyl (S) -4-chloro-3-hydroxybutyrate.</span>
    </p>
    <p num="0036" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  カルボニルレダクターゼ活性を有する上記ポリペプチドをコードする本発明のDNAは、配列リストの配列番号:2、4、6又は8から選択されるヌクレオチド配列を有し、補酵素再生酵素をコードする本発明のDNAは配列リストの配列番号:10又は12から選択されるヌクレオチド配列を有する。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性及び補酵素再生能力を有する両ポリペプチドをコードする本発明のプラスミドはpETDuet1-omp-CRS,omp-GDHである。<br class="style-scope patent-text">
  本発明にしたがって用いられる形質転換細胞は、上記プラスミドpETDuet1-omp-CRS,omp-GDHで形質転換される細胞の形質転換体である。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性及び補酵素再生能力の双方を有する形質転換体を作製するために本発明にしたがって用いられる細胞は、大腸菌BL21(DE3)、大腸菌C41(DE3)又は大腸菌C43(DE3)から選択される。<br class="style-scope patent-text">
  好ましい実施態様では、形質転換細胞は大腸菌BL21(DE3)+pETDuet1-omp-CRS,omp-GDHである。<br class="style-scope patent-text">
  より好ましい実施態様では、形質転換細胞は大腸菌C41(DE3)+pETDuet1-omp-CRS,omp-GDHである。
</span>The DNA of the present invention encoding the above polypeptide having a carbonyl reductase activity has a nucleotide sequence selected from SEQ ID NO: 2, 4, 6 or 8 in the sequence listing, and which encodes a coenzyme regenerating enzyme of the present invention The DNA has a nucleotide sequence selected from SEQ ID NO: 10 or 12 in the Sequence Listing. <br class="style-scope patent-text"> The plasmid of the present invention encoding both polypeptides having carbonyl reductase activity and coenzyme regeneration ability is pETDuet1-omp-CRS, omp-GDH. <br class="style-scope patent-text"> The transformant used in accordance with the present invention is a transformant of a cell transformed with the plasmid pETDuet1-omp-CRS, omp-GDH. <br class="style-scope patent-text"> The cells used according to the invention to produce transformants having both carbonyl reductase activity and coenzyme regenerating ability are selected from E. coli BL21 (DE3), E. coli C41 (DE3) or E. coli C43 (DE3) . <br class="style-scope patent-text"> In a preferred embodiment, the transformed cell is E. coli BL21 (DE3) + pETDuet1-omp-CRS, omp-GDH. <br class="style-scope patent-text"> In a more preferred embodiment, the transformed cell is E. coli C41 (DE3) + pETDuet1-omp-CRS, omp-GDH.</span>
    </p>
    <p num="0037" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  好ましい実施態様では、形質転換体の表面で2つのポリペプチド（一方はCRS活性を有し、他方はGDH活性を有する）を共同発現する形質転換体は、配列リストの配列番号:1のアミノ酸配列に1つ又はいくつかのアミノ酸の欠失、置換又は付加を含む、配列リストの配列番号:1のアミノ酸配列を有し、前記は効率的にエチル(S)-4-クロロ-3-ヒドロキシブチレートを還元し、さらに他方のポリペプチドは、配列リストの配列番号:9のアミノ酸配列に1つ又はいくつかのアミノ酸の欠失、置換又は付加を含む、配列リストの配列番号:9のアミノ酸配列を有し、光学的に純粋なエチル(S)-4-クロロ-3-ヒドロキシブチレートの製造のために補酵素再生活性を有する。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有する上記ポリペプチドをコードする本発明のDNAは、配列リストの配列番号:2のヌクレオチド配列を有し、補酵素再生酵素をコードする本発明のDNAは配列リストの配列番号:10のヌクレオチド配列を有する。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性及び補酵素再生能力を有する両ポリペプチドをコードする本発明のプラスミドはpETDuet1-omp-CRS;omp-GDHである。<br class="style-scope patent-text">
  本発明にしたがって用いられる形質転換細胞は、上記プラスミドpETDuet1-omp-CRS;omp-GDHで形質転換される細胞の形質転換体である。<br class="style-scope patent-text">
  好ましい実施態様では、形質転換細胞は大腸菌BL21(DE3)+pETDuet1-omp-CRS,omp-GDHである。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性及び補酵素再生能力の双方を有する形質転換体を作製するために本発明にしたがって用いられる細胞は、大腸菌BL21(DE3)、大腸菌C41(DE3)又は大腸菌C43(DE3)から選択される。<br class="style-scope patent-text">
  より好ましい実施態様では、形質転換細胞は大腸菌C41(DE3)+pETDuet1-omp-CRS;omp-GDHである。
</span>In a preferred embodiment, a transformant co-expressing two polypeptides (one having CRS activity and the other having GDH activity) on the surface of the transformant has the amino acid sequence of SEQ ID NO: 1 in the sequence listing. Have the amino acid sequence of SEQ ID NO: 1 in the Sequence Listing, including the deletion, substitution or addition of one or several amino acids in And the other polypeptide comprises the amino acid sequence of SEQ ID NO: 9 of SEQ ID NO: 9 including the deletion, substitution or addition of one or several amino acids in the amino acid sequence of SEQ ID NO: 9 of SEQ ID NO: And has coenzyme regenerating activity for the preparation of optically pure ethyl (S) -4-chloro-3-hydroxybutyrate. <br class="style-scope patent-text"> The DNA of the present invention encoding the above polypeptide having carbonyl reductase activity has the nucleotide sequence of SEQ ID NO: 2 in the sequence listing, and the DNA of the present invention encoding the coenzyme regenerating enzyme has the sequence number SEQ ID NO: 10 Have the nucleotide sequence of <br class="style-scope patent-text"> The plasmid of the present invention encoding both polypeptides having carbonyl reductase activity and coenzyme regeneration ability is pETDuet1-omp-CRS; omp-GDH. <br class="style-scope patent-text"> The transformant used in accordance with the present invention is a transformant of a cell transformed with the above plasmid pETDuet1-omp-CRS; omp-GDH. <br class="style-scope patent-text"> In a preferred embodiment, the transformed cell is E. coli BL21 (DE3) + pETDuet1-omp-CRS, omp-GDH. <br class="style-scope patent-text"> The cells used according to the invention to produce transformants having both carbonyl reductase activity and coenzyme regenerating ability are selected from E. coli BL21 (DE3), E. coli C41 (DE3) or E. coli C43 (DE3) . <br class="style-scope patent-text"> In a more preferred embodiment, the transformed cell is E. coli C41 (DE3) + pETDuet1-omp-CRS; omp-GDH.</span>
    </p>
    <p num="0038" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の目的は、工業的に重要で光学的に活性なアルコールを製造するための製造方法を提供することであり、前記は、形質転換体の培養条件、培養の採集、カルボニル基を有する基質のための反応条件、及び製造された光学的に活性なアルコールの採集を含む。<br class="style-scope patent-text">
  ある実施態様では、ケトンは式3で表される脂肪族化合物であり、生成される光学的に活性なアルコールは下記式5で表される：
</span>Another object of the present invention is to provide a production method for producing an industrially important optically active alcohol, which comprises culture conditions of transformant, collection of culture, carbonyl group, Reaction conditions for the substrate to have, and collection of the optically active alcohol produced. <br class="style-scope patent-text"> In one embodiment, the ketone is an aliphatic compound of Formula 3 and the optically active alcohol produced is represented by Formula 5:</span>
    </p>
    <p num="0039" class="style-scope patent-text">
      <chemistry id="" num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0040" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。<br class="style-scope patent-text">
  より好ましい実施態様では、R<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">2</sub>Clであり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>は(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">7</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はClであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>はCF<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>であるか、又はR<sub class="style-scope patent-text">1</sub>は(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CHであり、R<sub class="style-scope patent-text">2</sub>はHであり、さらにR<sub class="style-scope patent-text">3</sub>はCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>である。<br class="style-scope patent-text">
  別の実施態様では、ケトンは式4で表される芳香族化合物であり、生成される光学的に活性なアルコールは下記式6で表される：
</span>In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2)</sub> <sub class="style-scope patent-text">m,</sub> an X = Cl or Br, n = a 1-4, a further m = 1-8. <br class="style-scope patent-text"> In a more preferred embodiment, R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H and further R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">2</sub> is H, Further, R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">2</sub> Cl, R <sub class="style-scope patent-text">2</sub> is H, and R <sub class="style-scope patent-text">3</sub> is (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">7</sub> CH <sub class="style-scope patent-text">3</sub> , or R <sub class="style-scope patent-text">1</sub> is CH <sub class="style-scope patent-text">3</sub> R <sub class="style-scope patent-text">2</sub> is Cl and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> or R <sub class="style-scope patent-text">1</sub> is CF <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">2</sub> is H and R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> , Or R <sub class="style-scope patent-text">1</sub> is (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, R <sub class="style-scope patent-text">2</sub> is H, and further R <sub class="style-scope patent-text">3</sub> is CH <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> . <br class="style-scope patent-text"> In another embodiment, the ketone is an aromatic compound represented by Formula 4 and the optically active alcohol produced is represented by Formula 6 below:</span>
    </p>
    <p num="0041" class="style-scope patent-text">
      <chemistry id="" num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0042" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>はアルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、さらにnは1から5である。
</span>In the formula, R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 3R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> 5R <sub class="style-scope patent-text">5 、</sub> H, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , and R <sub class="style-scope patent-text">6</sub> is an alkyl group such as CH <sub class="style-scope patent-text">3</sub> Or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , further n is 1 to 5;</span>
    </p>
    <p num="0043" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  デザイナー全細胞生物触媒は遠心分離又はろ過によって発酵ブロスから単離できる。単離された生物触媒はそのようなものとして又は凍結乾燥粉末として用いることができる。カルボニル化合物からヒドロキシル化合物へのバイオ転換のために、生物触媒は、pH5.0−9.0（最適にはpH6.5）の適切な緩衝剤中に、10−45℃（最適には30℃）の温度で懸濁させることができる。最適には、溶剤（例えばジエチルエーテル、ジ-n-ブチルエーテル、メチルn-ブチルエーテル、酢酸エチル、酢酸ブチルなど）を反応混合物に添加できる。内容物をオービタルシェーカー上で活発に混合又は震盪することができる。<br class="style-scope patent-text">
  好ましい実施態様では、反応は、カルボニル化合物を全細胞生物触媒とジ-n-ブチルエーテルを含む30℃のリン酸緩衝液（pH6.5）中で接触させることによって実施される。
</span>Designer whole cell biocatalysts can be isolated from the fermentation broth by centrifugation or filtration. The isolated biocatalyst can be used as such or as a lyophilized powder. For bioconversion of carbonyl compounds to hydroxyl compounds, the biocatalyst is at 10-45 ° C. (optimally 30 ° C.) in a suitable buffer of pH 5.0-9.0 (optimally pH 6.5). It can be suspended at temperature. Optimally, solvents such as diethyl ether, di-n-butyl ether, methyl n-butyl ether, ethyl acetate, butyl acetate etc. can be added to the reaction mixture. The contents can be vigorously mixed or shaken on an orbital shaker. <br class="style-scope patent-text"> In a preferred embodiment, the reaction is carried out by contacting the carbonyl compound with the whole cell biocatalyst in 30 ° C. phosphate buffer (pH 6.5) containing di-n-butyl ether.</span>
    </p>
    <p num="0044" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  具体的な実施態様では、本発明は、工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートを約100％鏡像体過剰で製造するための製造方法を提供し、前記方法は以下の工程を含む：<br class="style-scope patent-text">
（i）エチル(S)-4-クロロ-3-オキソブチレートを提供する工程、及び<br class="style-scope patent-text">
（ii）前記エチル(S)-4-クロロ-3-オキソブチレートを、細胞の表面でCRSポリペプチドを発現する大腸菌株BL21(DE3)、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）、グルコースデヒドロゲナーゼ及び緩衝溶液と接触させて、エチル(S)-4-クロロ-3-オキソブチレートをエチル(S)-4-クロロ-3-ヒドロキシブチレートに変換するための反応混合物を形成する工程。場合によって、有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を前記反応混合物に添加することができる。<br class="style-scope patent-text">
  なお別の具体的な実施態様では、本発明は、工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートを約100％鏡像体過剰及び高収量で、エチル(S)-4-クロロ-3-オキソブチレートのデザイナー全細胞生物触媒還元を介して製造する製造方法を提供し、前記方法は以下の工程を含む：<br class="style-scope patent-text">
（i）エチル(S)-4-クロロ-3-オキソブチレートを提供する工程、及び<br class="style-scope patent-text">
（ii）前記エチル(S)-4-クロロ-3-オキソブチレートを、細胞の表面でCRSポリペプチド及びGDHポリペプチドを同時に発現する大腸菌株BL21(DE3)、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び緩衝溶液と接触させて、エチル(S)-4-クロロ-3-オキソブチレートをエチル(S)-4-クロロ-3-ヒドロキシブチレートに変換するための反応混合物を形成する工程。場合によって、有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を前記反応混合物に添加することができる。
</span>In a specific embodiment, the present invention provides a process for producing industrially important ethyl (S) -4-chloro-3-hydroxybutyrate in about 100% enantiomeric excess, said process Includes the following steps: <br class="style-scope patent-text"> (I) providing ethyl (S) -4-chloro-3-oxobutyrate, and (ii) CRS polypeptide at the surface of the cell, said ethyl (S) -4-chloro-3-oxobutyrate E. coli strain BL21 (DE3) expressing E. coli, nicotinamide adenine dinucleotide phosphate reduced form (NADPH), glucose dehydrogenase and a buffer solution to contact ethyl (S) -4-chloro-3-oxobutyrate S) forming a reaction mixture for conversion to 4-chloro-3-hydroxybutyrate. Optionally, an organic solvent (eg ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) can be added to the reaction mixture. <br class="style-scope patent-text"> In yet another specific embodiment, the present invention provides ethyl (S)-, which is an industrially important ethyl (S) -4-chloro-3-hydroxybutyrate in about 100% enantiomeric excess and in high yield. Provided is a process for the preparation of 4-chloro-3-oxobutyrate via designer whole cell biocatalytic reduction, said process comprising the steps of: <br class="style-scope patent-text"> (I) providing ethyl (S) -4-chloro-3-oxobutyrate, and (ii) CRS polypeptide at the surface of the cell, said ethyl (S) -4-chloro-3-oxobutyrate E. coli strain BL21 (DE3) co-expressing GDH polypeptide and nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and a buffer solution to give ethyl (S) -4-chloro-3-oxobutyrate Forming a reaction mixture for conversion to ethyl (S) -4-chloro-3-hydroxybutyrate. Optionally, an organic solvent (eg ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) can be added to the reaction mixture.</span>
    </p>
    <p num="0045" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  好ましい実施態様では、補因子としてニコチンアミドアデニンジヌクレオチドリン酸還元型（NAPDH）を用いる、エチル-4-クロロ-3-オキソブチレートからエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換速度は、CRSポリペプチド及びGDHポリペプチドを細胞の表面で同時に発現する大腸菌株BL21(DE3)を、CRSポリペプチド及びGDHポリペプチドを細胞の表面で同時に発現する大腸菌株C41(DE3)で取り替えると1.3倍高い。<br class="style-scope patent-text">
  好ましい実施態様では、補因子としてニコチンアミドアデニンジヌクレオチドリン酸還元型（NAPDH）を用いる、エチル-4-クロロ-3-オキソブチレートからエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換速度は、CRSポリペプチドのみを細胞の表面で発現し補因子リサイクリング用外部GDHの添加を要求する大腸菌株BL21(DE3)と比較して、CRSポリペプチド及びGDHポリペプチドを細胞の表面で同時に発現する大腸菌株C41(DE3)で約1.6倍高い。<br class="style-scope patent-text">
  具体的な実施態様では、本発明は、工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートを約100％鏡像体過剰で、高い生産性及び少なくとも150gl<sup class="style-scope patent-text">-1</sup>の生成物蓄積で製造する製造方法を提供する。
</span>In a preferred embodiment, ethyl-4-chloro-3-oxobutyrate to ethyl (S) -4-chloro-3-hydroxybutyrate using nicotinamide adenine dinucleotide phosphate reduced form (NAPDH) as a cofactor The rate of conversion of E. coli strain BL21 (DE3) co-expressing CRS polypeptide and GDH polypeptide on the cell surface, E. coli strain C41 (DE3) co-expressing CRS polypeptide and GDH polypeptide on the cell surface When replaced, it is 1.3 times higher. <br class="style-scope patent-text"> In a preferred embodiment, ethyl-4-chloro-3-oxobutyrate to ethyl (S) -4-chloro-3-hydroxybutyrate using nicotinamide adenine dinucleotide phosphate reduced form (NAPDH) as a cofactor The rate of conversion of CRS polypeptide and GDH polypeptide on the surface of the cell is as compared to E. coli strain BL21 (DE3), which expresses CRS polypeptide alone on the surface of the cell and requires the addition of external GDH for cofactor recycling. Is approximately 1.6 times higher in E. coli strain C41 (DE3) simultaneously expressed in <br class="style-scope patent-text"> In a specific embodiment, the present invention is a product of high productivity and at least 150 gl- <sup class="style-scope patent-text">1</sup> with about 100% enantiomeric excess of industrially important ethyl (S) -4-chloro-3-hydroxybutyrate. To provide a manufacturing method to manufacture by accumulation.</span>
    </p>
    <p num="0046" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  したがって、本発明の主要な実施態様はデザイナー細胞を提供し、前記デザイナー細胞は、配列リストの配列番号:1、3、5又は7から選択される配列の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、下記式1のエチル-4-クロロ-3-オキソブチレートから下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために配列リストの配列番号:13又は15又は17又は19の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較してCRSポリペプチドの単位質量当たり250倍から300倍高い活性を有する：
</span>
&nbsp;&nbsp;Thus, a major embodiment of the present invention provides a designer cell, said designer cell comprising a non-naturally occurring carbonyl reductase polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 of the sequence listing. Of the sequence list for conversion from ethyl-4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 1 Nos. 13 or 15 or 17 or 19 corresponding carbonyl reductase have a 250 to 300 times higher activity per unit mass of CRS polypeptide as compared to designer cells expressing in the cytoplasm of the cell:
</span>
    </p>
    <p num="0047" class="style-scope patent-text">
      <chemistry id="" num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0048" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、式1のエチル-4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために配列リストの配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較してCRSポリペプチドの単位質量当たり約275倍高い活性を有する。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列リストの配列番号:1、3、5又は7から選択される配列の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、式1のエチル-4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために配列リストの配列番号:13又は15又は17又は19の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して単位細胞質量当たり15倍から26倍高い活性を有する。
</span>Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell expresses at the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 of the Sequence Listing, For the conversion of ethyl-4-chloro-3-oxobutyrate to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2, the corresponding carbonyl reductase of SEQ ID NO: 13 in the cell is It has about 275 times higher activity per unit mass of CRS polypeptide compared to cytoplasmically expressed designer cells. <br class="style-scope patent-text"> Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell is a non-naturally occurring carbonyl reductase polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 of the sequence listing Is expressed on the surface of the cell, and the sequence of the sequence listing is for conversion of ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 No. 13 or 15 or 17 or 19 corresponding carbonyl reductase has a 15 to 26 times higher activity per unit cell mass as compared to designer cells expressing in the cytoplasm of the cells.</span>
    </p>
    <p num="0049" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、式1のエチル-4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために配列リストの配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して単位細胞質量当たり少なくとも15倍高い活性を有する。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、下記式3の化合物の還元のために配列リストの配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較してCRSポリペプチドの単位質量当たり50倍から275倍高い活性を有する：
</span>Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell expresses at the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 of the Sequence Listing, For the conversion of ethyl-4-chloro-3-oxobutyrate to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2, the corresponding carbonyl reductase of SEQ ID NO: 13 in the cell is It has at least 15 times higher activity per unit cell mass compared to cytoplasmically expressed designer cells. <br class="style-scope patent-text"> Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell expresses the non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 on the surface of the cell, as shown in formula 3 Has a 50- to 275-fold higher activity per unit mass of CRS polypeptide as compared to designer cells that express in the cytoplasm of the corresponding carbonyl reductase of sequence listing SEQ ID NO: 13 for reduction of compounds of:</span>
    </p>
    <p num="0050" class="style-scope patent-text">
      <chemistry id="" num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0051" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、下記式4の化合物の還元のために配列リストの配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較してCRSポリペプチドの単位質量当たり50倍から180倍高い活性を有する：
</span>In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2)</sub> <sub class="style-scope patent-text">m,</sub> an X = Cl or Br, n = a 1-4, a further m = 1-8. <br class="style-scope patent-text"> Another embodiment of the present invention provides a designer cell according to the present invention, wherein the cell expresses the non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 on the surface of the cell in the sequence list, Have a 50-fold to 180-fold higher activity per unit mass of CRS polypeptide as compared to designer cells that express in the cytoplasm of the corresponding carbonyl reductase of the sequence list SEQ ID NO: 13 for reduction of compounds of:</span>
    </p>
    <p num="0052" class="style-scope patent-text">
      <chemistry id="" num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0053" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、下記式3の化合物又は下記式4の化合物の還元のために配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して単位細胞質量当たり約3倍から15倍高い活性を有する：
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5; <br class="style-scope patent-text"> Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell expresses the non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 on the surface of the cell, as shown in formula 3 Of about 3 to 15 times higher activity per unit cell mass as compared to designer cells expressing the corresponding carbonyl reductase of SEQ ID NO: 13 in the cytoplasm of the cell for reduction of a compound of formula 4 or a compound of formula 4</span>
    </p>
    <p num="0054" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="9" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry>
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8であって；
</span> <chemistry id="" num="9" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X = Cl or Br, n = 1-4, and further m = 1-8;</span>
    </p>
    <p num="0055" class="style-scope patent-text">
      <chemistry id="" num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0056" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5;</span>
    </p>
    <p num="0057" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1、3、5又は7から選択される配列の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9又は11から選択される配列の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、配列リストの配列番号:13又は15又は17又は19の対応するCRS及び配列リストの配列番号:21又は23の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、下記式1のエチル4-クロロ-3-オキソブチレートから下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換についてCRSポリペプチドの単位質量当たり250倍から300倍高い活性、及びグルコースからグルコネートへの酸化についてGDHポリペプチドの単位質量当たり200倍から250倍強化された活性を有する：
</span>
&nbsp;&nbsp;Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell comprises a non-naturally occurring CRS polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7, and a sequence listing Simultaneously express on the surface of the cell a non-naturally occurring GDH polypeptide of a sequence selected from SEQ ID NO: 9 or 11 and the corresponding CRS of SEQ ID NO: 13 or 15 or 17 or 19 of the sequence listing and From ethyl 4-chloro-3-oxobutyrate of formula 1 below, ethyl (S) -4 of formula 2 below, compared to designer cells simultaneously expressing the corresponding GDH of SEQ ID NO: 21 or 23 in the cytoplasm of the cell 250 to 300 times higher activity per unit mass of CRS polypeptide for conversion to -chloro-3-hydroxybutyrate, and 200 to 250 times enhanced per unit mass of GDH polypeptide for glucose to gluconate oxidation Activity To:
</span>
    </p>
    <p num="0058" class="style-scope patent-text">
      <chemistry id="" num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0059" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換についてCRSポリペプチドの単位質量当たり約270倍高い活性、及びグルコースからグルコネートへの酸化についてGDHポリペプチドの単位質量当たり約225倍強化された活性を有する。
</span>
&nbsp;&nbsp;Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell comprises the non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and the non-naturally occurring GDH of SEQ ID NO: 9 in the sequence listing. The polypeptide is expressed simultaneously on the surface of the cell, as compared to a designer cell that simultaneously expresses in the cytoplasm of the cell the corresponding CRS of SEQ ID NO: 13 and the corresponding GDH of SEQ ID NO: 21 of the sequence list. About 270 times higher activity per unit mass of CRS polypeptide for conversion of ethyl 4-chloro-3-oxobutyrate of 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 and from glucose It has about 225-fold enhanced activity per unit mass of GDH polypeptide for oxidation to gluconate.
</span>
    </p>
    <p num="0060" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1、3、5又は7から選択される配列の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:<u class="style-scope patent-text">9又は11</u>から選択される配列の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、配列リストの配列番号:13又は15又は17又は19の対応するCRS及び配列リストの配列番号:21又は23の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換について単位細胞質量当たり約11倍から24倍高い活性、及びグルコースからグルコネートへの酸化について単位細胞質量当たり9倍から31倍強化された活性を有する。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換について単位細胞質量当たり約24倍高い活性、及びグルコースからグルコネートへの酸化について単位細胞質量当たり約31倍強化された活性を有する。
</span>Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell comprises a non-naturally occurring CRS polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7, and a sequence listing SEQ ID NO: <u class="style-scope patent-text">9 or 11</u> simultaneously expresses on the surface of the cell a non-naturally occurring GDH polypeptide of a sequence selected from SEQ ID NO: <u class="style-scope patent-text">9 or 11,</u> and the corresponding CRS of SEQ ID NO: 13 or 15 or 17 or 19 of the sequence list and the sequence list Ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro of formula 2 in comparison to designer cells co-expressing the corresponding GDH of SEQ ID NO: 21 or 23 in the cytoplasm of the cell It has about 11 to 24 times higher activity per unit cell mass for conversion to -3-hydroxybutyrate, and 9 to 31 times enhanced activity per unit cell mass for glucose to gluconate oxidation. <br class="style-scope patent-text"> Another embodiment of the present invention provides a designer cell according to the present invention, wherein said cell comprises the non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and the non-naturally occurring GDH of SEQ ID NO: 9 in the sequence listing. The polypeptide is expressed simultaneously on the surface of the cell, as compared to a designer cell that simultaneously expresses in the cytoplasm of the cell the corresponding CRS of SEQ ID NO: 13 and the corresponding GDH of SEQ ID NO: 21 of the sequence list. About 24 times higher activity per unit cell mass for conversion of ethyl 4-chloro-3-oxobutyrate of 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2, and glucose to gluconate It has about 31-fold enhanced activity per unit cell mass for oxidation.</span>
    </p>
    <p num="0061" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、下記式3の化合物の還元のために配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり約55倍から270倍高い活性を有する：
</span>
&nbsp;&nbsp;Another embodiment of the present invention provides the designer cell described in the present invention, wherein said cell comprises the non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and the non-naturally occurring GDH poly of SEQ ID NO: 9 in the Sequence Listing. The peptide is simultaneously expressed on the surface of the cell, and the corresponding CRS of SEQ ID NO: 13 in the Sequence Listing and the corresponding GDH of SEQ ID NO: 21 in the Sequence Listing are simultaneously expressed in the cytoplasm of the cell for reduction of the compound of Formula 3 below. It has about 55-fold to 270-fold higher activity per unit mass of CRS polypeptide as compared to the designer cells that do:
</span>
    </p>
    <p num="0062" class="style-scope patent-text">
      <chemistry id="" num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0063" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、下記式4の化合物の還元のために配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較してCRSポリペプチドの単位質量当たり約40倍から156倍高い活性を有する：
</span>In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2)</sub> <sub class="style-scope patent-text">m,</sub> an X = Cl or Br, n = a 1-4, a further m = 1-8. <br class="style-scope patent-text"> Another embodiment of the present invention provides the designer cell described in the present invention, wherein said cell comprises the non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and the non-naturally occurring GDH poly of SEQ ID NO: 9 in the Sequence Listing. The peptide is simultaneously expressed on the surface of the cell, and the corresponding CRS of SEQ ID NO: 13 in the sequence list and the corresponding GDH of SEQ ID NO: 21 in the sequence list simultaneously expressed in the cytoplasm of the cell for reduction of the compound of formula 4 below It has about 40-fold to 156-fold higher activity per unit mass of CRS polypeptide compared to the designer cells that do:</span>
    </p>
    <p num="0064" class="style-scope patent-text">
      <chemistry id="" num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0065" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。<br class="style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、前記細胞は、配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、下記式3の化合物又は下記式4の化合物の還元のために配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応する対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して単位細胞質量当たり約3倍から24倍高い活性を有する：
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5; <br class="style-scope patent-text"> Another embodiment of the present invention provides the designer cell described in the present invention, wherein said cell comprises the non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and the non-naturally occurring GDH poly of SEQ ID NO: 9 in the Sequence Listing. The peptide is simultaneously expressed on the surface of the cell, and the corresponding CRS of SEQ ID NO: 13 of the sequence list and the corresponding corresponding of SEQ ID NO: 21 of the sequence list for reduction of the compound of formula 3 or the compound of formula 4 It has about 3 to 24 times higher activity per unit cell mass compared to designer cells co-expressing GDH in the cytoplasm of the cell:</span>
    </p>
    <p num="0066" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <chemistry id="" num="14" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry>
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8であって；
</span> <chemistry id="" num="14" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X = Cl or Br, n = 1-4, and further m = 1-8;</span>
    </p>
    <p num="0067" class="style-scope patent-text">
      <chemistry id="" num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0068" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5;</span>
    </p>
    <p num="0069" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は本発明に記載するデザイナー細胞を提供し、ここで、前記デザイナー細胞は組換え大腸菌BL21(DE3)又は組換え大腸菌C41(DE3)又は組換え大腸菌C43(DE3)である。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1又は3又は5又は7のアミノ酸配列を有しカルボニルレダクターゼ活性を示すポリペプチドをコードするポリヌクレオチドを含む組換え発現ベクターを提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1又は3又は5又は7のアミノ酸配列を有しカルボニルレダクターゼ活性を示すポリペプチド、及び配列番号:9又は11のアミノ酸配列を有しGDH活性を示すポリペプチドをコードするポリヌクレオチドを含む組換え発現ベクターを提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートの約100％鏡像体過剰の製造における、本発明に記載するデザイナー細胞の使用を提供する：
</span>Another embodiment of the present invention provides a designer cell according to the present invention, wherein said designer cell is a recombinant E. coli BL21 (DE3) or a recombinant E. coli C41 (DE3) or a recombinant E. coli C43 (DE3) is there. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a recombinant expression vector comprising a polynucleotide encoding a polypeptide having an amino acid sequence of SEQ ID NO: 1 or 3 or 5 or 7 and exhibiting carbonyl reductase activity. <br class="style-scope patent-text"> Yet another embodiment of the present invention is a polypeptide having an amino acid sequence of SEQ ID NO: 1 or 3 or 5 or 7 and exhibiting carbonyl reductase activity, and an amino acid sequence of SEQ ID NO: 9 or 11 and a GDH activity Provided is a recombinant expression vector comprising a polynucleotide encoding the indicated polypeptide. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides the use of a designer cell according to the present invention in the production of about 100% enantiomeric excess of ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 To:</span>
    </p>
    <p num="0070" class="style-scope patent-text">
      <chemistry id="" num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0071" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のなお別の実施態様は、式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートの約100％鏡像体過剰の製造における、請求項8に記載のデザイナー細胞の使用を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、下記式5の化合物の製造における、本発明に記載するデザイナー細胞の使用を提供する：
</span>Yet another embodiment of the present invention provides the use of a designer cell according to claim 8 in the preparation of about 100% enantiomeric excess of ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2. Do. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides the use of a designer cell described in the present invention in the manufacture of a compound of formula 5:</span>
    </p>
    <p num="0072" class="style-scope patent-text">
      <chemistry id="" num="17" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0073" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。
</span>In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2)</sub> <sub class="style-scope patent-text">m,</sub> an X = Cl or Br, n = a 1-4, a further m = 1-8.</span>
    </p>
    <p num="0074" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のなお別の実施態様は、下記式5の化合物の製造における、本発明に記載するデザイナー細胞の使用を提供する：
</span>
&nbsp;&nbsp;Yet another embodiment of the present invention provides the use of a designer cell described in the present invention in the manufacture of a compound of formula 5:
</span>
    </p>
    <p num="0075" class="style-scope patent-text">
      <chemistry id="" num="18" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0076" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、下記式6の化合物の製造における、本発明に記載するデザイナー細胞の使用を提供する：
</span>In the formula, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> = H, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2)</sub> <sub class="style-scope patent-text">m,</sub> an X = Cl or Br, n = a 1-4, a further m = 1-8. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides the use of a designer cell described in the present invention in the manufacture of a compound of formula 6</span>
    </p>
    <p num="0077" class="style-scope patent-text">
      <chemistry id="" num="19" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0078" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、下記式6の化合物の製造における、本発明に記載するデザイナー細胞の使用を提供する：
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5; <br class="style-scope patent-text"> Yet another embodiment of the present invention provides the use of a designer cell described in the present invention in the manufacture of a compound of formula 6</span>
    </p>
    <p num="0079" class="style-scope patent-text">
      <chemistry id="" num="20" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0080" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である。
</span>In which R <sub class="style-scope patent-text">1</sub> 2R <sub class="style-scope patent-text">2</sub> 2R <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5;</span>
    </p>
    <p num="0081" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、アクセッション番号MTCC No.5806、MTCC No.5807、MTCC No.5808及びMTCC No.5809を有するデザイナー細胞を提供し、ここで、前記デザイナー細胞は配列番号:2、4、6及び8を有するヌクレオチド配列を含み、配列番号:2、4、6及び8を有する前記ヌクレオチド配列は配列番号:1、3、5及び7を有するアミノ酸配列を発現することができる。<br class="style-scope patent-text">
  本発明の別の実施態様は、アクセッション番号MTCC No.5810、MTCC No.5811、MTCC No.5812、MTCC No.5813、MTCC No.5814、MTCC No.5815、MTCC No.5816及びMTCC No.5817を有するデザイナー細胞を提供し、ここで、MTCC No.5810は配列番号:2及び配列番号:10を有するヌクレオチド配列を含み、MTCC No.5811のアクセッション番号を有するデザイナー細胞は配列番号:2及び配列番号:12を有するヌクレオチド配列を含み、MTCC No.5812のアクセッション番号を有するデザイナー細胞は配列番号:4及び配列番号:10を有するヌクレオチド配列を含み、MTCC No.5813のアクセッション番号を有するデザイナー細胞は配列番号:4及び配列番号:12を有するヌクレオチド配列を含み、MTCC No.5814のアクセッション番号を有するデザイナー細胞は配列番号:6及び配列番号:10を有するヌクレオチドを含み、MTCC No.5815のアクセッション番号を有するデザイナー細胞は配列番号:6及び配列番号:12を有するヌクレオチド配列を含み、MTCC No.5816のアクセッション番号を有するデザイナー細胞は配列番号:8及び配列番号:10を有するヌクレオチド配列を含み、MTCC No.5817のアクセッション番号を有するデザイナー細胞は配列番号:8及び配列番号:12を有するヌクレオチド配列を含み、さらに、MTCC No.5810のアクセッション番号を有するデザイナー細胞は配列番号:1及び配列番号:9を有するアミノ酸配列を発現でき、MTCC No.5811のアクセッション番号を有するデザイナー細胞は配列番号:1及び配列番号:11を有するアミノ酸配列を発現でき、MTCC No.5812のアクセッション番号を有するデザイナー細胞は配列番号:3及び配列番号:9を有するアミノ酸配列を発現でき、MTCC No.5813のアクセッション番号を有するデザイナー細胞は配列番号:3及び配列番号:11を有するアミノ酸配列を発現でき、MTCC No.5814のアクセッション番号を有するデザイナー細胞は配列番号:5及び配列番号:9を有するアミノ酸配列を発現でき、MTCC No.5815のアクセッション番号を有するデザイナー細胞は配列番号:5及び配列番号:11を有するアミノ酸配列を発現でき、MTCC No.5816のアクセッション番号を有するデザイナー細胞は配列番号:7及び配列番号:9を有するアミノ酸配列を発現でき、MTCC No.5817のアクセッション番号を有するデザイナー細胞は配列番号:7及び配列番号:11を有するアミノ酸配列を発現できる。
</span>Another embodiment of the present invention provides a designer cell having accession numbers MTCC No. 5806, MTCC No. 5807, MTCC No. 5808 and MTCC No. 5809, wherein said designer cell has SEQ ID NO: 2 , 4, 6, and 8, said nucleotide sequence having SEQ ID NO: 2, 4, 6 and 8 can express an amino acid sequence having SEQ ID NO: 1, 3, 5 and 7. <br class="style-scope patent-text"> Another embodiment of the present invention relates to Accession Nos. MTCC No. 5810, MTCC No. 5811, MTCC No. 5812, MTCC No. 5813, MTCC No. 5814, MTCC No. 5815, MTCC No. 5816 and MTCC No. Provided is a designer cell having 5817, wherein MTCC No. 5810 comprises a nucleotide sequence having SEQ ID NO: 2 and SEQ ID NO: 10, and a designer cell having an accession number of MTCC No. 5811 comprises SEQ ID NO: 2 And a designer cell having the accession number of MTCC No. 5812, which comprises the nucleotide sequence having SEQ ID NO: 12, and the accession number of MTCC No. 5813, which comprises the nucleotide sequence having SEQ ID NO: 4 and SEQ ID NO: 10 Designer cells having the nucleotide sequence having SEQ ID NO: 4 and SEQ ID NO: 12; designer cells having the accession number of MTCC No. 5814 have nucleotides having SEQ ID NO: 6 and SEQ ID NO: 10; Of the .5815 Designer cells having a session number comprise a nucleotide sequence having SEQ ID NO: 6 and SEQ ID NO: 12; designer cells having an accession number of MTCC No. 5816 have a nucleotide sequence having SEQ ID NO: 8 and SEQ ID NO: 10 The designer cell having the accession number of MTCC No. 5817 comprises the nucleotide sequence having SEQ ID NO: 8 and SEQ ID NO: 12, and the designer cell having the accession number of MTCC No. 5810 has the SEQ ID NO: 1 And a designer cell having the accession number of MTCC No. 5811 can express the amino acid sequence having SEQ ID NO: 1 and SEQ ID NO: 11, and an accession of MTCC No. 5812 The designer cell having the number can express the amino acid sequence having SEQ ID NO: 3 and SEQ ID NO: 9 and the accession number of MTCC No. 5813 Designer cells having the same can express an amino acid sequence having SEQ ID NO: 3 and SEQ ID NO: 11 and a designer cell having an accession number of MTCC No. 5814 can express an amino acid sequence having SEQ ID NO: 5 and SEQ ID NO: 9 Designer cells having the accession number of MTCC No. 5815 can express the amino acid sequence having SEQ ID NO: 5 and SEQ ID NO: 11, and designer cells having the accession number of MTCC No. 5816 have SEQ ID NO: 7 and the sequence A designer cell capable of expressing an amino acid sequence having the number 9 and having an accession number of MTCC No. 5817 can express the amino acid sequence having the sequence SEQ ID NO: 7 and SEQ ID NO: 11.</span>
    </p>
    <p num="0082" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートを約100％鏡像体過剰で製造するプロセスを提供し：
</span>
&nbsp;&nbsp;Another embodiment of the present invention provides a process for producing ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 below in about 100% enantiomeric excess:
</span>
    </p>
    <p num="0083" class="style-scope patent-text">
      <chemistry id="" num="21" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0084" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
前記プロセスは以下の工程を含む：<br class="style-scope patent-text">
a．下記式1のエチル4-クロロ-3-オキソブチレートを提供する工程：
</span>The process comprises the following steps: <br class="style-scope patent-text"> a. Providing ethyl 4-chloro-3-oxobutyrate of formula 1</span>
    </p>
    <p num="0085" class="style-scope patent-text">
      <chemistry id="" num="22" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0086" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
b．前記エチル4-クロロ-3-オキソブチレートを、本発明1に記載するデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させる工程；<br class="style-scope patent-text">
c．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程；<br class="style-scope patent-text">
d．前記反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程；<br class="style-scope patent-text">
e．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて前記生成物エチル(S)-4-クロロ-3-ヒドロキシブチレートを単離する工程。
</span>b. The ethyl 4-chloro-3-oxobutyrate is a designer cell according to the present invention 1 and 0.005 to 0.02 mol% of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase and pH 5 Contacting with 0 to 9.0 buffer solution; <br class="style-scope patent-text"> c. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ; <br class="style-scope patent-text"> d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .; <br class="style-scope patent-text"> e. Extracting the product obtained in step (d) in ethyl acetate and subsequently isolating said product ethyl (S) -4-chloro-3-hydroxybutyrate.</span>
    </p>
    <p num="0087" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、pHが好ましくは6.5である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、温度が好ましくは30℃である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、有機溶媒が好ましくはジ-n-ブチルエーテルである、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、デザイナー細胞が好ましくは組換え大腸菌C41(DE3)である、本発明に記載するプロセスを提供する。
</span>Another embodiment of the present invention provides the process described in the present invention, wherein the pH is preferably 6.5. <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the temperature is preferably 30.degree. <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the organic solvent is preferably di-n-butyl ether. <br class="style-scope patent-text"> Another embodiment of the present invention is a recombinant E. coli strain wherein the designer cells are selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3). Provide the process described in <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the designer cells are preferably recombinant E. coli C41 (DE3).</span>
    </p>
    <p num="0088" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、本発明に記載する下記式5の光学的に濃縮された脂肪族アルコールを製造するプロセスを提供し：
</span>
&nbsp;&nbsp;Another embodiment of the present invention provides a process for producing the optically concentrated aliphatic alcohol of the following formula 5 described in the present invention:
</span>
    </p>
    <p num="0089" class="style-scope patent-text">
      <chemistry id="" num="23" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0090" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である）、<br class="style-scope patent-text">
前記プロセスは以下の工程を含む：<br class="style-scope patent-text">
a．下記式3のケトンを提供する工程：
</span>(Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = an alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X = Cl or Br, n = 1-4, and further m = 1-8), <br class="style-scope patent-text"> The process comprises the following steps: <br class="style-scope patent-text"> a. Providing the ketone of formula 3</span>
    </p>
    <p num="0091" class="style-scope patent-text">
      <chemistry id="" num="24" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0092" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">m</sub>であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である）；<br class="style-scope patent-text">
b．工程（a）で提供される式3のケトンを、本発明に記載するデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程；<br class="style-scope patent-text">
c．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程；<br class="style-scope patent-text">
d．前記反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程；<br class="style-scope patent-text">
e．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式5の化合物を単離する工程。
</span>(Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub> = alkyl group such as CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">m</sub> , X = Cl or Br, n = 1-4, and further m = 1-8); <br class="style-scope patent-text"> b. The ketone of formula 3 provided in step (a) is used as a designer cell according to the invention and 0.005 to 0.02 mole% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase and Contacting with 0 to 9.0 buffer solution to form a reaction mixture; <br class="style-scope patent-text"> c. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ; <br class="style-scope patent-text"> d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .; <br class="style-scope patent-text"> e. Extracting the product obtained in step (d) in ethyl acetate and subsequently isolating the compound of formula 5.</span>
    </p>
    <p num="0093" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、pHが好ましくは6.5である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、温度が好ましくは30℃である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、有機溶媒が好ましくはジ-n-ブチルエーテルである、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、デザイナー細胞が好ましくは組換え大腸菌C41(DE3)である、本発明に記載するプロセスを提供する。
</span>Another embodiment of the present invention provides the process described in the present invention, wherein the pH is preferably 6.5. <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the temperature is preferably 30.degree. <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the organic solvent is preferably di-n-butyl ether. <br class="style-scope patent-text"> Another embodiment of the present invention is a recombinant E. coli strain wherein the designer cells are selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3). Provide the process described in <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the designer cells are preferably recombinant E. coli C41 (DE3).</span>
    </p>
    <p num="0094" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、本発明に記載する下記式6の光学的に濃縮されたアリールアルコールを製造するプロセスを提供し：
</span>
&nbsp;&nbsp;Another embodiment of the present invention provides a process for producing the optically enriched aryl alcohol of the following formula 6 described in the present invention:
</span>
    </p>
    <p num="0095" class="style-scope patent-text">
      <chemistry id="" num="25" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0096" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である）、<br class="style-scope patent-text">
前記プロセスは以下の工程を含む：<br class="style-scope patent-text">
a．下記式4のケトンを提供する工程：
</span>(Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example, CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> where n = 1 to 5), <br class="style-scope patent-text"> The process comprises the following steps: <br class="style-scope patent-text"> a. Providing a ketone of Formula 4 below:</span>
    </p>
    <p num="0097" class="style-scope patent-text">
      <chemistry id="" num="26" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0098" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基、例えばCH<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、n＝1から5である）；<br class="style-scope patent-text">
b．工程（a）で提供される式3のケトンを、本発明に記載するデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程；<br class="style-scope patent-text">
c．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程；<br class="style-scope patent-text">
d．前記反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程；<br class="style-scope patent-text">
e．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式6の化合物を単離する工程。
</span>(Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> , R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, for example, CH <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , n = 1 to 5); <br class="style-scope patent-text"> b. The ketone of formula 3 provided in step (a) is used as a designer cell according to the invention and 0.005 to 0.02 mole% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase and Contacting with 0 to 9.0 buffer solution to form a reaction mixture; <br class="style-scope patent-text"> c. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ; <br class="style-scope patent-text"> d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .; <br class="style-scope patent-text"> e. Extracting the product obtained in step (d) in ethyl acetate and subsequently isolating the compound of formula 6.</span>
    </p>
    <p num="0099" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、pHが好ましくは6.5である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、温度が好ましくは30℃である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、有機溶媒が好ましくはジ-n-ブチルエーテルである、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、本発明に記載するプロセスを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、デザイナー細胞が好ましくは組換え大腸菌C41(DE3)である、本発明に記載するプロセスを提供する。
</span>Another embodiment of the present invention provides the process described in the present invention, wherein the pH is preferably 6.5. <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the temperature is preferably 30.degree. <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the organic solvent is preferably di-n-butyl ether. <br class="style-scope patent-text"> Another embodiment of the present invention is a recombinant E. coli strain wherein the designer cells are selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3). Provide the process described in <br class="style-scope patent-text"> Another embodiment of the present invention provides the process described in the present invention, wherein the designer cells are preferably recombinant E. coli C41 (DE3).</span>
    </p>
    <p num="0100" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施態様は、アクセッション番号MTCC No.5806、MTCC No.5807、MTCC No.5808及びMTCC No.5809を有するデザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様はデザイナー細胞を提供し、前記デザイナー細胞は、アクセッション番号MTCC No.5806−5807を有し、配列番号:1、3、5及び7を有するアミノ酸配列を発現する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1、3、5、7を有するアミノ酸配列が配列番号:2、4、6及び8を有するヌクレオチド配列に一致する、本発明に記載するデザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1−8がカルボニルレダクターゼの天然に存在しない配列であるデザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、高活性のカルボニルレダクターゼを細胞表面で発現することができるデザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1−8を含み、さらに前記を発現することができる組換えベクター構築物を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、カルボニルレダクターゼ酵素の天然に存在しない配列を含む組換えベクター構築物を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、高活性のカルボニルレダクターゼを細胞表面で発現することができる、本発明に記載する組換えベクター構築物を提供する。
</span>Another embodiment of the present invention provides a designer cell having accession numbers MTCC No. 5806, MTCC No. 5807, MTCC No. 5808 and MTCC No. 5809. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a designer cell, said designer cell having an accession number MTCC No. 5806-5807 and expressing an amino acid sequence having SEQ ID NO: 1, 3, 5 and 7 . <br class="style-scope patent-text"> Yet another embodiment of the present invention is the designer cell according to the present invention, wherein the amino acid sequence having SEQ ID NO: 1, 3, 5, 7 corresponds to the nucleotide sequence having SEQ ID NO: 2, 4, 6 and 8. I will provide a. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a designer cell, wherein SEQ ID NO: 1-8 is a non-naturally occurring sequence of carbonyl reductase. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a designer cell capable of expressing high activity carbonyl reductase on the cell surface. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a recombinant vector construct comprising SEQ ID NO: 1-8 and which is capable of expressing the same. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a recombinant vector construct comprising a non-naturally occurring sequence of a carbonyl reductase enzyme. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a recombinant vector construct as described in the present invention which can express high activity carbonyl reductase on the cell surface.</span>
    </p>
    <p num="0101" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のなお別の実施態様は、アクセッション番号MTCC No.5810、MTCC No.5811、MTCC No.5812、MTCC No.5813、MTCC No.5814、MTCC No.5815、MTCC No.5816及びMTCC No.5817を有するデザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は以下のようなデザイナー細胞を提供する：MTCC No.5810のアクセッション番号を有し配列番号:1及び配列番号:9を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5811のアクセッション番号を有し配列番号:1及び配列番号:11を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5812のアクセッション番号を有し配列番号:3及び配列番号:9を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5813のアクセッション番号を有し配列番号:配列番号:3及び配列番号:11を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5814のアクセッション番号を有し配列番号:5及び配列番号:9を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5815のアクセッション番号を有し配列番号:5及び配列番号:11を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5816のアクセッション番号を有し配列番号:7及び配列番号:9を有するアミノ酸配列を発現するデザイナー細胞；MTCC No.5817のアクセッション番号を有し配列番号:7及び配列番号:11を有するアミノ酸配列を発現するデザイナー細胞。
</span>Still another embodiment of the present invention relates to Accession Nos. MTCC No. 5810, MTCC No. 5811, MTCC No. 5812, MTCC No. 5813, MTCC No. 5814, MTCC No. 5815, MTCC No. 5816 and MTCC No. Provide a designer cell with .5817. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides designer cells as follows: Designer cells having an accession number of MTCC No. 5810 and expressing an amino acid sequence having SEQ ID NO: 1 and SEQ ID NO: 9; MTCC Designer cells expressing the amino acid sequence having the accession number of SEQ ID NO: 1 and SEQ ID NO: 11 with the accession number of No. 5811; SEQ ID NO: 3 and SEQ ID NO: 9 with the accession number of MTCC No. 5812 Designer cells that express the amino acid sequence of the present invention; Designer cells that have the accession number of MTCC No. 5813 and express the amino acid sequence of the SEQ ID NO: 3 and SEQ ID NO: 11; accession number of MTCC No. 5814 Designer cells expressing an amino acid sequence having SEQ ID NO: 5 and SEQ ID NO: 9; an amino acid sequence having an accession number of MTCC No. 5815 having SEQ ID NO: 5 and SEQ ID NO: 11 Designer cells that express; designer cells that have an accession number of MTCC No. 5816 and that expresses an amino acid sequence having SEQ ID NO: 7 and SEQ ID NO: 9; have an accession number of MTCC No. 5817; SEQ ID NO: 7 And a designer cell that expresses the amino acid sequence having SEQ ID NO: 11.</span>
    </p>
    <p num="0102" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1、3、5、7、9及び11を有するアミノ酸配列が配列番号:2、4、6、8、10及び12を有するヌクレオチド配列に一致する、デザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、酵素カルボニルレダクターゼ及びグルコースデヒドロゲナーゼを細胞の表面で一緒に同時発現することができるデザイナー細胞を提供する。<br class="style-scope patent-text">
  本発明のなお別の実施態様は、配列番号:1、3、5、7、9及び11を有するアミノ酸配列並びに配列番号:2、4、6、8、10及び12を有するヌクレオチド配列を含み、さらに前記を発現することができる組換えベクターを提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、酵素カルボニルレダクターゼ及びグルコースデヒドロゲナーゼを細胞表面で一緒に共同発現することができる、本発明に記載する組換えベクター構築物を提供する。<br class="style-scope patent-text">
  本発明の別の実施態様は、本発明の例えばここに記載するように式5又は式6又は式2の化合物を製造する方法を提供し、前記方法は以下の工程を含む：（a）本発明の例えばここに記載するように式3を有するケトンを提供する工程；（b）工程（a）の式3のケトンを、配列番号:1−12を単独で又は本発明の例えばここに記載するように組み合わせて含む本発明の例えばここに記載するデザイナー細胞、並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）、場合によって必要ならば100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程；（c）工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程；（d）前記反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、及び工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式5又は式6又は式2の化合物を単離する工程。
</span>Yet another embodiment of the present invention corresponds to a nucleotide sequence wherein the amino acid sequence having SEQ ID NO: 1, 3, 5, 7, 9 and 11 has SEQ ID NO: 2, 4, 6, 8, 10 and 12. , Provide designer cells. <br class="style-scope patent-text"> Yet another embodiment of the present invention provides a designer cell that can co-express the enzymes carbonyl reductase and glucose dehydrogenase together on the surface of the cell. <br class="style-scope patent-text"> Yet another embodiment of the present invention comprises the amino acid sequence having SEQ ID NO: 1, 3, 5, 7, 9 and 11 and the nucleotide sequence having SEQ ID NO: 2, 4, 6, 8, 10 and 12. Furthermore, a recombinant vector capable of expressing the above is provided. <br class="style-scope patent-text"> Another embodiment of the invention provides a recombinant vector construct according to the invention, which is capable of co-expressing the enzymes carbonyl reductase and glucose dehydrogenase together on the cell surface. <br class="style-scope patent-text"> Another embodiment of the present invention provides a method of producing a compound of formula 5 or 6 or 2 as described for example herein of the present invention, said method comprising the steps of: (a) this Providing a ketone having the formula 3 as described herein, for example; (b) a ketone of the formula 3 of step (a), alone or as described for example herein The designer cells of the invention, for example, as described herein, comprising in combination as well as 0.005 to 0.02 mol% of nicotinamide adenine dinucleotide phosphate reduced form (NADPH), optionally 100 to 500 units of glucose dehydrogenase and optionally (c) forming a reaction mixture by contacting with a buffer solution of pH 5.0 to 9.0; (c) an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl) in the reaction mixture obtained in step (b) (B) mixing the reaction mixture vigorously at a constant temperature of 20 to 40 ° C. on a magnetic stirrer. Extracting the product obtained in step (d), in ethyl acetate, and subsequently isolating the compound of formula 5 or formula 6 or formula 2.</span>
    </p>
    <p num="0103" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">本発明の利点</u> <br class="style-scope patent-text">
  1．本発明は全細胞生物触媒を提供し、前記生物触媒は、エチル4-クロロ-3-オキソブチレートを工業的に重要なエチル(S)-4-クロロ-3-ヒドロキシブチレートに変換する従来技術の生物触媒と比較して、CRSの単位質量当たり少なくとも250倍改善された変換速度を有する。<br class="style-scope patent-text">
  2．本発明は全細胞生物触媒を提供し、前記生物触媒は、同じ細胞の表面にレダクターゼ及び補酵素再生活性の両方が存在するが故に補因子ローディングに対しより高い効率を有する。そのような系では、補因子ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）/ニコチンアミドアデニンジヌクレオチドリン酸（NADP）は、細胞の表面で非常に近接して配置されるCRSとGDH酵素との間を水路で運ばれる。<br class="style-scope patent-text">
  3．鏡像体的に濃縮されたアルコールが顕著に高い変換速度で製造される。より具体的には、エチル(S)-4-クロロ-3-ヒドロキシブチレートは、顕著に高い変換速度で少なくとも150gl<sup class="style-scope patent-text">-1</sup>の生成物蓄積とともに約100％の鏡像体過剰で生成される（前記は、ヒドロキシメチルグルタリル-CoA（HMG-CoA）レダクターゼ阻害剤の製造のためにキラル構築ブロック及び中間体として有用である）。
</span> <u class="style-scope patent-text">Advantages of the invention</u> <br class="style-scope patent-text"> 1. The present invention provides a whole cell biocatalyst, said biocatalyst converting ethyl 4-chloro-3-oxobutyrate into industrially important ethyl (S) -4-chloro-3-hydroxybutyrate It has at least a 250-fold improved conversion rate per unit mass of CRS as compared to the biocatalysts of the art. <br class="style-scope patent-text"> 2. The present invention provides a whole cell biocatalyst, which has higher efficiency for cofactor loading due to the presence of both reductase and coenzyme regenerating activity on the surface of the same cell. In such systems, the cofactor nicotinamide adenine dinucleotide phosphate reduced (NADPH) / nicotinamide adenine dinucleotide phosphate (NADP) is placed in close proximity to the surface of the cell with the CRS and GDH enzymes. Are transported by waterways. <br class="style-scope patent-text"> 3. Enantiomerically enriched alcohols are produced at significantly higher conversion rates. More specifically, ethyl (S) -4-chloro-3-hydroxybutyrate is produced in about 100% enantiomeric excess with a product accumulation of at least 150 gl <sup class="style-scope patent-text">-1</sup> at a significantly higher conversion rate (as described above Are useful as chiral building blocks and intermediates for the preparation of hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors).</span>
    </p>
    <p num="0104" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">プラスミド及び形質転換体</u> <br class="style-scope patent-text">
  本発明の発現プラスミドはpET23(a)-omp-CRSを含み、前記は配列番号:1又は3又は5又は7によって表されるアミノ酸配列を有するポリペプチド（カルボニルレダクターゼ活性を示す）をコードする、配列リストの配列番号:2又は4又は6又は8によって表されるDNA配列を有する。<br class="style-scope patent-text">
  本発明の発現プラスミドはpETDuet1-omp-CRS; omp-GDHを含み、前記は、配列番号:1又は3又は5又は7によって表されるアミノ酸配列を有するCRSポリペプチド（カルボニルレダクターゼ活性を示す）をコードする配列番号:2又は4又は6又は8によって表されるDNA配列、及び配列番号:9又は11によって表されるアミノ酸配列を有するGDHポリペプチド（GDH活性を示す）をコードする配列番号:10又は12によって表されるDNA配列を有する。<br class="style-scope patent-text">
  本発明のDNAを含むプラスミドは化学的にコンピテントな宿主細胞に公知の方法によって導入できる。大腸菌DH5αをクローニング宿主として、さらに大腸菌BL21(DE3)、大腸菌C41(DE3)及び大腸菌C43(DE3)を発現宿主として用いた。<br class="style-scope patent-text">
  本発明の形質転換体の例として、大腸菌BL21(DE3)+pET23(a)-omp-CRSを記載することができる。<br class="style-scope patent-text">
  より具体的には、本発明の形質転換体の例として、大腸菌C41(DE3)+pET23(a)-omp-CRSを記載することができる。
</span> <u class="style-scope patent-text">Plasmid and Transformant</u> The expression plasmid of the present invention comprises pET23 (a) -omp-CRS, which has the amino acid sequence represented by SEQ ID NO: 1 or 3 or 5 or 7 (shows carbonyl reductase activity) And the DNA sequence represented by SEQ ID NO: 2 or 4 or 6 or 8 in the sequence listing. <br class="style-scope patent-text"> The expression plasmid of the present invention comprises pETDuet1-omp-CRS; omp-GDH, which is a CRS polypeptide having the amino acid sequence represented by SEQ ID NO: 1 or 3 or 5 or 7 (showing carbonyl reductase activity) SEQ ID NO: 10 encoding the DNA sequence represented by SEQ ID NO: 2 or 4 or 6 or 8 and the GDH polypeptide having the amino acid sequence represented by SEQ ID NO: 9 or 11 (indicating GDH activity) Or have a DNA sequence represented by 12. <br class="style-scope patent-text"> The plasmid containing the DNA of the present invention can be introduced into chemically competent host cells by known methods. E. coli DH5α was used as a cloning host, and E. coli BL21 (DE3), E. coli C41 (DE3) and E. coli C43 (DE3) were used as an expression host. <br class="style-scope patent-text"> As an example of the transformant of the present invention, E. coli BL21 (DE3) + pET23 (a) -omp-CRS can be described. <br class="style-scope patent-text"> More specifically, E. coli C41 (DE3) + pET23 (a) -omp-CRS can be described as an example of the transformant of the present invention.</span>
    </p>
    <p num="0105" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">カルボニルレダクターゼ活性を有する形質転換体</u> <br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有する形質転換体が、基質（エチル4-クロロ-3-オキソブチレートを含む）のカルボニル基及び補酵素ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）と反応すると、前記はカルボニル基を有する化合物（エチル4-クロロ-3-オキソブチレートを含む）を不整還元して、光学的に純粋な対応するアルコール（エチル(S)4-クロロ-3-ヒドロキシブチレートを含む）を生成する。発現プラスミドpET23(a)-omp-CRS及びpETDuet1-omp-CRS;omp-GDHを有する上記に記載する本発明の形質転換体はカルボニルレダクターゼ活性を有する。より正確には、発現プラスミドpET23(a)-omp-CRS及びpETDuet1-omp-CRS;omp-GDHを有する上記に記載する本発明の形質転換体は、カルボニルレダクターゼ活性を有するポリペプチドを細胞の表面で発現した。
</span> <u class="style-scope patent-text">Transformant having carbonyl reductase activity A transformant having</u> carbonyl reductase activity has a carbonyl group of a substrate (including ethyl 4-chloro-3-oxobutyrate) and a coenzyme nicotinamide adenine dinucleotide phosphate-reduced form (NADPH And asymmetrically reduce a compound having a carbonyl group (including ethyl 4-chloro-3-oxobutyrate) to give an optically pure corresponding alcohol (ethyl (S) 4-chloro-3). Generate hydroxybutyrate). The transformant of the present invention described above having the expression plasmids pET23 (a) -omp-CRS and pETDuet1-omp-CRS; omp-GDH has a carbonyl reductase activity. More precisely, the transformant of the present invention described above having the expression plasmids pET23 (a) -omp-CRS and pETDuet1-omp-CRS; Expressed in</span>
    </p>
    <p num="0106" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">カルボニルレダクターゼ及び補酵素再生活性の両方を有する形質転換体</u> <br class="style-scope patent-text">
  CRS及びGDH発現プラスミドを一緒に含む（すなわちpETDuet1-omp-CRS;omp-GDHを含む）、上記に記載する本発明の形質転換体は、カルボニルレダクターゼ及び補酵素再生活性の両方を示す。より正確には、発現プラスミドpETDuet1-omp-CRS;omp-GDHを有する上記に記載する本発明の形質転換体は、カルボニルレダクターゼ及び補酵素再生活性の両方を有するポリペプチドを細胞の表面で発現した。
</span> <u class="style-scope patent-text">Transformant having both carbonyl reductase and coenzyme regenerating activity</u> <br class="style-scope patent-text"> The transformants of the invention described above which contain CRS and GDH expression plasmids together (ie pETDuet1-omp-CRS; contains omp-GDH) exhibit both carbonyl reductase and coenzyme regenerating activity. More precisely, the transformant of the present invention described above having the expression plasmid pETDuet1-omp-CRS; omp-GDH expressed at the surface of the cell a polypeptide having both carbonyl reductase and coenzyme regenerating activity .</span>
    </p>
    <p num="0107" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">株の呼称及び寄託の詳細</u> <br class="style-scope patent-text">
  “CRSポリペプチド”及び“GDHポリペプチド”を発現する合成した組換え大腸菌株を下記の国際寄託機関に寄託した：International Depository Authority, Microbial Type Culture Collection and Gene Bank (MTCC), Institute of Microbial Technology, Sector 39A, Chandigarh 160036, India。前記株の呼称及び割り当てられたアクセッション番号は以下に提供する。株MTCC 5806、5807、5808及び5809は“CRSポリペプチド”配列番号:1、3、5及び7をそれぞれ発現する。株MTCC 5810から5817は“CRSポリペプチド”（配列番号:1、3、5及び7）及び“GDHポリペプチド”（配列番号:9及び11）を共同発現する。説明中でアミノ酸配列には奇数が割り当てられている。個々のアミノ酸をコードするヌクレオチド配列は直ぐ次の偶数が割り当てられている。例えば、配列番号:1のアミノ酸については、対応するコードヌクレオチド配列には配列番号:2が割り当てられている。
</span> <u class="style-scope patent-text">Strain designations and details of the deposit The</u> synthesized recombinant E. coli strains expressing "CRS polypeptide" and "GDH polypeptide" were deposited in the following international depository: International Depository Authority, Microbial Type Culture Collection and Gene Bank (MTCC) ), Institute of Microbial Technology, Sector 39A, Chandigarh 160036, India. The stock designations and assigned accession numbers are provided below. Strains MTCC 5806, 5807, 5808 and 5809 express "CRS polypeptide" SEQ ID NO: 1, 3, 5 and 7, respectively. Strains MTCC 5810-5817 co-express "CRS polypeptides" (SEQ ID NO: 1, 3, 5 and 7) and "GDH polypeptides" (SEQ ID NO: 9 and 11). In the description, the amino acid sequences are assigned odd numbers. Nucleotide sequences encoding individual amino acids are assigned the next even integer. For example, for the amino acids of SEQ ID NO: 1, SEQ ID NO: 2 has been assigned to the corresponding coding nucleotide sequence.</span>
    </p>
    <p num="0108" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p num="0109" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">大腸菌表面でのCRS発現の提示</u> <br class="style-scope patent-text">
  CRSを発現する組換え細胞を溶解させ、遠心分離によって細胞屑を除去し、続いて膜分画及び可溶性分画の分離のために上清を4℃で1,000,000gにて2時間超遠心分離に付した。膜分画を含む沈降物を緩衝液で洗浄し、膜可溶化緩衝液（25 mMトリスHCl、20％グリセロース及び2％トリトンX100（pH7.5））に再懸濁させた。3つの分画全て（無細胞抽出物、膜分画及び可溶性タンパク質分画）の活性を基質としてエチル4-クロロ-3-ヒドロキシブチレートを用いてアッセイした。活性の大半は膜分画から回収された。<br class="style-scope patent-text">
  大腸菌細胞の表面におけるCRSの存在は、大腸菌の超薄切片で実施したEM免疫金標識試験によってさらにまた確認された。抗CRSポリクローナル抗体は精製CRSに対してウサギで作製し、それらの特異性についてはウェスタンブロッティングによってアッセイした。精製CRSを還元条件下でSDS-PAGE上で泳動し、ニトロセルロース膜へ電気的にブロッティングした後でウサギ抗CRSポリクローナル抗体を用いてプローブし、前記をさらにアルカリホスファターゼ結合ヤギ抗ウサギIgG（全分子）二次抗体でプローブした。続いて、5-ブロモ-4-クロロ-3-インドリルホスフェート（BCIP, 0.15mg/mL）、ニトロブルーテトラゾリウム（NBT, 0.30mg/mL）、トリスHCl（100mM）及びMgCl<sub class="style-scope patent-text">2</sub>（5mM）（pH9.5）を含む基質溶液に前記を10分間浸漬することによってブロットをデベロップさせた。純粋なCRSを特異的に標識するポリクローナル抗体はまたomp-CRSを特異的に標識することができた。<br class="style-scope patent-text">
  数回の脱水工程の後で、大腸菌細胞をLR白色樹脂に包埋し、続いて前記を固定液として0.2％グルタルアルデヒドを用い数工程で脱水した。ウルトラミクロトームを用いて切り出した薄い切片を、ウサギ抗CRSポリクローナル抗体、続いてナノゴールド標識ヤギ抗ウサギIgG（全分子）二次抗体とともにインキュベートし、透過型電子顕微鏡下で可視化した。種々の視野を観察し、金粒子は細胞の表面に重点的に存在することが見出された（図7）。陰性コントロールとしての細胞では標識は生じなかった。
</span> <u class="style-scope patent-text">Presentation of CRS expression on E. coli surface</u> <br class="style-scope patent-text"> The recombinant cells expressing CRS are lysed and cell debris is removed by centrifugation followed by ultracentrifugation of the supernatant at 1,000,000 g for 2 hours at 4 ° C. for separation of membrane and soluble fractions Attached. The sediment containing the membrane fraction was washed with buffer and resuspended in membrane solubilization buffer (25 mM Tris HCl, 20% glycerol and 2% Triton X 100 (pH 7.5)). The activity of all three fractions (cell-free extract, membrane fraction and soluble protein fraction) was assayed using ethyl 4-chloro-3-hydroxybutyrate as a substrate. Most of the activity was recovered from the membrane fraction. <br class="style-scope patent-text"> The presence of CRS on the surface of E. coli cells was further confirmed by the EM immunogold labeling test performed on ultra thin sections of E. coli. Anti-CRS polyclonal antibodies were raised in rabbits against purified CRS and assayed for their specificity by Western blotting. The purified CRS is electrophoresed on SDS-PAGE under reducing conditions, electroblotted onto nitrocellulose membrane and then probed with rabbit anti-CRS polyclonal antibody, which is further conjugated to alkaline phosphatase conjugated goat anti-rabbit IgG (whole molecule ) Probed with a secondary antibody. Subsequently, 5-bromo-4-chloro-3-indolyl phosphate (BCIP, 0.15mg / mL), nitroblue tetrazolium (NBT, 0.30mg / mL), tris HCl (100 mM) and MgCl <sub class="style-scope patent-text">2</sub> (5mM) (pH9 The blot was developed by immersing it in a substrate solution containing .5) for 10 minutes. Polyclonal antibodies that specifically label pure CRS were also able to specifically label omp-CRS. <br class="style-scope patent-text"> After several dehydration steps, E. coli cells were embedded in LR white resin and subsequently dehydrated in several steps using 0.2% glutaraldehyde as fixative. Thin sections cut with an ultramicrotome were incubated with rabbit anti-CRS polyclonal antibody followed by nanogold labeled goat anti-rabbit IgG (whole molecule) secondary antibody and visualized under a transmission electron microscope. The various fields of view were observed and gold particles were found to be predominantly present on the surface of the cells (FIG. 7). No labeling occurred in cells as a negative control.</span>
    </p>
    <p num="0110" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換体の使用</u> <br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有するポリペプチドをコードするDNAを含む本発明の形質転換体を用いるとき、光学的に純粋なアルコールを製造することができる。さらにまた、カルボニルレダクターゼ活性を有するポリペプチドを発現する発現プラスミドpET23(a)-omp-CRSを有する形質転換体が用いられるならば、光学的に純粋なアルコールを製造することができる。カルボニルレダクターゼ活性及び補酵素再生活性を有するポリペプチドを発現する発現ベクターpETDuet1-omp-CRS;omp-GDHを有する形質転換体が用いられるとき、光学的に純粋なアルコールを製造することができる。特に、カルボニルレダクターゼ活性及び補酵素再生活性を有するポリペプチドを発現する発現ベクターpETDuet1-omp-CRS;omp-GDHを有する形質転換体が用いられるとき、光学的に活性なアルコールはより効率的に製造され得る。<br class="style-scope patent-text">
  本発明のカルボニルレダクターゼ活性を有するポリペプチドをコードするDNA及び補酵素再生能力を有するポリペプチドをコードするDNAの両方を含む形質転換体は、本発明のカルボニルレダクターゼ活性を有するポリペプチドをコードするDNA及び補酵素再生能力を有するポリペプチドをコードするDNAの両方を単一ベクターに導入することによって入手できる。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有するポリペプチドをコードするDNA及び補酵素再生能力を有するポリペプチドをコードするDNAの両方が導入されたベクターの例として、pETDuet1-omp-CRS;omp-GDHを記載することができる。<br class="style-scope patent-text">
  さらにまた、カルボニルレダクターゼ活性を有するポリペプチドをコードするDNA及び補酵素再生能力を有するポリペプチドをコードするDNAの両方を含む形質転換体の例として、大腸菌BL21(DE3)を該当ベクターで形質転換することによって入手される大腸菌BL21(DE3)+pETDuet1-omp-CRS;omp-GDHを記載することができる。<br class="style-scope patent-text">
  さらにまた、カルボニルレダクターゼ活性を有するポリペプチドをコードするDNA及び補酵素再生能力を有するポリペプチドをコードするDNAの両方を含む形質転換体の例として、大腸菌C43(DE3)を該当ベクターで形質転換することによって入手される大腸菌C41(DE3)+pETDuet1-omp-CRS;omp-GDHを記載することができる。<br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有するポリペプチドをコードするDNAを含む形質転換体、並びにカルボニルレダクターゼ活性を有するポリペプチドをコードするDNA及び補酵素再生能力を有するポリペプチドをコードするDNAの両方を含む形質転換体の培養は、一般的に用いられている、炭素原、窒素原、無機塩及び有機栄養物などを含有する液体栄養培地で（前記転換体が増殖するかぎり）実施することができる。
</span> <u class="style-scope patent-text">Use of</u> Transformants When using the transformant of the present invention containing a DNA encoding a polypeptide having a carbonyl reductase activity, optically pure alcohols can be produced. Furthermore, optically pure alcohols can be produced if transformants with the expression plasmid pET23 (a) -omp-CRS expressing polypeptides having carbonyl reductase activity are used. When a transformant having an expression vector pETDuet1-omp-CRS; omp-GDH which expresses a polypeptide having a carbonyl reductase activity and a coenzyme regenerating activity is used, an optically pure alcohol can be produced. In particular, when a transformant having an expression vector pETDuet1-omp-CRS; omp-GDH which expresses a polypeptide having a carbonyl reductase activity and a coenzyme regenerating activity is used, optically active alcohol is more efficiently produced. It can be done. <br class="style-scope patent-text"> A transformant containing both a DNA encoding a polypeptide having a carbonyl reductase activity of the present invention and a DNA encoding a polypeptide having a coenzyme regeneration ability comprises a DNA encoding a polypeptide having a carbonyl reductase activity of the present invention And DNA encoding a polypeptide having coenzyme regeneration ability can be obtained by introducing into a single vector. <br class="style-scope patent-text"> PETDuet1-omp-CRS; omp-GDH can be described as an example of a vector into which both a DNA encoding a polypeptide having carbonyl reductase activity and a DNA encoding a polypeptide having coenzyme regenerating ability have been introduced. . <br class="style-scope patent-text"> Furthermore, E. coli BL21 (DE3) is transformed with the corresponding vector as an example of a transformant containing both a DNA encoding a polypeptide having a carbonyl reductase activity and a DNA encoding a polypeptide having a coenzyme regeneration ability. E. coli BL21 (DE3) + pETDuet1-omp-CRS; omp-GDH which can be obtained by <br class="style-scope patent-text"> Furthermore, E. coli C43 (DE3) is transformed with the corresponding vector as an example of a transformant containing both a DNA encoding a polypeptide having a carbonyl reductase activity and a DNA encoding a polypeptide having a coenzyme regeneration ability. E. coli C41 (DE3) + pETDuet1-omp-CRS; omp-GDH which can be obtained by <br class="style-scope patent-text"> A transformant comprising DNA encoding a polypeptide having carbonyl reductase activity, and a transformant comprising both a DNA encoding a polypeptide having carbonyl reductase activity and a DNA encoding a polypeptide having coenzyme regeneration ability Culturing can be carried out in a generally used liquid nutrient medium containing carbon sources, nitrogen sources, inorganic salts, organic nutrients and the like (as long as the transformant grows).</span>
    </p>
    <p num="0111" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">酵素活性のアッセイ方法</u> <br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有するポリペプチドを発現する形質転換体の活性は通常の方法で測定できる。例えば、カルボニルレダクターゼの活性は、50mMのリン酸緩衝液（pH6.5）中の1mLの反応混合物で入手できる。前記反応混合物は、2mMのECAA、0.2mMニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び5−20μLの全細胞生物触媒又は5−10μgの精製タンパク質又は10<sup class="style-scope patent-text">6</sup>−10<sup class="style-scope patent-text">7</sup>の全細胞生物触媒を含み、反応は、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の酸化について分光光度計によって15から60分間340nm（分子吸収係数6.22mM<sup class="style-scope patent-text">-1</sup>cm<sup class="style-scope patent-text">-1</sup>）でモニターされた。<br class="style-scope patent-text">
  補酵素再生活性を有するポリペプチドを発現する形質転換体の活性は通常の方法で測定できる。例えば、グルコースデヒドロゲナーゼの活性は、100mMのトリスHCl緩衝液（pH8.0）中の1mLの反応混合物で入手できる。前記反応混合物は、10mMグルコース、0.5mMニコチンアミドアデニンジヌクレオチドリン酸（NADP）及び5−20μLの全細胞生物触媒又は5−10μgの精製タンパク質又は10<sup class="style-scope patent-text">6</sup>−10<sup class="style-scope patent-text">7</sup>の全細胞生物触媒を含み、反応は、ニコチンアミドアデニンジヌクレオチドリン酸（NADP）の還元について分光光度計によって15から60分間340nm（分子吸収係数6.22mM<sup class="style-scope patent-text">-1</sup>cm<sup class="style-scope patent-text">-1</sup>）でモニターされた。
</span> <u class="style-scope patent-text">Assay Method for Enzymatic Activity The activity of</u> a transformant expressing a polypeptide having carbonyl reductase activity can be measured by a conventional method. For example, the activity of carbonyl reductase is available in 1 mL of reaction mixture in 50 mM phosphate buffer (pH 6.5). The reaction mixture, 2mM of ECAA, whole cell biocatalyst of 0.2mM nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and whole cell biocatalysts or 5-10μg of the purified protein or 10 <sup class="style-scope patent-text">6</sup> -10 <sup class="style-scope patent-text">7</sup> 5-20μL The reaction was monitored at 340 nm (molecular absorption coefficient 6.22 mM <sup class="style-scope patent-text">−1</sup> cm <sup class="style-scope patent-text">−1</sup> ) by a spectrophotometer for oxidation of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) for 15 to 60 minutes. <br class="style-scope patent-text"> The activity of a transformant expressing a polypeptide having coenzyme regenerating activity can be measured by a conventional method. For example, the activity of glucose dehydrogenase is available in 1 mL of reaction mixture in 100 mM Tris HCl buffer (pH 8.0). The reaction mixture comprises a whole cell biocatalyst of 10mM glucose, 0.5 mM nicotinamide adenine dinucleotide phosphate (NADP) and whole cell biocatalyst or 5-10μg of 5-20μL purified protein or 10 <sup class="style-scope patent-text">6</sup> -10 <sup class="style-scope patent-text">7,</sup> The reaction was monitored by spectrophotometer at 340 nm (molecular absorption coefficient 6.22 mM <sup class="style-scope patent-text">−1</sup> cm <sup class="style-scope patent-text">−1</sup> ) for 15 to 60 minutes for reduction of nicotinamide adenine dinucleotide phosphate (NADP).</span>
    </p>
    <p num="0112" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">光学的に活性なアルコールの製造</u> <br class="style-scope patent-text">
  カルボニルレダクターゼ活性を有する形質転換体及び市場で入手できるグルコースデヒドロゲナーゼ、又はカルボニルレダクターゼ活性及び補酵素再生活性の両方を有する形質転換体のどちらかを用いる光学的に活性なアルコールの製造は、基質として適切なカルボニル基を含む化合物（エチル4-クロロ-3-オキソブチレートを含む）、補酵素ニコチンアミドアデニンジヌクレオチドリン酸（NADP）及びグルコースを適切な溶媒に添加し、pHを調節しつつ該混合物を攪拌することによって実施できる。<br class="style-scope patent-text">
  反応は、水性溶媒又は水性溶媒と有機溶媒の混合物中で実施できる。有機溶媒の例には、酢酸n-ブチル、酢酸エチル、ジエチルエーテル、メチルn-ブチルエーテル、ジ-n-ブチルエーテルなどが含まれる。好ましくは、反応は30℃で実施でき、反応溶液のpHは、5NのNaOHで6.5に維持される。
</span> <u class="style-scope patent-text">Production of Optically Active Alcohol Optically Active Using</u> Transformant Having Carbonyl Reductase Activity and Commercially Available Glucose Dehydrogenase, or Transformant Having Both Carbonyl Reductase Activity and Coenzyme Regeneration Activity In the production of alcohol, a compound containing an appropriate carbonyl group as a substrate (including ethyl 4-chloro-3-oxobutyrate), coenzyme nicotinamide adenine dinucleotide phosphate (NADP) and glucose are added to an appropriate solvent This can be done by stirring the mixture while adjusting the pH. <br class="style-scope patent-text"> The reaction can be carried out in an aqueous solvent or a mixture of aqueous and organic solvents. Examples of organic solvents include n-butyl acetate, ethyl acetate, diethyl ether, methyl n-butyl ether, di-n-butyl ether and the like. Preferably, the reaction can be carried out at 30 ° C. and the pH of the reaction solution is maintained at 6.5 with 5N NaOH.</span>
    </p>
    <p num="0113" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">基質及び生成物</u> <br class="style-scope patent-text">
  基質として適切なカルボニル基を有する脂肪族化合物の例には、下記式1で表されるエチル4-クロロ-3-オキソブチレート、下記式7で表されるエチル-3-オキソブタノエート、下記式8で表されるエチル4-メチル-3-オキソペンタノエート、下記式9で表されるオクチル4-クロロ-3-オキソブタノエート、下記式10で表されるエチル4,4,4-トリフルオロ-3-オキソブタノエート、及び下記式11で表されるエチル2-クロロ-3-オキソブチレートが含まれる：
</span>Examples of aliphatic compounds having a carbonyl group suitable as a <u class="style-scope patent-text">substrate and a product</u> substrate include ethyl 4-chloro-3-oxobutyrate represented by the following formula 1 and ethyl-3-oxo represented by the following formula 7 Butanoate, ethyl 4-methyl-3-oxopentanoate represented by the following formula 8, octyl 4-chloro-3-oxobutanoate represented by the following formula 9, ethyl represented by the following formula 10 Included are 4,4,4-trifluoro-3-oxobutanoate, and ethyl 2-chloro-3-oxobutyrate represented by Formula 11 below:</span>
    </p>
    <p num="0114" class="style-scope patent-text">
      <chemistry id="" num="27" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0115" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  基質として適切なカルボニル基を有する芳香族化合物の例には、下記の式12で表されるアセトフェノン、式13で表される1-(4-フルオロフェニル)エタノン、式14で表される1-(4-クロロフェニル)エタノン、式15で表される1-(4-ブロモフェニル)エタノン、式16で表される1-(4-(トリフルオロメチル)フェニル)エタノン、式17で表される1-p-トリルエタノン、式18で表される1-(4-メトキシフェニル)エタノン及び式19で表されるインドリン-2,3-ジオンが含まれる：
</span>
&nbsp;&nbsp;Examples of the aromatic compound having a carbonyl group suitable as a substrate include acetophenone represented by the following formula 12, 1- (4-fluorophenyl) ethanone represented by the formula 13, 1- (4-chlorophenyl) ethanone, 1- (4-bromophenyl) ethanone represented by formula 15, 1- (4- (trifluoromethyl) phenyl) ethanone represented by formula 16, 1 represented by formula 17 and p-tolyl ethanone, 1- (4-methoxyphenyl) ethanone of formula 18 and indoline-2,3-diones of formula 19:
</span>
    </p>
    <p num="0116" class="style-scope patent-text">
      <chemistry id="" num="28" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0117" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上述の反応条件下で、基質として上記式1で表されるエチル4-クロロ-3-オキソブチレートが用いられるとき、下記式2で表されるエチル(S)-4-クロロ-3-ヒドロキシブチレートを入手できる。<br class="style-scope patent-text">
  基質として上記式7で表されるエチル-3-オキソブタノエートが用いられるとき、下記式20で表されるエチル(R)-3-ヒドロキシブタノエートを入手できる。<br class="style-scope patent-text">
  基質として上記式8で表されるエチル4-メチル-3-オキソペンタノエートが用いられるとき、下記式21で表されるエチル(S)-3-ヒドロキシ-4-メチルペンタノエ−トを入手できる。<br class="style-scope patent-text">
  基質として上記式9で表されるオクチル4-クロロ-3-オキソブタノエートが用いられるとき、下記式22で表されるオクチル(S)-4-クロロ-3-ヒドロキシブタノエートを入手できる。<br class="style-scope patent-text">
  基質として上記式10で表されるエチル4,4,4-トリフルオロ-3-オキソブタノエートが用いられるとき、下記式23で表されるオクチル(S)-4-クロロ-3-ヒドロキシブタノエートを入手できる。<br class="style-scope patent-text">
  基質として上記式11で表されるエチル2-クロロ-3-オキソブタノエートが用いられるとき、下記式24で表される(2R,3R)-エチル2-クロロ-3-ヒドロキシブタノエートを入手できる。
</span>When ethyl 4-chloro-3-oxobutyrate represented by the above formula 1 is used as a substrate under the above reaction conditions, ethyl (S) -4-chloro-3-hydroxy represented by the following formula 2 Butyrate is available. <br class="style-scope patent-text"> When ethyl 3-oxobutanoate represented by the above formula 7 is used as a substrate, ethyl (R) -3-hydroxybutanoate represented by the following formula 20 can be obtained. <br class="style-scope patent-text"> When ethyl 4-methyl-3-oxopentanoate represented by the above formula 8 is used as a substrate, ethyl (S) -3-hydroxy-4-methylpentanoate represented by the following formula 21 is obtained it can. <br class="style-scope patent-text"> When octyl 4-chloro-3-oxobutanoate represented by the above formula 9 is used as a substrate, octyl (S) -4-chloro-3-hydroxybutanoate represented by the following formula 22 can be obtained . <br class="style-scope patent-text"> When ethyl 4,4,4-trifluoro-3-oxobutanoate represented by the above formula 10 is used as a substrate, octyl (S) -4-chloro-3-hydroxybuta represented by the following formula 23 Nooate is available. <br class="style-scope patent-text"> When ethyl 2-chloro-3-oxobutanoate represented by the above formula 11 is used as a substrate, (2R, 3R) -ethyl 2-chloro-3-hydroxybutanoate represented by the following formula 24 It is available.</span>
    </p>
    <p num="0118" class="style-scope patent-text">
      <chemistry id="" num="29" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0119" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  基質として上記式12で表されるアセトフェノンが用いられるとき、下記式25で表される (R)-1-フェニルエタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式13で表される1-(4-フルオロフェニル)エタノンが用いられるとき、下記式26で表される(R)-1-(4-フルオロフェニル)エタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式14で表される1-(4-クロロフェニル)エタノンが用いられるとき、下記式27で表される(R)-1-(4-クロロフェニル)エタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式15で表される1-(4-ブロモフェニル)エタノンが用いられるとき、下記式28で表される(R)-1-(4-ブロモフェニル)エタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式16で表される1-(4-(トリフルオロメチル)フェニル)エタノンが用いられるとき、下記式29で表される(R)-1-(4-(トリフルオロメチル)フェニル)エタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式17で表される1-p-トリルエタノンが用いられるとき、下記式30で表される(R)-1-p-トリルエタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式18で表される1-(4-メトキシフェニル)エタノンが用いられるとき、下記式31で表される(R)-1-(4-メトキシフェニル)エタノールを入手できる。<br class="style-scope patent-text">
  基質として上記式9で表される1-(4-ニトロフェニル)エタノンが用いられるとき、下記式32で表される(R)-1-(4-ニトロフェニル)エタノールを入手できる。
</span>When acetophenone represented by the above formula 12 is used as a substrate, (R) -1-phenylethanol represented by the following formula 25 can be obtained. <br class="style-scope patent-text"> When 1- (4-fluorophenyl) ethanone represented by the above formula 13 is used as a substrate, (R) -1- (4-fluorophenyl) ethanol represented by the following formula 26 can be obtained. <br class="style-scope patent-text"> When 1- (4-chlorophenyl) ethanone represented by the above formula 14 is used as a substrate, (R) -1- (4-chlorophenyl) ethanol represented by the following formula 27 can be obtained. <br class="style-scope patent-text"> When 1- (4-bromophenyl) ethanone represented by the above Formula 15 is used as a substrate, (R) -1- (4-bromophenyl) ethanol represented by the following Formula 28 can be obtained. <br class="style-scope patent-text"> When 1- (4- (trifluoromethyl) phenyl) ethanone represented by the above formula 16 is used as a substrate, (R) -1- (4- (trifluoromethyl) phenyl) represented by the following formula 29 Ethanol is available. <br class="style-scope patent-text"> When 1-p-tolyletanone represented by the above formula 17 is used as a substrate, (R) -1-p-tolylethanol represented by the following formula 30 can be obtained. <br class="style-scope patent-text"> When 1- (4-methoxyphenyl) ethanone represented by the above formula 18 is used as a substrate, (R) -1- (4-methoxyphenyl) ethanol represented by the following formula 31 can be obtained. <br class="style-scope patent-text"> When 1- (4-nitrophenyl) ethanone represented by the above formula 9 is used as a substrate, (R) -1- (4-nitrophenyl) ethanol represented by the following formula 32 can be obtained.</span>
    </p>
    <p num="0120" class="style-scope patent-text">
      <chemistry id="" num="30" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p num="0121" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">精製及び分析</u> <br class="style-scope patent-text">
  前記反応によって製造される光学的に純粋なアルコールは、通常的方法、例えば前記方法によって生成された光学的に純粋なアルコールを含む反応混合物を有機溶媒の酢酸エチルで抽出し、減圧下で蒸留して有機溶媒を除去し、生成混合物を蒸留、再結晶化又はクロマトグラフィープロセスに付すことによって精製することができる。<br class="style-scope patent-text">
  生成物の光学的純粋性は、ダイセル化学工業（Daicel Chemical Industries）の製品のキラセル（Chiracel）OB-H、キラセルOD-H、キラセルOJを用い高速液体クロマトグラフィーによって測定した。<br class="style-scope patent-text">
  全ての化合物の構造をNMRで確認した。NMRは溶媒としてCDCl<sub class="style-scope patent-text">3</sub>、CD<sub class="style-scope patent-text">3</sub>OD又はCD<sub class="style-scope patent-text">3</sub>SOCD<sub class="style-scope patent-text">3</sub>を用いて実施した。化学的シフトは内部標準として用いたTMSからのダウンフィールドとして報告される。カップリング定数Jの値はHzで報告される。
</span> <u class="style-scope patent-text">Purification and analysis The</u> optically pure alcohol produced by the above reaction is extracted by a conventional method, for example, the reaction mixture containing the optically pure alcohol produced by the above method with the organic solvent ethyl acetate, under reduced pressure Can be purified by distillation to remove the organic solvent and subjecting the product mixture to a distillation, recrystallization or chromatography process. <br class="style-scope patent-text"> The optical purity of the product was determined by high performance liquid chromatography using Chiracel OB-H, Kiraceel OD-H, Kiracel OJ, a product of Daicel Chemical Industries. <br class="style-scope patent-text"> The structures of all compounds were confirmed by NMR. NMR was performed using CDCl <sub class="style-scope patent-text">3</sub> , CD <sub class="style-scope patent-text">3</sub> OD or CD <sub class="style-scope patent-text">3</sub> SOCD <sub class="style-scope patent-text">3</sub> as solvent. Chemical shifts are reported as downfield from TMS used as an internal standard. The value of coupling constant J is reported in Hz.</span>
    </p>
    <p num="0122" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">分析データ</u> <br class="style-scope patent-text">
  ケトンの生物触媒還元から得られたアルコールは、シリカゲル上でのフラッシュクロマトグラフィーによって精製された。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式2の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.28 (3H, t, J = 7.2 Hz); 2.63 (3H, m); 3.61 (2H, dd, J = 7.2, 5.4 Hz); 4.18 (2H, q, J = 7.2 Hz); 4.23 (1H, m).HPLC: キラセルOB-H, λ217, ヘキサン:イソプロパノール 96:4, 1 mL/分．保持時間 13.2分(R) 及び 14.3 分(S).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -22.1 (c = 8.72, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式20の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.21 (3H, d, J = 6.5 Hz); 1.26 (3H, t, J = 6.8 Hz); 2.46 (2H, m); 3.00 (1H, bs); 4.16 (3H, m).HPLC: キラセルOB-H, λ217, ヘキサン:イソプロパノール 96:4, 1 mL/分．保持時間 9.4 分(S)及び10.5分 (R).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -44.2 (c = 2.03, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式21の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 0.90 and 0.93 (各3H, 各t, J = 6.8 Hz); 1.26 (3H, t, J = 7.2 Hz); 1.69 (1H, m); 2.38 (1H, dd, J = 9.6, 16.5 Hz); 2.52 (1H, dd, J = 2.8, 16.5 Hz); 2.94 (1H, bs); 3.75 (1H, m,); 4.14 (2H, q, J = 7.2 Hz).HPLC: キラセルOD-H, λ217, ヘキサン:イソプロパノール95:5, 1 mL/分．保持時間 5.3 分(S) 及び7.7分(R).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -40.8 (c = 2.56, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式22の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 0.86 (3H, t, J = 6.9 Hz, H2 CH3); 1.27 (10H, m, 5 x CH<sub class="style-scope patent-text">2</sub>); 1.61 (2H, m); 2.62 (2H, m); 3.60 (2H, m); 4.11 (2H, t, J = 6.8 Hz); 4.14 (1H, m, H3).HPLC: キラセルOB-H, λ217, ヘキサン:イソプロパノール 96:4, 1 mL/分．保持時間 5.7分(R) 及び7.6 分(S).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -15.9 (c = 4.60, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式23の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.29 (3H, t, J = 7.2 Hz); 2.70 (2H, m); 4.21 (2H, q, J = 7.2 Hz); 4.43 (1H, m).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -20.3 (c = 1.87, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式24の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.34 (m, 6H); 4.25 (m, 4H).de = &gt;96％ by GC: Factorfour<sup class="style-scope patent-text">TM</sup> (Varian, 30m x 0.25mm, 140℃, N<sub class="style-scope patent-text">2</sub> 1 kg/分), 保持時間9.98 (syn), 8.85 (anti); &gt;99% anti.Ee.&gt;98％ GC betaDex<sup class="style-scope patent-text">TM</sup> (Supelco, 30m x 0.25mm, 140℃, N<sub class="style-scope patent-text">2</sub> 1 kg/分), 文献による旋光性の比較に基づいて一時的に割り当てた (2R, 3R) 立体配置 [α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -3.8 (c = 1.13, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式25の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.49 (3H, d, J = 6.5 Hz); 2.10 (1H, bs); 4.87 (1H, q, J = 6.5 Hz); 7.35 (5H, m).HPLC:キラセル OB-H, λ217, ヘキサン:iイソプロパノール 96:4, 1 mL/分.保持時間6.2分(R)及び9.2分(S).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +54.8 (c = 2.74, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式26の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.49 (3H, d, J = 6.5 Hz); 2.03 (1H, bs); 4.89 (1H, q, J = 6.5 Hz); 7.01 and 7.03 (各2H, 各 d, J = 8.6 Hz).HPLC: キラセルOB-H, λ217, ヘキサン:イソプロパノール96:4, 1 mL/分.保持時間7.8分 (S)及び8.8 分(R).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +48.8 (c = 1.4, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式27の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.47 (3H, d, J = 6.5 Hz); 2.1 (1H, bs, OH); 4.87 (1H, q, J = 6.5 Hz); 7.31 (4H, s).HPLC: キラセルOB-H, λ217, ヘキサン:イソプロパノール96:4, 1 mL/分.保持時間8.9分(S)及び10.5分(R).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +49.2 (c = 1.83,エーテル)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式28の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl3): 1.47 (3H, d, J = 6.5 Hz); 2.08 (1H, bs); 4.87 (1H, q, J = 6.5 Hz); 7.25及び7.47 (各2H, 各, J = 8.7 Hz).HPLC:キラセルOB-H, λ217, ヘキサン:イソプロパノール96:4, 1 mL/分.保持時間9.4分(S)及び11.4分 (R).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +38.3 (c = 1.55, CHCl<sub class="style-scope patent-text">3</sub>).<br class="style-scope patent-text">
  <u class="style-scope patent-text">式29の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.5 (3H, d, J = 6.51 Hz); 2.33 (1H, bs); 4.98 (1H, q, J = 6.5 Hz); 7.48及び7.60 (各2H, 各d, J = 8.2 Hz).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +27.2 (c 2.08, MeOH).<br class="style-scope patent-text">
  <u class="style-scope patent-text">式30の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.48 (3H, d, J = 6.5 Hz); 2.01 (1H, bs); 2.38 (1H, s); 4.87 (1H, q, J = 6.5 Hz); 7.15及び7.26 (各2H, 各d, J = 7.9 Hz).HPLC:キラセル OB-H, λ217, ヘキサン:イソプロパノール95:5, 1 mL/分.保持時間10.1分(S)及び12.9分(R).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +52.1 (c = 1.98, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  <u class="style-scope patent-text">式31の化合物</u>：<sup class="style-scope patent-text">1</sup>H NMR(300 MHz, CDCl3): 1.46 (3H, d, J = 6.5 Hz); 2.08 (1H, bs); 3.80 (3H, s); 4.84 (1H, q, J = 6.5 Hz); 6.86及び7.28 (各2H, 各d, J = 8.2).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">22</sup>= +51.4 (c 1.72, CHCl<sub class="style-scope patent-text">3</sub>)。<br class="style-scope patent-text">
  式32の化合物：<sup class="style-scope patent-text">1</sup>H NMR (300 MHz, CDCl<sub class="style-scope patent-text">3</sub>): 1.52 (3H, t, J = 6.5 Hz, CH<sub class="style-scope patent-text">3</sub>); 2.50 (1H, bs, OH); 5.02 (1H, q, J = 6.5 Hz, CH); 7.54及び8.12 (各2H, 各d, J = 8.9 Hz,アリール).[α]<sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +31.4 (c = 3.99, CHCl<sub class="style-scope patent-text">3</sub>)。
</span> <u class="style-scope patent-text">Analytical Data The</u> alcohol obtained from the biocatalytic reduction of the ketone was purified by flash chromatography on silica gel. <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of Formula 2</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.28 (3 H, t, J = 7.2 Hz); 2.63 (3 H, m); 3.61 (2 H, dd, J = 7.2, 5.4 Hz); (2H, q, J = 7.2 Hz); 4.23 (1 H, m). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 96: 4, 1 mL / min. Retention time 13.2 minutes (R) and 14.3 minutes (S). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -22.1 (c = 8.72, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of formula 20</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.21 (3 H, d, J = 6.5 Hz); 1.26 (3 H, t, J = 6.8 Hz); 2.46 (2 H, m); 3.00 (1 H , bs); 4.16 (3H, m). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 96: 4, 1 mL / min. Retention time 9.4 minutes (S) and 10.5 minutes (R). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -44.2 (c = 2.03, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of formula 21</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 0.90 and 0.93 (each 3 H, each t, J = 6.8 Hz); 1.26 (3 H, t, J = 7.2 Hz); 1. 69 (1 H, m) 2.38 (1 H, dd, J = 9.6, 16.5 Hz); 2.52 (1 H, dd, J = 2.8, 16.5 Hz); 2.94 (1 H, bs); 3.75 (1 H, m,); 4.14 (2 H, q, J = 7.2 Hz). HPLC: Kiracel OD-H, λ 217, hexane: isopropanol 95: 5, 1 mL / min. Retention time 5.3 minutes (S) and 7.7 minutes (R). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -40.8 (c = 2.56, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of Formula 22</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 0.86 (3 H, t, J = 6.9 Hz, H <sub class="style-scope patent-text">2</sub> CH <sub class="style-scope patent-text">3</sub> ); 1. 27 (10 H, m, 5 x CH <sub class="style-scope patent-text">2</sub> ); 1.61 (2 H, m); 2.62 (2H, m); 3.60 (2H, m); 4.11 (2H, t, J = 6.8 Hz); 4.14 (1 H, m, H3). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 96: 4 , 1 mL / min. Retention time 5.7 minutes (R) and 7.6 minutes (S). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -15.9 (c = 4.60, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of Formula 23</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.29 (3 H, t, J = 7.2 Hz); 2.70 (2 H, m); 4.21 (2 H, q, J = 7.2 Hz); 4.43 (1 H , m). [α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -20.3 (c = 1.87, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compounds of formula <sup class="style-scope patent-text">24: 1 H NMR (300 MHz</sup> </u> , CDCl 3): 1.34 (m, 6H); 4.25 (m, 4H) .de =&gt; 96% by GC: Factorfour TM (Varian, 30m x 0.25mm, 140 ℃ , N <sub class="style-scope patent-text">2</sub> 1 kg / min), retention time 9.98 (syn), 8.85 (anti);&gt; 99% anti.Ee.&gt; 98% GC betaDex <sup class="style-scope patent-text">TM</sup> (Supelco, 30m x 0.25 mm, 140 ° C, N <sub class="style-scope patent-text">2</sub> 1 kg / Minutes), temporally assigned (2R, 3R) configuration based on comparison of optical rotations by literature [α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = -3.8 (c = 1.13, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of formula 25</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.49 (3 H, d, J = 6.5 Hz); 2. 10 (1 H, bs); 4. 87 (1 H, q, J = 6.5 Hz); 7. 35 (5 H , m). HPLC: Kiracel OB-H, λ 217, hexane: i-isopropanol 96: 4, 1 mL / min, retention time 6.2 min (R) and 9.2 min (S). [α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +54.8 (c = 2.74, CHCl <sub class="style-scope patent-text">3).</sub> <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of formula 26</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.49 (3 H, d, J = 6.5 Hz); 2.03 (1 H, bs); 4. 89 (1 H, q, J = 6.5 Hz); 7.01 and 7.03 (Each 2 H, each d, J = 8.6 Hz). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 96: 4, 1 mL / min. Retention time 7.8 min (S) and 8.8 min (R). ] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = + 48.8 (c = 1.4, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of Formula 27</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.47 (3 H, d, J = 6.5 Hz); 2.1 (1 H, bs, OH); 4. 87 (1 H, q, J = 6.5 Hz); 7.31 (4H, s). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 96: 4, 1 mL / min. Retention time 8.9 min (S) and 10.5 min (R). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +49.2 ( c = 1.83, ether). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of formula 28</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl 3): 1.47 (3 H, d, J = 6.5 Hz); 2.08 (1 H, bs); 4. 87 (1 H, q, J = 6.5 Hz); 7.25 and 7.47 ( Each 2 H, each, J = 8.7 Hz). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 96: 4, 1 mL / min, retention time 9.4 minutes (S) and 11.4 minutes (R). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25 = +38.3 (c = 1.55,</sup> CHCl 3). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compounds of formula 29</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.5 (3 H, d, J = 6.51 Hz); 2.33 (1 H, bs); 4.98 (1 H, q, J = 6.5 Hz); 7.48 and 7.60 (Each 2 H, each d, J = 8.2 Hz). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +27.2 (c 2.08, MeOH). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of formula 30</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.48 (3 H, d, J = 6.5 Hz); 2.01 (1 H, bs); 2. 38 (1 H, s); 4. 87 (1 H, q, J = 6.5 Hz); 7.15 and 7.26 (each 2 H, each d, J = 7.9 Hz). HPLC: Kiracel OB-H, λ 217, hexane: isopropanol 95: 5, 1 mL / min, retention time 10.1 min (S) and 12.9 Minutes (R). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">25</sup> = +52.1 (c = 1.98, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> <u class="style-scope patent-text">Compound of Formula 31</u> : <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl 3): 1.46 (3 H, d, J = 6.5 Hz); 2.08 (1 H, bs); 3. 80 (3 H, s); 4. 84 (1 H, q, J = 6.5) Hz); 6.86 and 7.28 (each 2 H, each d, J = 8.2). [Α] <sub class="style-scope patent-text">D</sub> <sup class="style-scope patent-text">22</sup> = +51.4 (c 1.72, CHCl <sub class="style-scope patent-text">3</sub> ). <br class="style-scope patent-text"> Compound of formula 32: <sup class="style-scope patent-text">1</sup> H NMR (300 MHz, CDCl <sub class="style-scope patent-text">3</sub> ): 1.52 (3 H, t, J = 6.5 Hz, CH <sub class="style-scope patent-text">3</sub> ); 2.50 (1 H, bs, OH); 5.02 (1 H, q, J = 6.5 Hz , CH);. 7.54 and 8.12 (each 2H, each d, J = 8.9 Hz, <sub class="style-scope patent-text"> <sup class="style-scope patent-text">aryl) [α] D 25 = +31.4</sup> </sub> (c = 3.99, CHCl 3).</span>
    </p>
    <p num="0123" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  下記の記載は単に実施態様の見本であり、本発明に対しその範囲、応用性又は構成をいかなる態様でも制限することを意図せず、むしろ以下の記載は、本発明の典型的な実施態様の実行のための便利な例示を提供し、記載した実施態様に対する種々の変更を本発明の範囲を逸脱することなく記載の成分の機能及び構成において実施することが可能である。<br class="style-scope patent-text">
  <u class="style-scope patent-text">実施例</u> <br class="style-scope patent-text">
  以下の実施例で用いられる組換えDNA技術に関する具体的な操作方法は以下の文献に記載されている：Sambrook, J.et al.Molecular Cloning: A Laboratory Manual.Cold Spring Harbor Laboratory Press.1989; Vol.2。
</span>The following description is merely a sample of the embodiments and is not intended to limit the scope, applicability or configuration of the present invention in any manner to the present invention, but rather the following description is a representative embodiment of the present invention. It provides a convenient illustration for implementation and that various modifications to the described embodiments can be made in the function and arrangement of the described components without departing from the scope of the present invention. <br class="style-scope patent-text"> <u class="style-scope patent-text">EXAMPLES</u> Specific procedures for recombinant DNA techniques used in the following examples are described in the following documents: Sambrook, J. et al. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press. 1989 Vol.2.</span>
    </p>
    <embodiments-example ex-num="1" class="style-scope patent-text">
      <p num="0124" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">大腸菌の表面でカルボニルレダクターゼを発現する発現プラスミドpET23(a)-omp-CRSの構築</u> <br class="style-scope patent-text">
  本発明のDNAを有する人工的な注文合成プラスミドpUC19-omp-CRSは、配列リストの配列番号:1のアミノ酸配列をコードする配列リストの配列番号:2のヌクレオチド配列を有する。前記プラスミドをNde1及びEcoR1で二重消化し、生成物をアガロースゲル電気泳動によって分離した。1.3KbのDNAフラグメントは配列リストの配列番号:2のヌクレオチド配列を有し、前記をゲルから切り出しキアクイックキット（Qiaquick kit（Qiagen））を用いて精製した。プラスミドpET23(a)を別にNde1及びEcoR1で消化し、続いて自家結合を回避するためにウシ腸アルカリホスファターゼを用いて脱リン酸化を実施した。Nde1及びEcoR1（NEB Ltd, UK）消化1.3Kb DNAフラグメントは配列リストの配列番号:2のヌクレオチド配列を有し、pET23(a)がT4DNAリガーゼ（NEB Ltd, UK）を用いて連結され、大腸菌DH5αを形質転換した。生成クローンをアンピシリン（100mg/mL）含有LBブロスで増殖させ、プラスミドを単離し、続いて前記をNde1及びEcoR1で二重消化した。二重消化後にプラスミドは3.6KbのpET23(a)骨格及び1.3KbのDNA挿入物を生じ、配列リストの配列番号:2のヌクレオチド配列がpET23(a)のlacプロモーターの下流でクローニングされ、4.9KbのプラスミドpET23(a)-omp-CRSを生じたことを示唆した。<br class="style-scope patent-text">
  プラスミドpET23(a)-omp-CRSの制限マップは図5に示されている。<br class="style-scope patent-text">
  大腸菌BL21(DE3)、大腸菌C41(DE3)又は大腸菌C43(DE3)が、プラスミドpET23(a)-omp-CRSで形質転換された（前記プラスミドは形質転換体の表面でカルボニルレダクターゼを発現する）。
</span> <u class="style-scope patent-text">Construction of Expression Plasmid pET23 (a) -omp-CRS Expressing a Carbonyl Reductase on the Surface of Escherichia coli</u> An artificial custom-made plasmid pUC19-omp-CRS carrying the DNA of the present invention is the amino acid sequence of SEQ ID NO: 1 in the Sequence Listing Has the nucleotide sequence of SEQ ID NO: 2 of the sequence listing encoding The plasmid was double digested with Nde1 and EcoR1 and the products separated by agarose gel electrophoresis. The 1.3 Kb DNA fragment has the nucleotide sequence of SEQ ID NO: 2 in the Sequence Listing and was excised from the gel and purified using the Qiaquick kit (Qiaquick kit (Qiagen)). The plasmid pET23 (a) was separately digested with Nde1 and EcoR1, followed by dephosphorylation using calf intestinal alkaline phosphatase to avoid self-binding. The Nde1 and EcoR1 (NEB Ltd, UK) digested 1.3 Kb DNA fragment has the nucleotide sequence of SEQ ID NO: 2 in the Sequence Listing, pET23 (a) is ligated using T4 DNA ligase (NEB Ltd, UK), E. coli DH5α Was transformed. The resulting clone was grown in LB broth containing ampicillin (100 mg / mL), the plasmid was isolated and subsequently it was double digested with Nde1 and EcoR1. After double digestion, the plasmid yields a 3.6 Kb pET23 (a) backbone and a 1.3 Kb DNA insert, and the nucleotide sequence of SEQ ID NO: 2 in the sequence listing is cloned downstream of the lac promoter of pET23 (a), 4.9 Kb It suggested that the plasmid pET23 (a) -omp-CRS was generated. <br class="style-scope patent-text"> The restriction map of plasmid pET23 (a) -omp-CRS is shown in FIG. <br class="style-scope patent-text"> E. coli BL21 (DE3), E. coli C41 (DE3) or E. coli C43 (DE3) were transformed with plasmid pET23 (a) -omp-CRS, which expresses carbonyl reductase on the surface of transformants.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="2" class="style-scope patent-text">
      <p num="0125" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換体の細胞質でカルボニルレダクターゼを発現する発現ベクターpET23(a)-CRSの構築</u> <br class="style-scope patent-text">
  前記を米国特許2010/0028972に開示された情報を用いて構築した。クローニング用CRSF（配列番号:26）及びCRSR（配列番号:28）プライマーは、配列リストの配列番号:14で表されるカルボニルレダクターゼ遺伝子のヌクレオチド配列に基づいて合成された（配列番号:14は配列リストの配列番号:13のアミノ酸配列を有するポリペプチドをコードする）。注文合成pUC19-omp-CRSプラスミドを1反応30サイクルのポリメラーゼ連鎖反応（PCR）に付した。PCR条件は、95℃で5分の最初の変性、続いて以下の30サイクル（95℃で60秒、58℃で60秒及び72℃で60秒とともに72℃で5分の最後の伸長工程）であった。精製PCR生成物をNde1及びXho1で消化し、1％アガロースゲル上で泳動した。0.87KbのNde1及びXho1消化フラグメントをゲルから切り出し、キアクイックキット（Qiagen）を用いて精製した。プラスミドpET23(a)を別にNde1及びXho1で消化し、続いて自家結合を回避するためにウシ腸アルカリホスファターゼを用いて脱リン酸化を実施した。Nde1及びXho1消化0.87Kb は配列リストの配列番号:14のヌクレオチド配列を有し、pET23(a)がT4DNAリガーゼを用いて連結され、大腸菌DH5αを形質転換した。生成クローンをアンピシリン含有LBブロスで増殖させ、プラスミドを単離し、続いて前記をNde1及びXho1で二重消化した。二重消化後にプラスミドは3.6KbのpET23(a)骨格及び0.87Kbの挿入物を生じ、0.87Kb遺伝子はpET23(a)のlacプロモーターの下流でクローニングされ、4.4KbのプラスミドpET23(a)-CRSを生じたことを示唆した。<br class="style-scope patent-text">
  大腸菌BL21(DE3)がプラスミドpET23(a)-CRSで形質転換された（前記プラスミドは細胞質でカルボニルレダクターゼを発現する）。
</span> <u class="style-scope patent-text">Construction of Expression Vector pET23 (a) -CRS Expressing Carbonyl Reductase in the Cytoplasm of Transformant The</u> above was constructed using the information disclosed in US Patent 2010/0028972. The CRSF (SEQ ID NO: 26) and CRSR (SEQ ID NO: 28) primers for cloning were synthesized based on the nucleotide sequence of the carbonyl reductase gene represented by SEQ ID NO: 14 in the sequence listing (SEQ ID NO: 14 is a sequence) Encoding a polypeptide having the amino acid sequence of SEQ ID NO: 13 in the list). Custom synthesized pUC19-omp-CRS plasmid was subjected to one reaction 30 cycles of polymerase chain reaction (PCR). The PCR conditions are: first denaturation for 5 minutes at 95 ° C., followed by 30 cycles (last extension step for 5 minutes at 72 ° C. with 60 seconds at 95 ° C., 60 seconds at 58 ° C. and 60 seconds at 72 ° C.) Met. The purified PCR product was digested with Nde1 and Xho1 and run on a 1% agarose gel. The 0.87 Kb Nde1 and Xho1 digested fragments were excised from the gel and purified using the QIAQUICK kit (Qiagen). The plasmid pET23 (a) was separately digested with Nde1 and Xho1, followed by dephosphorylation using calf intestinal alkaline phosphatase to avoid self-binding. Nde1 and Xho1 digested 0.87 Kb has the nucleotide sequence of SEQ ID NO: 14 in the Sequence Listing, and pET23 (a) was ligated with T4 DNA ligase to transform E. coli DH5α. The resulting clones were grown in LB broth containing ampicillin, plasmids were isolated and subsequently double digested with Nde1 and Xho1. After double digestion the plasmid yielded a 3.6 Kb pET23 (a) backbone and a 0.87 Kb insert, the 0.87 Kb gene was cloned downstream of the lac promoter of pET23 (a) and the 4.4 Kb plasmid pET23 (a) -CRS It suggested that it occurred. <br class="style-scope patent-text"> E. coli BL21 (DE3) was transformed with plasmid pET23 (a) -CRS, which expresses carbonyl reductase in the cytoplasm.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="3" class="style-scope patent-text">
      <p num="0126" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">カルボニルレダクターゼ及びグルコースデヒドロゲナーゼを形質転換体の表面で共同発現する発現ベクターpETDuet1-omp-CRSの構築</u> <br class="style-scope patent-text">
  発現ベクターpETDuet1-omp-CRSは2つのポリペプチドを共同発現する。前記ポリペプチドの一方は、配列リストの配列番号:１のアミノ酸配列を有し、カルボニルレダクターゼ活性を示し、他方のポリペプチドは配列リストの配列番号:<u class="style-scope patent-text">９</u>のアミノ酸配列を有し形質転換体の表面で補酵素再生活性を示す。前記発現ベクターの構築という目標を達成するために、発明者らは、2つのマルチクローニングサイトを含むプラスミドpETDuet1を選択した（前記マルチクローニングサイトの各々でT7プロモーター/lacオペレーター及びリボソーム結合部位（rbs）が先行する）。omp-CRS及びomp-GDH遺伝子をpETDuet1プラスミドでクローニングした（前記は二段工程である）。<br class="style-scope patent-text">
  第一の工程では、本発明のDNA（配列リストの配列番号:1のアミノ酸配列を有するポリペプチドをコードする配列リストの配列番号:2のヌクレオチド配列を有する）をプラスミドpUC19-omp-CRSから増幅した（前記はプライマーoc1F（配列番号:30）及びoc1R（配列番号:32）によるポリメラーゼ連鎖反応（PCR）の鋳型として用いられた）。PCR条件は、95℃で5分の最初の変性、続いて以下の30サイクル（95℃で60秒、55℃で60秒及び72℃で90秒とともに72℃で5分の最後の伸長工程）であった。精製PCR生成物をNco1及びHind3で消化し、1％アガロースゲル上で泳動した。1.3KbのNco1及びHind3消化フラグメントをゲルから切り出し、キアクイックキット（Qiagen）を用いて精製した。プラスミドpETDuetを別にNco1及びHind3で消化し、続いて自家結合を回避するためにウシ腸アルカリホスファターゼを用いて脱リン酸化を実施した。T4DNAリガーゼを用いてNco1及びHind3消化omp-CRS及びpETDuet1を連結し、大腸菌DH5αを形質転換した。生成クローンをアンピシリン（100μg/mL）含有LBブロスで増殖させ、前記からプラスミドを単離し、続いてNco1及びHind3で二重消化した。二重消化後にプラスミドは〜5.4KbのpETDuet1骨格及び1.3Kbの配列番号:2の挿入物を生じ、配列番号:2はpETDuet1のlacプロモーターの下流の第一のマルチクローニングサイトでクローニングされ、6.7KbのプラスミドpETDuet1-omp-CRSを生じたことを示唆した。<br class="style-scope patent-text">
  第二の工程では、本発明のDNA（配列リストの配列番号:<u class="style-scope patent-text">９</u>のアミノ酸配列を有するポリペプチドをコードする配列リストの配列番号:<u class="style-scope patent-text">１０</u>のヌクレオチド配列を有する）を人工的な注文製作プラスミドpUC19-omp-GDHから増幅した（前記はプライマーogF（配列番号:34）及びogR（配列番号:36）によるポリメラーゼ連鎖反応（PCR）の鋳型として用いられた）。PCR条件は、95℃で5分の最初の変性、続いて以下の30サイクル（95℃で60秒、55℃で60秒及び72℃で90秒とともに72℃で5分の最後の伸長工程）であった。精製PCR生成物をNde1及びXho1で消化し、アガロースゲル上で泳動した。1.2KbのNde1及びXho1消化フラグメントをゲルから切り出し、キアクイックキット（Qiagen）を用いて精製した。上記記載のように構築した6.7KbプラスミドpETDuet1-omp-CRSを別にNde1及びXho1で消化し、続いて自家結合を回避するためにウシ腸アルカリホスファターゼを用いて脱リン酸化を実施した。T4DNAリガーゼを用いてNde1及びXho1消化配列番号:4及びpETDuet1-omp-CRSを連結し、大腸菌DH5αを形質転換した。生成クローンをアンピシリン含有LBブロスで増殖させ、前記からプラスミドを単離し、続いてNde1及びXho1で二重消化した。二重消化後にプラスミドは〜6.7KbのpETDuet1-omp-CRS骨格及び1.2Kbのomp-GDH挿入物を生じ、omp-GDHはpETDuet1-omp-CRSのlacプロモーターの下流の第二のマルチクローニングサイトでクローニングされ、7.8KbのプラスミドpETDuet1-omp-CRS,omp-GDHを生じたことを示唆した。<br class="style-scope patent-text">
  プラスミドpETDuet1-omp-CRS,omp-GDHの制限マップは図6に示されている。<br class="style-scope patent-text">
  大腸菌BL21(DE3)、大腸菌C41(DE3)又は大腸菌C43(DE3)が、プラスミドpETDuet1-omp-CRS,omp-GDHで形質転換された（前記は形質転換体の表面でカルボニルレダクターゼ及びグルコースデヒドロゲナーゼを共同発現する）。
</span> <u class="style-scope patent-text">Construction of</u> Expression Vector pETDuet1-omp-CRS <u class="style-scope patent-text">Co-Expressing Carbonyl Reductase and Glucose Dehydrogenase on the Surface of Transformant The</u> expression vector pETDuet1-omp-CRS co-expresses two polypeptides. One of the polypeptides has the amino acid sequence of SEQ ID NO: 1 in the sequence listing and shows carbonyl reductase activity, and the other polypeptide has the amino acid sequence of SEQ ID NO: <u class="style-scope patent-text">9 in</u> the sequence listing and the surface of the transformant. Show coenzyme regeneration activity. In order to achieve the goal of constructing the expression vector, we selected the plasmid pETDuet1 containing two multicloning sites (T7 promoter / lac operator and ribosome binding site (rbs) at each of the multicloning sites) Precedes). The omp-CRS and omp-GDH genes were cloned into the pETDuet1 plasmid (which is a two step process). <br class="style-scope patent-text"> In the first step, the DNA of the present invention (having the nucleotide sequence of SEQ ID NO: 2 of the sequence list encoding the polypeptide having the amino acid sequence of SEQ ID NO: 1) is amplified from plasmid pUC19-omp-CRS (Which was used as a template for polymerase chain reaction (PCR) with primers oc1F (SEQ ID NO: 30) and oc1R (SEQ ID NO: 32)). The PCR conditions are: first denaturation for 5 minutes at 95 ° C., followed by 30 cycles (60 seconds at 95 ° C., 60 seconds at 55 ° C. and 90 seconds at 72 ° C. and a final extension step of 5 minutes at 72 ° C.) Met. The purified PCR product was digested with Nco1 and Hind3 and run on a 1% agarose gel. The 1.3 Kb Nco1 and Hind3 digested fragments were excised from the gel and purified using the Qeaquick kit (Qiagen). The plasmid pETDuet was separately digested with Nco1 and Hind3, followed by dephosphorylation using calf intestinal alkaline phosphatase to avoid self-ligation. Nco1 and Hind3 digested omp-CRS and pETDuet1 were ligated using T4 DNA ligase, and E. coli DH5α was transformed. The resulting clones were grown in LB broth containing ampicillin (100 μg / mL), from which the plasmid was isolated and subsequently double digested with Nco1 and Hind3. After double digestion the plasmid results in an insert of ̃5.4 Kb pETDuet1 backbone and 1.3 Kb SEQ ID NO: 2 and SEQ ID NO: 2 was cloned at the first multicloning site downstream of the pETDuet1 lac promoter, 6.7 Kb It suggested that the plasmid pETDuet1-omp-CRS was generated. <br class="style-scope patent-text"> In the second step, the DNA of the present invention (having the nucleotide sequence of SEQ ID NO: <u class="style-scope patent-text">10</u> of the sequence list encoding the polypeptide having the amino acid sequence of SEQ ID NO: <u class="style-scope patent-text">9</u> ) was artificially constructed with the plasmid pUC19- Amplified from omp-GDH (which was used as a template for polymerase chain reaction (PCR) with primers ogF (SEQ ID NO: 34) and ogR (SEQ ID NO: 36)). The PCR conditions are: first denaturation for 5 minutes at 95 ° C., followed by 30 cycles (60 seconds at 95 ° C., 60 seconds at 55 ° C. and 90 seconds at 72 ° C. and a final extension step of 5 minutes at 72 ° C.) Met. The purified PCR product was digested with Nde1 and Xho1 and run on an agarose gel. The 1.2 Kb Nde1 and Xho1 digested fragments were excised from the gel and purified using the QIAQUICK kit (Qiagen). The 6.7 Kb plasmid pETDuet1-omp-CRS, constructed as described above, was separately digested with Nde1 and Xho1, followed by dephosphorylation using calf intestinal alkaline phosphatase to avoid self-binding. Nde1 and Xho1 digested SEQ ID NO: 4 and pETDuet1-omp-CRS were ligated using T4 DNA ligase to transform E. coli DH5α. The resulting clones were grown in LB broth containing ampicillin, the plasmid was isolated from above and subsequently double digested with Nde1 and Xho1. After double digestion, the plasmid yields a -6.7 Kb pETDuet1-omp-CRS backbone and a 1.2 Kb omp-GDH insert, omp-GDH at the second multicloning site downstream of the pETDuet1-omp-CRS lac promoter It was cloned, suggesting that the 7.8 kb plasmid pETDuet1-omp-CRS, omp-GDH was generated. <br class="style-scope patent-text"> The restriction map of the plasmid pETDuet1-omp-CRS, omp-GDH is shown in FIG. <br class="style-scope patent-text"> E. coli BL21 (DE3), E. coli C41 (DE3) or E. coli C43 (DE3) were transformed with plasmid pETDuet1-omp-CRS, omp-GDH (which co-operates with carbonyl reductase and glucose dehydrogenase at the surface of transformants) Express).</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="4" class="style-scope patent-text">
      <p num="0127" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換体の調製</u> <br class="style-scope patent-text">
  実施例1で構築した組換えプラスミドpET23(a)-omp-CRSを用いて、大腸菌BL21(DE3)、大腸菌C41(DE3)及び大腸菌C43(DE3)の形質転換受容性細胞を形質転換して、表面でカルボニルレダクターゼを発現する大腸菌BL21(DE3)+pET23(a)-omp-CRS、大腸菌C41(DE3)+pET23(a)-omp-CRS及び大腸菌C43(DE3)+pET23(a)-omp-CRSを得た。<br class="style-scope patent-text">
  同様に、実施例3で構築した組換えプラスミドpETDuet1-omp-CRS;omp-GDHを用いて、大腸菌BL21(DE3)、大腸菌C41(DE3)及び大腸菌C43(DE3)の形質転換受容性細胞を形質転換して、表面でカルボニルレダクターゼ及びグルコースデヒドロゲナーゼの両方を発現する大腸菌BL21(DE3)+pETDuet1-omp-CRS;omp-GDH、大腸菌C41(DE3)+pETDuet1-omp-CRS;omp-GDH及び大腸菌C43(DE3)+pETDuet1-omp-CRS;omp-GDHを得た。<br class="style-scope patent-text">
  実施例2で構築した組換えプラスミドpET23(a)-CRSを用いて、大腸菌BL21(DE3)の形質転換受容性細胞を形質転換して、細胞の細胞質でカルボニルレダクターゼを発現する大腸菌BL21(DE3)+pET23(a)-CRSを得た。<br class="style-scope patent-text">
  実施例2で構築した組換えプラスミドpET23(a)-CRS及び下記のように構築されるpET29(a)-GDHを用いて、大腸菌BL21(DE3)の形質転換受容性細胞を形質転換して、細胞の細胞質でカルボニルレダクターゼ及びグルコースデヒドロゲナーゼを発現する大腸菌BL21(DE3)+pET23(a)-CRS,pET29(a)-GDHを得た。大腸菌BL21(DE3)+pET23(a)-CRS,pET29(a)-gdhは、Kizakiらの文献に開示された技術を用いて構築した（Kizaki, N.et al.Applied Microbiology and Biotechnology 2001, 55, 590-595）。
</span> <u class="style-scope patent-text">Preparation of Transformant The</u> recombinant plasmid pET23 (a) -omp-CRS constructed in Example 1 was used to transform E. coli BL21 (DE3), E. coli C41 (DE3) and E. coli C43 (DE3) into competent cells. E. coli BL21 (DE3) + pET23 (a)-omp-CRS, E. coli C 41 (DE 3) + pET 23 (a)-omp-CRS and E. coli C 43 (DE 3) + pET 23 (transformed to express carbonyl reductase on the surface) a)-omp-CRS was obtained. <br class="style-scope patent-text"> Similarly, transformation competent cells of E. coli BL21 (DE3), E. coli C41 (DE3) and E. coli C43 (DE3) were transformed using recombinant plasmid pETDuet1-omp-CRS constructed in Example 3; omp-GDH. E. coli BL21 (DE3) + pETDuet1-omp-CRS; omp-GDH, E. coli C41 (DE3) + pETDuet1-omp-CRS; omp-GDH and E. coli C43, which convert and express both carbonyl reductase and glucose dehydrogenase on the surface. (DE3) + pETDuet1-omp-CRS; omp-GDH were obtained. <br class="style-scope patent-text"> E. coli BL21 (DE3) that expresses carbonyl reductase in the cytoplasm of the cell by transforming the competent cells of transformation of E. coli BL21 (DE3) with the recombinant plasmid pET23 (a) -CRS constructed in Example 2 + pET23 (a) -CRS was obtained. <br class="style-scope patent-text"> Transforming competent cells of E. coli BL21 (DE3) with the recombinant plasmid pET23 (a) -CRS constructed in Example 2 and pET29 (a) -GDH constructed as follows: E. coli BL21 (DE3) + pET23 (a)-CRS, pET 29 (a)-GDH expressing carbonyl reductase and glucose dehydrogenase in cell cytoplasm were obtained. E. coli BL21 (DE3) + pET23 (a)-CRS, pET 29 (a)-gdh were constructed using the techniques disclosed in the literature of Kizaki et al. (Kizaki, N. et al. Applied Microbiology and Biotechnology 2001, 55 , 590-595).</span>
      </p>
      <p num="0128" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">組換えプラスミドpET29(a)-GDHの構築</u>：クローニング用gdhF（配列番号:38）及びgdhR（配列番号:40）プライマーを、配列リストの配列番号:26で表されるグルコースデヒドロゲナーゼ遺伝子のヌクレオチド配列に基づいて合成した（配列番号:26は配列リストの配列番号:25のアミノ酸配列を有するポリペプチドをコードする）。注文合成pUC19-omp-gdhプラスミドを1反応30サイクルのポリメラーゼ連鎖反応（PCR）に付した。PCR条件は、95℃で5分の最初の変性、続いて以下の30サイクル（95℃で60秒、52℃で60秒及び72℃で60秒とともに72℃で5分の最後の伸長工程）であった。精製PCR生成物をNde1及びXho1で消化し、1％アガロースゲル上で泳動した。0.81Kb のNde1及びXho1消化フラグメントをゲルから切り出し、キアクイックキット（Qiagen）を用いて精製した。プラスミドpET29(a)を別にNde1及びXho1で消化し、続いて自家結合を回避するためにウシ腸アルカリホスファターゼを用いて脱リン酸化を実施した。Nde1及びXho1消化0.81Kb は配列リストの配列番号:26のヌクレオチド配列を有し、pET29(a)がT4DNAリガーゼを用いて連結され、大腸菌DH5αを形質転換した。生成クローンをカナマイシン含有LBブロスで増殖させ、プラスミドを単離し、続いて前記をNde1及びXho1で二重消化した。二重消化後にプラスミドは5.4KbのpET29(a)骨格及び0.81Kbの挿入物を生じ、0.81Kb遺伝子はpET29(a)のlacプロモーターの下流でクローニングされ、6.0KbのプラスミドpET29(a)-GDHを生じたことを示唆した。
</span> <u class="style-scope patent-text">Construction of recombinant plasmid pET29 (a)-GDH</u> : The gdhF (SEQ ID NO: 38) and gdhR (SEQ ID NO: 40) primers for cloning were added to the nucleotide sequence of the glucose dehydrogenase gene represented by SEQ ID NO: 26 in the sequence listing. It was synthesized based on it (SEQ ID NO: 26 encodes a polypeptide having the amino acid sequence of SEQ ID NO: 25 in the Sequence Listing). Custom synthesized pUC19-omp-gdh plasmid was subjected to one reaction 30 cycles of polymerase chain reaction (PCR). The PCR conditions are: first denaturation for 5 minutes at 95 ° C., followed by 30 cycles (60 seconds at 95 ° C., 60 seconds at 52 ° C. and 60 seconds at 72 ° C., and a final extension step of 5 minutes at 72 ° C.) Met. The purified PCR product was digested with Nde1 and Xho1 and run on a 1% agarose gel. The 0.81 Kb Nde1 and Xho1 digested fragments were excised from the gel and purified using the QIAQUICK kit (Qiagen). The plasmid pET29 (a) was separately digested with Nde1 and Xho1, followed by dephosphorylation using calf intestinal alkaline phosphatase to avoid self-ligation. Nde1 and Xho1 digested 0.81 Kb have the nucleotide sequence of SEQ ID NO: 26 in the Sequence Listing, and pET29 (a) was ligated with T4 DNA ligase to transform E. coli DH5α. The resulting clones were grown in kanamycin containing LB broth, the plasmids were isolated and subsequently double digested with Nde1 and Xho1. After double digestion, the plasmid yields a 5.4 Kb pET 29 (a) backbone and a 0.81 Kb insert, the 0.81 Kb gene is cloned downstream of the lac promoter of pET 29 (a), and the 6.0 Kb plasmid pET 29 (a) -GDH It suggested that it occurred.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="5" class="style-scope patent-text">
      <p num="0129" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換体での遺伝子の発現</u> <br class="style-scope patent-text">
  プラスミドを保持する組換え大腸菌の新鮮な培養を、抗生物質を含む10mLのルリアベルタニ（Luria Bertani）HiVegブロス培地（1％HiVegヒドロラーゼ、0.5％酵母抽出物、1％塩化ナトリウム（pH7.5））にて37℃で増殖させ、6時間の増殖後、1mLの培養を抗生物質（アンピシリン、カナマイシン、クロラムフェニコールなど、単独又は組み合わせて）を含む100mLの新鮮なLB培地に接種し、200rpmの震盪状態下にて37℃で増殖させた。600nmのODが0.5−0.6に達したとき、最終濃度0.2mMのIPTGで培養を誘発し、前記を200rpmの震盪状態下にて20℃でさらに16時間増殖させた。
</span>Fresh cultures of recombinant E. coli harboring <u class="style-scope patent-text">expression</u> plasmids <u class="style-scope patent-text">of genes in transformants,</u> 10 mL of Luria Bertani HiVeg broth medium (1% HiVeg hydrolase, 0.5% yeast extract, 1% chloride) containing antibiotics Grow at 37 ° C. in sodium (pH 7.5) and after 6 hours of growth, 1 mL culture with 100 mL fresh LB containing antibiotics (ampicillin, kanamycin, chloramphenicol etc, alone or in combination) The medium was inoculated and grown at 37 ° C. under shaking at 200 rpm. When the OD at 600 nm reached 0.5-0.6, cultures were induced with IPTG at a final concentration of 0.2 mM and grown for an additional 16 hours at 200C under shaking at 200 rpm.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="6" class="style-scope patent-text">
      <p num="0130" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS、配列番号:1）表面でのカルボニルレダクターゼの発現の提示</u> <br class="style-scope patent-text">
  形質転換大腸菌BL21(DE3)+pET23(a)-omp-CRSを100mLの培地で上記実施例5に記載したように増殖させた。遠心分離によって細胞を単離し、50mMのリン酸緩衝液（pH7.0）で洗浄した。続いて前記細胞を5mLの溶解緩衝液（50 mM NaH<sub class="style-scope patent-text">2</sub>PO<sub class="style-scope patent-text">4</sub>、150 mM NaCl、1mg mL<sup class="style-scope patent-text">-1</sup>リゾチーム（pH8.0））に4℃で30分懸濁した。続いて前記細胞懸濁物を4℃で20分超音波処理した（30秒パルスON及び30秒パルスOFF）。14,000rpmで30分遠心分離することによって細胞屑を除去した。続いて膜分画及び可溶性分画を分離するために上清（無細胞抽出物）を4℃、1,000,000gで2時間の超遠心分離に付した。膜分画を含む沈殿物を同じ緩衝液で洗浄し、膜可溶化緩衝液（25 mMトリスHCl、20％グリセロール及び2％トリトンX100（pH7.5））に再懸濁した。3つの分画全て（無細胞抽出物、膜分画及び可溶性タンパク質分画）を、エチル4-クロロ-3-オキソブチレートをエチル4-クロロ-3-ヒドロキシブチレートに還元する活性についてアッセイした。例えば、50mMリン酸緩衝液（pH7.0）中の標準反応混合物（1mL）（0.2mMニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）、2.0mMのECOB及び1−50μLのサンプルを含む）を30℃でインキュベートし、全活性を決定した。結果は表1に要約されている。期待したように、活性の大半は膜分画から回収された。有意義なことに、大腸菌BL21(DE3)+pET23(a)（陰性コントロール）は活性を全く欠いていた。
</span> <u class="style-scope patent-text">Display of expression of carbonyl reductase on the surface of transformed E. coli BL21 (DE3) + pET23 (a)-omp-CRS (CRS, SEQ ID NO: 1)</u> transformed E. coli BL21 (DE3) + pET23 (a)-omp-CRS Growth was as described in Example 5 above in 100 mL of culture medium. The cells were isolated by centrifugation and washed with 50 mM phosphate buffer (pH 7.0). Subsequently, the cells were suspended in 5 mL of lysis buffer (50 mM NaH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> , 150 mM NaCl, 1 mg mL <sup class="style-scope patent-text">−1</sup> lysozyme (pH 8.0)) at 4 ° C. for 30 minutes. The cell suspension was subsequently sonicated at 4 ° C. for 20 minutes (30 seconds pulse on and 30 seconds pulse off). Cellular debris was removed by centrifugation at 14,000 rpm for 30 minutes. Subsequently, the supernatant (cell-free extract) was subjected to ultracentrifugation at 1,000,000 g for 2 hours at 4 ° C. to separate membrane fractions and soluble fractions. The precipitate containing the membrane fraction was washed with the same buffer and resuspended in membrane solubilization buffer (25 mM Tris HCl, 20% glycerol and 2% Triton X 100 (pH 7.5)). All three fractions (cell-free extract, membrane fraction and soluble protein fraction) were assayed for the activity of reducing ethyl 4-chloro-3-oxobutyrate to ethyl 4-chloro-3-hydroxybutyrate . For example, a standard reaction mixture (1 mL) in 50 mM phosphate buffer (pH 7.0) (containing 0.2 mM nicotinamide adenine dinucleotide phosphate reduced form (NADPH), 2.0 mM ECOB and 1-50 μL sample) Incubate at 30 ° C. and determine total activity. The results are summarized in Table 1. As expected, most of the activity was recovered from the membrane fraction. Significantly, E. coli BL21 (DE3) + pET23 (a) (negative control) were completely devoid of activity.</span>
      </p>
      <p num="0131" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表1：大腸菌BL21(DE3)+ｐET23(a)及び大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS, 配列番号:1）から得られた種々の分画のカルボニルレダクターゼ（CRS）活性<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
  大腸菌BL21(DE3)+pET23(a)-omp-CRSの表面にCRSが存在することは、さらにまた大腸菌BL21(DE3)+pET23(a)-omp-cr1細胞の超薄切片を用いて実施されるEM免疫金標識試験で確認された。抗CRSポリクローナル抗体を精製CRSに対してウサギで作製し、ウェスタンブロットによってそれら抗体の特異性についてアッセイした。精製CRSを還元条件下のSDS-PAGEで泳動し、ニトロセルロース膜への電気的ブロッティングの後でウサギ抗CRSポリクローナル抗体を用いてプローブし、前記をさらにアルカリホスファターゼ結合ヤギ抗ウサギIgG（全分子）二次抗体でプローブした。続いて、5-ブロモ-4-クロロ-3-インドリルホスフェート（BCIP, 0.15mg/mL）、ニトロブルーテトラゾリウム（NBT, 0.30mg/mL）、トリスHCl（100mM）及びMgCl<sub class="style-scope patent-text">2</sub>（5mM）（pH9.5）を含む基質溶液に前記を10分間浸漬することによってブロットをデベロップさせた。純粋なCRSを特異的に標識するポリクローナル抗体はまたomp-CRSを特異的に標識することができた。<br class="style-scope patent-text">
  数回の脱水工程の後で、組換え大腸菌BL21(DE3)+ｐET23(a)（陰性コントロール）及び大腸菌BL21(DE3)+pET23(a)-omp-CRSをLR白色樹脂に包埋し、続いて固定液として0.2％グルタルアルデヒドを用い数工程で脱水した。ウルトラミクロトームを用いて切り出した薄い切片を、ウサギ抗CRSポリクローナル抗体、続いてナノゴールド標識ヤギ抗ウサギIgG（全分子）二次抗体とともにインキュベートし、透過型電子顕微鏡下で可視化した。種々の視野を観察し、金粒子は細胞の表面に重点的に存在することが見出された（図7）。陰性コントロールとしての細胞では標識は生じなかった。
</span>Table 1: Various fractions of carbonyl reductase (CRS) obtained from E. coli BL21 (DE3) + pET23 (a) and E. coli BL21 (DE 3) + pET23 (a)-omp-CRS (CRS, SEQ ID NO: 1) Activity <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> The presence of CRS on the surface of E. coli BL21 (DE3) + pET23 (a) -omp-CRS is also performed using ultrathin sections of E. coli BL21 (DE3) + pET23 (a) -omp-cr1 cells. It was confirmed in the EM immunogold labeling test. Anti-CRS polyclonal antibodies were generated in rabbits against purified CRS and assayed for their specificity by Western blot. Purified CRS is electrophoresed on SDS-PAGE under reducing conditions and electroblotted onto nitrocellulose membrane followed by probing with rabbit anti-CRS polyclonal antibody, which is further conjugated to alkaline phosphatase conjugated goat anti-rabbit IgG (whole molecule) Probed with secondary antibody. Subsequently, 5-bromo-4-chloro-3-indolyl phosphate (BCIP, 0.15mg / mL), nitroblue tetrazolium (NBT, 0.30mg / mL), tris HCl (100 mM) and MgCl <sub class="style-scope patent-text">2</sub> (5mM) (pH9 The blot was developed by immersing it in a substrate solution containing .5) for 10 minutes. Polyclonal antibodies that specifically label pure CRS were also able to specifically label omp-CRS. <br class="style-scope patent-text"> After several dehydration steps, recombinant E. coli BL21 (DE3) + pET23 (a) (negative control) and E. coli BL21 (DE3) + pET23 (a) -omp-CRS are embedded in LR white resin, and then It was dehydrated in several steps using 0.2% glutaraldehyde as a fixative. Thin sections cut with an ultramicrotome were incubated with rabbit anti-CRS polyclonal antibody followed by nanogold labeled goat anti-rabbit IgG (whole molecule) secondary antibody and visualized under a transmission electron microscope. The various fields of view were observed and gold particles were found to be predominantly present on the surface of the cells (FIG. 7). No labeling occurred in cells as a negative control.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="7" class="style-scope patent-text">
      <p num="0132" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS, 配列番号:1）における細胞質及び表面発現CRSの相対的発現レベル</u> <br class="style-scope patent-text">
  組換え大腸菌BL21(DE3)+pET23(a)-CRS（CRS, 配列番号:1）及び大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS, 配列番号:1）の新鮮培養を増殖させ、各クローンの全細胞プロテオームを調製した。種々の濃度の細胞から入手したプロテオームを還元状態下の12.5％SDS-PAGEで泳動した。ニトロセルロース膜への電気的ブロッティングの後で、前記をウサギ抗CRSポリクローナル抗体によりプローブし、さらにアルカリホスファターゼ結合ヤギ抗ウサギIgG抗体でプローブした。抗体によるプローブ後に、5-ブロモ-4-クロロ-3-インドリルホスフェート（BCIP, 0.15mg/mL）、ニトロブルーテトラゾリウム（NBT, 0.30mg/mL）、トリスHCl（100mM）及びMgCl<sub class="style-scope patent-text">2</sub>（5mM）（pH9.5）を含む基質溶液に前記を10分間浸漬することによってブロットをデベロップさせた。CRSの発現は、対応するクローンのバンド強度をソフトウェア（Scion Image）によって分析して決定した。強度を採取細胞量に対してプロットし、細胞内発現及び表面発現の勾配（dy/dx）を比較した。Omp-CRS融合タンパク質としての細胞の表面におけるCRSの発現は、細胞質で発現されるCRSと比較して17.9倍少ないことが見出された。
</span> <u class="style-scope patent-text">Relative expression levels of cytoplasmic and surface expressed CRS in transformed E. coli BL21 (DE3) + pET23 (a)-omp-CRS (CRS, SEQ ID NO: 1)</u> recombinant E. coli BL21 (DE3) + pET23 (a)-CRS (CRS) Fresh cultures of CRS, SEQ ID NO: 1) and E. coli BL21 (DE3) + pET23 (a) -omp-CRS (CRS, SEQ ID NO: 1) were grown to prepare whole cell proteome of each clone. The proteome obtained from various concentrations of cells was electrophoresed on 12.5% SDS-PAGE under reducing conditions. After electroblotting to nitrocellulose membrane, the probe was probed with rabbit anti-CRS polyclonal antibody and further probed with alkaline phosphatase conjugated goat anti-rabbit IgG antibody. After probing with the antibody, 5-bromo-4-chloro-3-indolyl phosphate (BCIP, 0.15 mg / mL), nitro blue tetrazolium (NBT, 0.30 mg / mL), Tris HCl (100 mM) and MgCl <sub class="style-scope patent-text">2</sub> (5 mM) The blot was developed by immersing it in a substrate solution containing (pH 9.5) for 10 minutes. The expression of CRS was determined by analyzing the band intensity of the corresponding clones by software (Scion Image). Intensity was plotted against harvested cell mass and intracellular expression and surface expression gradients (dy / dx) were compared. The expression of CRS on the surface of cells as Omp-CRS fusion protein was found to be 17.9 fold less compared to cytoplasmically expressed CRS.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="8" class="style-scope patent-text">
      <p num="0133" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">表面発現CRSは細胞質CRSと比較してエチル4-クロロ-3-オキソブチレートの還元について275倍の増加活性を示した</u> <br class="style-scope patent-text">
  組換え大腸菌BL21(DE3)+pET23(a)-CRS（CRS, 配列番号:1）及び大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS 配列番号:1）の新鮮培養を増殖させ、カルボニルレダクターゼ活性の測定に用いた。アッセイは、基質としてエチル4-クロロ-3-オキソブチレート及び補酵素としてニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）を用いて実施した。カルボニルレダクターゼ活性の初速は、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）のλ<sub class="style-scope patent-text">340</sub>の吸収低下をモニターすることによって決定した。50mMリン酸緩衝液（pH7.0）中の標準反応混合物（1mL）は、0.2mMニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）、10<sup class="style-scope patent-text">6</sup>−10<sup class="style-scope patent-text">8</sup>の組換え大腸菌細胞、及び2.0mMのエチル(S)-4-クロロ-3-オキソブタノエートを含んでいた。活性1ユニットは、特定の条件下で1分毎に1μmolのニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の酸化を触媒する乾燥細胞の重量と定義した。表面でomp-CRSを発現する組換え大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS 配列番号:1）の活性は、156.20ｘ10<sup class="style-scope patent-text">3</sup>nmol/分/gm乾燥細胞と決定された。対比して、細胞質でCRSを発現する組換え大腸菌BL21(DE3)+pET23(a)-CRS（CRS, 配列番号:1）の活性は、10.16ｘ10<sup class="style-scope patent-text">3</sup>nmol/分/gm乾燥細胞と決定された。したがって、等量の細胞では、表面提示CRSは15.4倍高い活性を示した。しかしながら、我々は、等量の細胞では組換え大腸菌BL21(DE3)+pET23(a)-CRSは、組換え大腸菌BL21+pET23(a)-omp-CRSと比較して17.9倍多くのタンパク質を発現することを示した。したがって、組換え大腸菌BL21(DE3)+pET23(a)-omp-CRSの単位タンパク質当たりの活性は、組換え大腸菌BL21(DE3)+pET23(a)-omp-CRSよりも275倍高かった。結果は表2に要約されている。
</span> <u class="style-scope patent-text">Surface-expressed CRS exhibited a 275-fold increase in the reduction of ethyl 4-chloro-3-oxobutyrate compared to cytosolic CRS</u> recombinant E. coli BL21 (DE3) + pET23 (a)-CRS (CRS, SEQ ID NO: : 1) and fresh cultures of E. coli BL21 (DE3) + pET23 (a)-omp-CRS (CRS SEQ ID NO: 1) were grown and used to measure carbonyl reductase activity. The assay was performed using ethyl 4-chloro-3-oxobutyrate as substrate and nicotinamide adenine dinucleotide phosphate reduced form (NADPH) as coenzyme. Initial speed of carbonyl reductase activity was determined by monitoring the decrease absorption of lambda <sub class="style-scope patent-text">340</sub> of nicotinamide adenine dinucleotide phosphate reduced form (NADPH). 50mM phosphate buffer (pH7.0) standard reaction mixture in (1 mL) is, 0.2 mM nicotinamide adenine dinucleotide phosphate reduced form (NADPH), 10 <sup class="style-scope patent-text">6</sup> -10 <sup class="style-scope patent-text">8</sup> of recombinant E. coli cells, and 2.0mM of It contains ethyl (S) -4-chloro-3-oxobutanoate. One unit of activity was defined as the weight of dry cells which catalyzes the oxidation of 1 μmol of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) per minute under certain conditions. The activity of recombinant E. coli BL21 (DE3) + pET23 (a) -omp-CRS (CRS SEQ ID NO: 1) expressing omp-CRS on the surface was determined to be 156.20 × 10 <sup class="style-scope patent-text">3</sup> nmol / min / gm dry cells. In contrast, the activity of recombinant E. coli BL21 (DE3) + pET23 (a)-CRS (CRS, SEQ ID NO: 1) expressing CRS in the cytoplasm was determined to be 10.16 x 10 <sup class="style-scope patent-text">3</sup> nmol / min / gm dry cells . Thus, in equal amounts of cells, surface-displayed CRS showed 15.4 times higher activity. However, we show that in equivalent cells recombinant E. coli BL21 (DE3) + pET23 (a) -CRS express 17.9 fold more protein compared to recombinant E. coli BL21 + pET23 (a) -omp-CRS Showed that Therefore, the activity per unit protein of recombinant E. coli BL21 (DE3) + pET23 (a) -omp-CRS was 275 times higher than that of recombinant E. coli BL21 (DE3) + pET23 (a) -omp-CRS. The results are summarized in Table 2.</span>
      </p>
      <p num="0134" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表2：omp-CRS融合タンパク質としてCRS（CRS配列番号:1）を表面で発現する組換え大腸菌と細胞質でCRS（CRS配列番号:1）を発現する組換え大腸菌の相対的活性<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
*DCW＝乾燥細胞重量<br class="style-scope patent-text">
#陰性コントロール大腸菌BL21(DE3)+pET23(a)はいかなる活性も生じなかった。
</span>Table 2: Relative activity of recombinant E. coli expressing CRS (CRS SEQ ID NO: 1) as omp-CRS fusion protein on the surface and recombinant E. coli expressing CRS (CRS SEQ ID NO: 1) in the cytoplasm <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> * DCW = dry cell weight <br class="style-scope patent-text"> # Negative control E. coli BL21 (DE3) + pET23 (a) did not produce any activity.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="9" class="style-scope patent-text">
      <p num="0135" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">種々のケトンの還元について表面発現CRSは細胞質CRSと比較して50倍から275倍増加活性を示した</u> <br class="style-scope patent-text">
  アッセイは96ウェルELISAプレートで実施した。50mMリン酸緩衝液（pH7.0）中に、0.2mMニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）、2.0mMの基質、50μg/mLの大腸菌細胞（細胞集合物の計算のために、OD<sub class="style-scope patent-text">600</sub>＝1の細胞懸濁物が0.25mg/mLの乾燥細胞重量と等しいとみなした）から成る反応混合物を30℃で基質の消費に応じて約30分から12時間インキュベートした。ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の消費はλ<sub class="style-scope patent-text">340</sub>の吸収低下によってモニターした。結果は表3及び3に要約されている。期待したように、表面発現CRS（CRS配列番号:1）は、種々の脂肪族及び芳香族ケトンの還元において細胞内で発現されるCRS（CRS配列番号:1）よりもはるかに効率的であった。一般的に、活性の増加は、これらの条件下ではCRSタンパク質1ユニット当たり50倍から275倍の範囲であった。CRSの相対的濃度は実施例7に記載したように決定した。
</span>Assays in <u class="style-scope patent-text">which surface expressed CRS showed 50- to 275-fold increased activity compared to cytosolic CRS for reduction of various ketones</u> were performed in 96-well ELISA plates. 0.2 mM nicotinamide adenine dinucleotide phosphate reduced form (NADPH) in 50 mM phosphate buffer (pH 7.0), 2.0 mM substrate, 50 μg / mL E. coli cells (OD for calculation of cell aggregates <sub class="style-scope patent-text">The</sub> reaction mixture consisting of <sub class="style-scope patent-text">600</sub> = 1 cell suspension was considered equal to 0.25 mg / mL dry cell weight) was incubated at 30 ° C for about 30 minutes to 12 hours depending on substrate consumption. Consumption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) was monitored by decrease absorption lambda <sub class="style-scope patent-text">340.</sub> The results are summarized in Tables 3 and 3. As expected, surface expressed CRS (CRS SEQ ID NO: 1) is much more efficient than intracellularly expressed CRS (CRS SEQ ID NO: 1) in the reduction of various aliphatic and aromatic ketones The Generally, the increase in activity ranged from 50-fold to 275-fold per CRS protein unit under these conditions. The relative concentration of CRS was determined as described in Example 7.</span>
      </p>
      <p num="0136" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表3：omp-CRS融合タンパク質としてCRS（CRS配列番号:1）を表面で発現する組換え大腸菌と細胞質でCRS（CRS配列番号:1）を発現する組換え大腸菌の種々のケトン<sup class="style-scope patent-text">a</sup>での相対的活性<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<sup class="style-scope patent-text">a</sup>補因子リサイクルのために外部GDHをアッセイ混合物に添加した。<br class="style-scope patent-text">
*DCW＝乾燥細胞重量<br class="style-scope patent-text">
#DCW1グラム当たりのCRS発現は、細胞質発現CRSと比較して表面発現CRSで17.9倍低かった（実施例7）。
</span>Table 3: Relative to various ketones <sup class="style-scope patent-text">a</sup> of recombinant E. coli expressing CRS (CRS SEQ ID NO: 1) on the surface as omp-CRS fusion protein and recombinant E. coli expressing CRS (CRS SEQ ID NO: 1) in cytoplasm Activity <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <sup class="style-scope patent-text">a</sup> External GDH was added to the assay mixture for cofactor recycling. <br class="style-scope patent-text"> * DCW = dry cell weight <br class="style-scope patent-text"> CRS expression per gram of DCW was 17.9 fold lower for surface expressed CRS compared to cytoplasmic expressed CRS (Example 7).</span>
      </p>
      <p num="0137" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表4：omp-CRS融合タンパク質及びomp-GDHタンパク質としてCRS（配列番号:1）及びGDH（配列番号:9）を表面で共同発現する組換え大腸菌と細胞質でCRS（配列番号:1）及びGDH（配列番号:1）を共同発現する組換え大腸菌の種々のケトンにおける相対的活性<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
*DCW＝乾燥細胞重量<br class="style-scope patent-text">
#DCW1グラム当たりのCRS発現は、細胞質発現CRSと比較して表面発現CRSで17.9倍低かった。
</span>Table 4: CRS (SEQ ID NO: 1) and GDH in recombinant E. coli co-expressed on the surface with CRS (SEQ ID NO: 1) and GDH (SEQ ID NO: 9) as omp-CRS fusion proteins and omp-GDH proteins Relative activity in various ketones of recombinant E. coli co-expressing (SEQ ID NO: 1) <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> * DCW = dry cell weight <br class="style-scope patent-text"> # CRS expression per gram of DCW was 17.9 fold lower in surface expressed CRS compared to cytoplasmic expressed CRS.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="10" class="style-scope patent-text">
      <p num="0138" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">形質転換大腸菌C41(DE3)+pETDuet1-omp-CRS,omp-GDH（CRS, 配列番号:1；GDH, 配列番号:9）の表面におけるグルコースデヒドロゲナーゼ発現の提示</u> <br class="style-scope patent-text">
  形質転換大腸菌C41(DE3)+pETDuet1-omp-CRS;omp-GDH（CRS, 配列番号:1；GDH, 配列番号:9）を100mLの培地で上記実施例5に記載したように増殖させた。遠心分離によって細胞を単離し、50mMのリン酸緩衝液（pH7.0）で洗浄した。続いて前記細胞を5mLの溶解緩衝液（50 mM NaH<sub class="style-scope patent-text">2</sub>PO<sub class="style-scope patent-text">4</sub>、150 mM NaCl、1mg mL<sup class="style-scope patent-text">-1</sup>リゾチーム（pH8.0））に4℃で30分懸濁した。続いて前記細胞懸濁物を4℃で20分超音波処理した（30秒パルスON及び30秒パルスOFF）。14000rpmで30分遠心分離することによって細胞屑を除去し、上清（無細胞抽出物）を更なる分析のために採取した。以前に記載したように膜分画及び可溶性分画を上清（無細胞抽出物）から分離した。3つの分画全て（無細胞抽出物、膜分画及び可溶性タンパク質分画）をグルコースからグルコネートに酸化する能力についてアッセイした。例えば、100mMトリスHCl緩衝液（pH8.0）中の標準反応混合物（1mL）（0.5mMニコチンアミドアデニンジヌクレオチドリン酸（NADP）（7.78mg/mLの50μL）、5mMグルコース（180mg/mLの25μL）及び1−50μLのサンプルを含む）を30℃でインキュベートし、ニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の生成をλ<sub class="style-scope patent-text">340</sub>でモニターすることによって活性を決定した。結果は表5に要約されている。期待したように、活性の大半は膜分画から回収された。大腸菌C41(DE3)+pETDuet1（陰性コントロール）は活性を全く欠いていた。
</span> <u class="style-scope patent-text">Display of glucose dehydrogenase expression on the surface of transformed E. coli C41 (DE3) + pETDuet1-omp-CRS, omp-GDH (CRS, SEQ ID NO: 1; GDH, SEQ ID NO: 9)</u> transformed E. coli C41 (DE3) + pETDuet1- omp-CRS; omp-GDH (CRS, SEQ ID NO: 1; GDH, SEQ ID NO: 9) were grown as described in Example 5 above in 100 mL of medium. The cells were isolated by centrifugation and washed with 50 mM phosphate buffer (pH 7.0). Subsequently, the cells were suspended in 5 mL of lysis buffer (50 mM NaH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> , 150 mM NaCl, 1 mg mL <sup class="style-scope patent-text">−1</sup> lysozyme (pH 8.0)) at 4 ° C. for 30 minutes. The cell suspension was subsequently sonicated at 4 ° C. for 20 minutes (30 seconds pulse on and 30 seconds pulse off). Cell debris was removed by centrifugation at 14000 rpm for 30 minutes and the supernatant (cell free extract) was collected for further analysis. Membrane and soluble fractions were separated from the supernatant (cell free extract) as previously described. All three fractions (cell-free extract, membrane fraction and soluble protein fraction) were assayed for their ability to oxidize glucose to gluconate. For example, standard reaction mixture (1 mL) (0.5 mM nicotinamide adenine dinucleotide phosphate (NADP) (50 μL of 7.78 mg / mL) in 100 mM Tris HCl buffer (pH 8.0), 25 μL of 5 mM glucose (180 mg / mL) And 1 to 50 μL of the sample) were incubated at 30 ° C., and the activity was determined by monitoring the formation of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) at λ <sub class="style-scope patent-text">340</sub> . The results are summarized in Table 5. As expected, most of the activity was recovered from the membrane fraction. E. coli C41 (DE3) + pETDuet1 (negative control) lacked any activity.</span>
      </p>
      <p num="0139" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表5：大腸菌C41(DE3)+pETDuet1-omp-CRS;omp-GDH（CRS, 配列番号:1；GDH, 配列番号:9）及び大腸菌C41(DE3)+pETDuet1の種々の分画におけるグルコースデヒドロゲナーゼ（GDH）活性<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
</span>Table 5: Glucose dehydrogenase (E. coli C41 (DE3) + pETDuet 1-omp-CRS; omp-GDH (CRS, SEQ ID NO: 1; GDH, SEQ ID NO: 9) and various fractions of E. coli C41 (DE3) + pETDuet 1 ( GDH) activity <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="11" class="style-scope patent-text">
      <p num="0140" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">大腸菌C41(DE3)における細胞質発現及び表面発現GDH（配列番号:9）の相対的発現レベル</u> <br class="style-scope patent-text">
  組換え大腸菌C41(DE3)+pET29(a)-CRS+pET29(a)-GDH（CRS, 配列番号:1；GDH, 配列番号:9）及び大腸菌C41(DE3)+pETDuet1-omp-CRS,omp-GDH（CRS, 配列番号:1；GDH, 配列番号:9）のグルコースデヒドロゲナーゼ活性を、基質としてグルコースを用いてニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）の吸収増加を分光光度計により340nmでモニターすることによって決定した。50mMトリス-HCl緩衝液（pH8.0）中の反応混合物（1mL）は、0.5mMニコチンアミドアデニンジヌクレオチドリン酸(NADP)<sup class="style-scope patent-text">+</sup>、10<sup class="style-scope patent-text">6</sup>−10<sup class="style-scope patent-text">8</sup>細胞及び5.0mMグルコースを含んでいた。活性1ユニットは、これらの条件下で1分毎に1μmolのNADPの還元を触媒する細胞量（乾燥細胞重量）と定義された。細胞の表面でomp-GDH融合タンパク質としてGDHを発現する組換え大腸菌は683.52ｘ10<sup class="style-scope patent-text">3</sup>nmol/分/gm乾燥細胞の活性を示し、一方、細胞質でGDHを発現する大腸菌は41.87ｘ10<sup class="style-scope patent-text">3</sup>nmol/分/gm乾燥細胞の活性を示した。表面及び細胞質で発現されるGDHの相対的発現レベルはSDS-PAGEから概算した。細胞質発現は、組換え大腸菌の表面発現タンパク質と比較して約13.8倍高いと概算された。大腸菌C41(DE3)+pETDuet1-omp-CRS,omp-GDHは、組換え大腸菌C41(DE3)+pET29(a)-CRS+pET29(a)-GDHと比較して225倍高かった。結果は表6に要約されている。
</span> <u class="style-scope patent-text">Relative expression levels of cytoplasmic and surface expressed GDH (SEQ ID NO: 9) in</u> E. coli C41 (DE 3) recombinant E. coli C41 (DE 3) + pET 29 (a)-CRS + pET 29 (a)-GDH (CRS, SEQ ID NO: 1; glucose dehydrogenase activity of GDH, SEQ ID NO: 9) and E. coli C41 (DE3) + pETDuet1-omp-CRS, omp-GDH (CRS, SEQ ID NO: 1; GDH, SEQ ID NO: 9), and glucose as a substrate The increase in absorption of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) was determined by monitoring with a spectrophotometer at 340 nm. The reaction mixture (1 mL) in 50 mM Tris-HCl buffer (pH 8.0) contained 0.5 mM nicotinamide adenine dinucleotide phosphate (NADP) <sup class="style-scope patent-text">+</sup> , 10 <sup class="style-scope patent-text">6</sup> -10 <sup class="style-scope patent-text">8</sup> cells and 5.0 mM glucose. One unit of activity was defined as the cell mass (dry cell weight) that catalyzes the reduction of 1 μmol NADP per minute under these conditions. Recombinant E. coli expressing GDH as omp-GDH fusion protein on the surface of the cells show 683.52 × 10 <sup class="style-scope patent-text">3</sup> nmol / min / gm dry cell activity, while E. coli expressing GDH in the cytoplasm 41.87 × 10 <sup class="style-scope patent-text">3</sup> nmol / min / It showed the activity of gm dry cells. The relative expression levels of surface and cytoplasmic expressed GDH were estimated from SDS-PAGE. Cytoplasmic expression was estimated to be approximately 13.8 times higher compared to surface expressed proteins of recombinant E. coli. E. coli C41 (DE3) + pETDuet1-omp-CRS, omp-GDH were 225 times higher than recombinant E. coli C41 (DE3) + pET29 (a) -CRS + pET29 (a) -GDH. The results are summarized in Table 6.</span>
      </p>
      <p num="0141" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表6：omp-GDP（配列番号:9）融合タンパク質としてGDHを発現する組換え大腸菌及び細胞質でGDH（配列番号:9）を発現する組換え大腸菌の相対的活性<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
*DCW＝乾燥細胞重量<br class="style-scope patent-text">
#陰性コントロール大腸菌BL21(DE3)+pET23(a)はいかなる活性も生じなかった。
</span>Table 6: Relative activity of recombinant E. coli expressing GDH as omp-GDP (SEQ ID NO: 9) fusion protein and recombinant E. coli expressing GDH (SEQ ID NO: 9) in cytoplasm <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> * DCW = dry cell weight <br class="style-scope patent-text"> # Negative control E. coli BL21 (DE3) + pET23 (a) did not produce any activity.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="12" class="style-scope patent-text">
      <p num="0142" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">生物触媒として形質転換大腸菌BL21(DE3)+pET23(a)-omp-CRS（CRS, 配列番号:1）又はC41(DE3)+pET23(a)-omp-CRS（CRS, 配列番号:1）を用いるエチル(S)-4-クロロ-3-ヒドロキシブチレートの生成</u> <br class="style-scope patent-text">
  反応は、補助溶媒としてオートタイトレーター（718 STAT Titrino, Metrohm, スイス）中のジエチルエーテルを用い2相系で実施した。大腸菌BL21(DE3)+pET23(a)-omp-CRS細胞又はC41(DE3)+pET23(a)-omp-CRS（1.38g；乾燥細胞重量基準）を20mLのリン酸緩衝液（100mM、pH6.5）に懸濁した。15mLのジブチルエーテル中のグルコース（9g、50mmol）、グルコースデヒドロゲナーゼ（3600U）、ニコチンアミドアデニンジヌクレオチドリン酸（NADP）（18mg、0.02mmol）及びECOB（6g、36.5mmol）を前記懸濁物に添加し、内容物を磁気攪拌装置上にて穏やかに30℃で攪拌した。5MのNaOHで反応物のpHを6.5に維持した。反応の進行は以下のように1時間間隔でモニターした。各々0.2mLアリコットを取り出し、2mLの酢酸エチルで抽出した。有機相を遠心分離により分離し、硫酸ナトリウム上で乾燥させ溶媒を除去して残留物を残し、前記を<sup class="style-scope patent-text">1</sup>H NMRによって分析した。<sup class="style-scope patent-text">1</sup>H NMRでは、ECOB中のCH<sub class="style-scope patent-text">2</sub>Clに対応するメチレン基はδ3.65の一重項として出現し、一方、前記は還元生成物ECHBでは3.60でddとして出現した。これらのピークは<sup class="style-scope patent-text">1</sup>H NMRで十分に分解されたセグメントとして出現するので、2つの化合物の混合物ではそれらの相対的濃度は、δ3.60及び3.65における共鳴の相対的積分値を比較することによって容易に算出できる。<br class="style-scope patent-text">
  出発物質が存在しないことが反応混合物で示されたら、内容物を酢酸エチルで抽出した。有機相を遠心分離により分離し、硫酸ナトリウム上で乾燥させ溶媒を除去してエチル(S)-4-クロロ-3-ヒドロキシブチレートを得た。エチル(S)-4-クロロ-3-ヒドロキシブチレートの光学的純度を高速液体クロマトグラフィーで以下を用いて測定した：キラセルOB-H（ダイセル化学工業（Daicel Chemical Industries）の製品）；溶剤：ヘキサン/イソプロパノール＝96/4；流速：1mL/分；検出：217nm；カラム温度：室温。
</span> <u class="style-scope patent-text">As a biocatalyst, transformed E. coli BL21 (DE3) + pET23 (a)-omp-CRS (CRS, SEQ ID NO: 1) or C41 (DE 3) + pET23 (a)-omp-CRS (CRS, SEQ ID NO: 1) The</u> reaction for <u class="style-scope patent-text">the formation of the ethyl (S) -4-chloro-3-hydroxybutyrate</u> used was carried out in a two-phase system using diethyl ether in an autotitrator (718 STAT Titrino, Metrohm, Switzerland) as auxiliary solvent. E. coli BL21 (DE3) + pET23 (a)-omp-CRS cells or C41 (DE3) + pET23 (a)-omp-CRS (1.38 g; dry cell weight basis) in 20 mL phosphate buffer (100 mM, pH6. Suspended in 5). Glucose (9 g, 50 mmol), glucose dehydrogenase (3600 U), nicotinamide adenine dinucleotide phosphate (NADP) (18 mg, 0.02 mmol) and ECOB (6 g, 36.5 mmol) in 15 mL of dibutyl ether are added to the suspension The contents were gently stirred at 30 ° C. on a magnetic stirrer. The pH of the reaction was maintained at 6.5 with 5 M NaOH. The progress of the reaction was monitored at one hour intervals as follows. Each 0.2 mL aliquot was removed and extracted with 2 mL of ethyl acetate. The organic phase was separated by centrifugation, dried over sodium sulfate and the solvent removed to leave a residue which was analyzed by <sup class="style-scope patent-text">1</sup> H NMR. <sup class="style-scope patent-text">In 1</sup> H NMR, the methylene group corresponding to CH <sub class="style-scope patent-text">2</sub> Cl in ECOB appeared as a singlet of δ 3.65, while it appeared as dd at 3.60 in the reduction product ECHB. Since these peaks appear as well resolved segments in <sup class="style-scope patent-text">1</sup> H NMR, their relative concentrations in mixtures of two compounds are easy to compare by comparing the relative integrals of the resonances at δ 3.60 and 3.65. It can be calculated to <br class="style-scope patent-text"> When the reaction mixture indicated that no starting material was present, the contents were extracted with ethyl acetate. The organic phase was separated by centrifugation, dried over sodium sulfate and the solvent was removed to give ethyl (S) -4-chloro-3-hydroxybutyrate. The optical purity of ethyl (S) -4-chloro-3-hydroxybutyrate was determined by high performance liquid chromatography using the following: Kiracel OB-H (product of Daicel Chemical Industries); solvent: Hexane / isopropanol = 96/4; flow rate: 1 mL / min; detection: 217 nm; column temperature: room temperature.</span>
      </p>
    </embodiments-example>
    <embodiments-example ex-num="13" class="style-scope patent-text">
      <p num="0143" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">生物触媒として形質転換大腸菌BL21(DE3)+pETDuet1-omp-CRS,omp-GDH（CRS, 配列番号:1；GDH, 配列番号：9）又は大腸菌C41(DE3)+pET Duet1-omp-CRS,omp-GDH（CRS, 配列番号:1；GDH, 配列番号：9）を用いるエチル(S)-4-クロロ-3-ヒドロキシブチレートの生成</u> <br class="style-scope patent-text">
  生成方法は、グルコースデヒドロゲナーゼが反応物に添加されなかったことを除き実施例12に記載した方法と同じであった。<br class="style-scope patent-text">
  <u class="style-scope patent-text">本発明の好ましい態様は以下の通りである。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１．配列リストの配列番号:1、3、5又は7から選択される配列の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現するデザイナー細胞であって、配列リストの配列番号:13又は15又は17又は19の対応するカルボニルレダクターゼを下記式1のエチル4-クロロ-3-オキソブチレートから下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために細胞の細胞質で発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり250倍から300倍高い活性を有する、前記デザイナー細胞：</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">２．配列リストの天然に存在しないカルボニルレダクターゼポリペプチド配列番号:1を細胞の表面で発現し、配列リストの配列番号:13の対応するカルボニルレダクターゼを式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために細胞の細胞質で発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり約275倍高い活性を有する、上記1に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３．配列リストの配列番号:1、3、5又は7から選択される配列の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、配列リストの配列番号:13又は15又は17又は19の対応するカルボニルレダクターゼを式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために細胞の細胞質で発現するデザイナー細胞と比較して、単位細胞質量当たり15倍から26倍高い活性を有する、上記1に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４．配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、配列リストの配列番号:13の対応するカルボニルレダクターゼを式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換のために細胞の細胞質で発現するデザイナー細胞と比較して、単位細胞質量当たり少なくとも15倍高い活性を有する、上記1に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５．配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、配列リストの配列番号:13の対応するカルボニルレダクターゼを下記式3の化合物の還元のために細胞の細胞質で発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり50倍から275倍高い活性を有する、上記1に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６．配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、配列リストの配列番号:13の対応するカルボニルレダクターゼを下記式4の化合物の還元のために細胞の細胞質で発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり50倍から180倍高い活性を有する、上記1に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">７．配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現し、配列番号:13の対応するカルボニルレダクターゼを下記式3の化合物又は下記式4の化合物の還元のために細胞の細胞質で発現するデザイナー細胞と比較して、単位細胞質量当たり約3倍から15倍高い活性を有する、上記1に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8であって；</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">  式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">８．配列番号:1、3、5又は7から選択される配列の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9又は11から選択される配列の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現するデザイナー細胞であって、配列リストの配列番号:13又は15又は17又は19の対応するCRS及び配列リストの配列番号:21又は23の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、下記式1のエチル4-クロロ-3-オキソブチレートから下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換についてCRSポリペプチドの単位質量当たり250倍から300倍高い活性、及びグルコースからグルコネートへの酸化についてGDHポリペプチドの単位質量当たり200倍から250倍強化された活性を有する、前記デザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">９．配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換についてCRSポリペプチドの単位質量当たり約270倍高い活性、及びグルコースからグルコネートへの酸化についてGDHポリペプチドの単位質量当たり約225倍強化された活性を有する、上記8に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１０．配列番号:1、3、5又は7から選択される配列の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9、11、13又は15から選択される配列の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現し、配列リストの配列番号:13又は15又は17又は19の対応するCRS及び配列リストの配列番号:21又は23の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換について単位細胞質量当たり約11倍から24倍高い活性、及びグルコースからグルコネートへの酸化について単位細胞質量当たり9倍から31倍強化された活性を有する、上記8に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１１．配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換について単位細胞質量当たり約15倍高い活性、及びグルコースからグルコネートへの酸化につい単位細胞質量当たり約16倍強化された活性を有する、上記8に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１２．配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを下記式3の化合物の還元のために細胞の細胞質で同時に発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり約55倍から270倍高い活性を有する、上記8に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１３．配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを下記式4の化合物の還元のために細胞の細胞質で同時に発現するデザイナー細胞と比較して、CRSポリペプチドの単位質量当たり約40倍から156倍高い活性を有する、上記8に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１４．配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現し、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを下記式3の化合物又は下記式4の化合物の還元のために細胞の細胞質で同時に発現するデザイナー細胞と比較して、単位細胞質量当たり約2倍から15倍高い活性を有する、上記8に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１５．デザイナー細胞が、組換え大腸菌（Escherichia coli）BL21(DE3)、又は組換え大腸菌C41(DE3)、又は組換え大腸菌C43(DE3)である、上記1から14に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１６．カルボニルレダクターゼ活性を示す、配列番号:1又は3又は5又は7のアミノ酸配列を有するポリペプチドをコードするポリヌクレオチドを含む組換え発現ベクター。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１７．カルボニルレダクターゼ活性を示す配列番号:1又は3又は5又は7のアミノ酸配列を有するポリペプチド、及びGDH活性を示す配列番号:9又は11のアミノ酸配列有するポリペプチドをコードするポリヌクレオチドを含む組換え発現ベクター。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">１８．下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートの約100％鏡像体過剰の製造のための上記1に記載のデザイナー細胞の使用。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">１９．式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートの約100％鏡像体過剰の製造のための上記8に記載のデザイナー細胞の使用。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２０．下記式5の化合物の製造のための上記1に記載のデザイナー細胞の使用。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２１．下記式5の化合物の製造のための上記8に記載のデザイナー細胞の使用。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２２．下記式6の化合物の製造のための上記1に記載のデザイナー細胞の使用。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２３．下記式6の化合物の製造のための上記8に記載のデザイナー細胞の使用。</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２４．下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートを約100％鏡像体過剰で製造する方法であって、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">  前記方法が、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">f．下記式1のエチル4-クロロ-3-オキソブチレートを提供する工程、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">g．該エチル4-クロロ-3-オキソブチレートを、上記1に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させる工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">h．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">i．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">j．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて当該生成物エチル(S)-4-クロロ-3-ヒドロキシブチレートを単離する工程を含む、前記方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２５．pHが、好ましくは6.5である、上記24に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２６．温度が、好ましくは30℃である、上記24に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２７．有機溶媒が、好ましくはジ-n-ブチルエーテルである、上記24に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２８．デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、上記24に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">２９．デザイナー細胞が、好ましくは組換え大腸菌C41(DE3)である、上記24に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３０．下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートを約100％鏡像体過剰で製造する方法であって、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">  前記方法が、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">a．下記式1のエチル4-クロロ-3-オキソブチレートを提供する工程、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">b．該エチル4-クロロ-3-オキソブチレートを、上記8に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及びpH5.0から9.0の緩衝溶液と接触させる工程；</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">c．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程；</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">d．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程；</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">e．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて当該生成物エチル(S)-4-クロロ-3-ヒドロキシブチレートを単離する工程を含む、前記方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３１．pHが、好ましくは6.5である、上記30に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３２．温度が、好ましくは30℃である、上記30に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３３．有機溶媒が、好ましくはジ-n-ブチルエーテルである、上記30に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３４．デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、上記30に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３５．デザイナー細胞が、組換え大腸菌BL21(DE3)である、上記30に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３６．デザイナー細胞が、好ましくは組換え大腸菌C41(DE3)である、上記30に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３７．光学的に濃縮された下記式5の脂肪族アルコールを製造する方法であって</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">  前記方法が、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">f．下記式3のケトンを提供する工程、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">g．工程（a）で提供される式3のケトンを、上記1に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">h．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">i．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">j．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式5の化合物を単離する工程を含む、前記方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３８．pHが、好ましくは6.5である、上記37に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">３９．温度が、好ましくは30℃である、上記37に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４０．有機溶媒が、好ましくはジ-n-ブチルエーテルである、上記37に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４１．デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、上記37に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４２．デザイナー細胞が、好ましくは組換え大腸菌C41(DE3)である、上記37に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４３．光学的に濃縮された下記式6のアリールアルコールを製造する方法であって、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">前記方法が、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">f．下記式4のケトンを提供する工程、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">g．工程（a）で提供される式3のケトンを、上記1に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">h．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">i．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">j．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式6の化合物を単離する工程を含む、前記方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４４．pHが、好ましくは6.5である、上記43に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４５．温度が、好ましくは30℃である、上記43に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４６．有機溶媒が、好ましくはジ-n-ブチルエーテルである、上記43に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４７．デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、上記43に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４８．デザイナー細胞が、好ましくは組換え大腸菌C41(DE3)である、上記43に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">４９．光学的に濃縮された下記式5の脂肪族アルコールを製造する方法であって、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">  前記方法が、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">a．下記式3のケトンを提供する工程、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">X、(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">CH、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝H、X又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">であり、X＝Cl又はBrであり、n＝1−4であり、さらにm＝1−8である。）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">b．工程（a）で提供される式3のケトンを、上記8に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">c．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">d．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">e．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式5の化合物を単離する工程を含む、前記方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５０．pHが、好ましくは6.5である、上記49に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５１．温度が、好ましくは30℃である、上記49に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５２．有機溶媒が、好ましくはジ-n-ブチルエーテルである、上記49に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５３．デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、上記49に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５４．デザイナー細胞が、好ましくは組換え大腸菌C41(DE3)である、上記49に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５５．光学的に濃縮された下記式6のアリールアルコールを製造する方法であって、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である）、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">前記方法が、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">a．下記式4のケトンを提供する工程、</u> <br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
<u class="style-scope patent-text">（式中、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">＝R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">＝H、CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、F、Cl、Br、I、CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">、NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">又はOCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">であり、R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">＝アルキル基、例えばCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">又はCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">であり、n＝1から5である）、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">b．工程（a）で提供される式3のケトンを、上記8に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">c．工程（b）で得られる反応混合物に有機溶媒（例えば酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテル）を10：1から1：1の範囲の比率で添加する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">d．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">e．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式6の化合物を単離する工程を含む、前記方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５６．pHが、好ましくは6.5である、上記55に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５７．温度が、好ましくは30℃である、上記55に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５８．有機溶媒が、好ましくはジ-n-ブチルエーテルである、上記55に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">５９．デザイナー細胞が、組換え大腸菌BL21(DE3)、組換え大腸菌C41(DE3)、及び組換え大腸菌C43(DE3)から選択される組換え大腸菌株である、上記55に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６０．デザイナー細胞が、好ましくは組換え大腸菌C41(DE3)である、上記55に記載の方法。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６１．アクセッション番号MTCC No.5806、MTCC No.5807、MTCC No.5808及びMTCC No.5809を有するデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６２．アクセッション番号MTCC5806−5809を有するデザイナー細胞が配列番号:1、3、5及び7を有するアミノ酸配列を発現する、上記61に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６３．配列番号:1、3、5及び7を有するアミノ酸配列が配列番号:2、4、6、8を有するヌクレオチド配列と一致する、上記61−62に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６４．配列番号:1−8が、天然に存在しないカルボニルレダクターゼ酵素配列である、上記61−63に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６５．細胞表面で高活性のカルボニルレダクターゼを発現することができる、上記61−64に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６６．配列番号:1−8を含みかつ該配列を発現することができる組換えベクター構築物。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６７．天然に存在しないカルボニルレダクターゼ酵素配列を含む、上記66に記載の組換えベクター構築物。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６８．細胞表面で高活性のカルボニルレダクターゼを発現することができる、上記66−67に記載の組換えベクター構築物。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">６９．アクセッション番号MTCC No.5810、MTCC No.5811、MTCC No.5812、MTCC No.5813、MTCC No.5814、MTCC No.5815、MTCC No.5816及びMTCC No.5817を有するデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">７０．デザイナー細胞が、MTCC No.5810のアクセッション番号を有し配列番号:1及び配列番号:9を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5811のアクセッション番号を有し配列番号:1及び配列番号:11を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5812のアクセッション番号を有し配列番号:3及び配列番号:9を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5813のアクセッション番号を有し配列番号:配列番号:3及び配列番号:11を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5814のアクセッション番号を有し配列番号:5及び配列番号:9を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5815のアクセッション番号を有し配列番号:5及び配列番号:11を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5816のアクセッション番号を有し配列番号:7及び配列番号:9を有するアミノ酸配列を発現する、デザイナー細胞がMTCC No.5817のアクセッション番号を有し配列番号:7及び配列番号:11を有するアミノ酸配列を発現する、上記69に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">７１．配列番号:1、3、5、7、9及び11を有するアミノ酸配列が、配列番号:2、4、6、8、10及び12を有するヌクレオチド配列と一致する、上記69−70に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">７２．酵素カルボニルレダクターゼ及びグルコナーゼデヒドロゲナーゼを細胞表面で一緒に共同発現することができる、上記65−67に記載のデザイナー細胞。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">７３．上記71に記載の配列を含み、さらに前記を発現することができる組換えベクター。</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">７４．酵素カルボニルレダクターゼ及びグルコナーゼデヒドロゲナーゼを細胞表面で一緒に共同発現することができる、上記73に記載の組換えベクター。</u>
</span> <u class="style-scope patent-text">Transformed E. coli BL21 (DE3) + pETDuet1-omp-CRS, omp-GDH (CRS, SEQ ID NO: 1; GDH, SEQ ID NO: 9) or E. coli C41 (DE3) + pET Duet-omp-CRS, omp as biocatalysts Production of ethyl (S) -4-chloro-3-hydroxybutyrate using -GDH (CRS, SEQ ID NO: 1; GDH, SEQ ID NO: 9) The</u> production method was that no glucose dehydrogenase was added to the reaction The procedure was as described in Example 12 with the exception of <br class="style-scope patent-text"> <u class="style-scope patent-text">Preferred embodiments of the present invention are as follows.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">1. A designer cell that expresses on the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 of SEQ ID NO: 1, comprising SEQ ID NO: 13 or 15 of SEQ ID NO: For conversion of 17 or 19 corresponding carbonyl reductases from ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 Said designer cells having a 250-fold to 300-fold higher activity per unit mass of CRS polypeptide as compared to cytoplasmically expressed designer cells:</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">2. The non-naturally occurring carbonyl reductase polypeptide SEQ ID NO: 1 of the sequence listing is expressed on the surface of the cell, and the corresponding carbonyl reductase of the sequence listing SEQ ID NO: 13 from ethyl 4-chloro-3-oxobutyrate of formula 1 Has approximately 275 times higher activity per unit mass of CRS polypeptide as compared to the designer cell in the cytoplasm of the cell for conversion to ethyl (S) -4-chloro-3-hydroxybutyrate of Formula 2 , The designer cell described in 1 above.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">3. A non-naturally occurring carbonyl reductase polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 of the Sequence Listing is expressed on the surface of the cell, corresponding to SEQ ID NO: 13 or 15 or 17 or 19 of the Sequence Listing Designers that express the corresponding carbonyl reductase in the cytoplasm of the cell for the conversion of ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 In comparison, the designer cell according to 1 above, which has 15 to 26 times higher activity per unit cell mass.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">4. The non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 is expressed on the surface of the cell, and the corresponding carbonyl reductase of SEQ ID NO: 13 is ethyl 4-chloro-3-oxobutyrate of formula 1 Having at least a 15-fold higher activity per unit cell mass as compared to the designer cell in the cytoplasm of the cell for conversion of Formula 2 to ethyl (S) -4-chloro-3-hydroxybutyrate Designer cell according to 1.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">5. The non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 is expressed on the surface of the cell, and the corresponding carbonyl reductase of SEQ ID NO: 13 is cytosolic due to reduction of the compound of formula 3 The designer cell according to 1 above, which has 50 to 275 times higher activity per unit mass of CRS polypeptide as compared to a designer cell expressed in.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">6. The non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 is expressed on the surface of the cell, and the corresponding carbonyl reductase of SEQ ID NO: 13 is cytosolic of the cell due to reduction of the compound of formula 4 The designer cell according to 1 above, which has 50-fold to 180-fold higher activity per unit mass of CRS polypeptide as compared to a designer cell expressed in</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5)</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">7. The non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 of the Sequence Listing is expressed on the surface of the cell, and the corresponding carbonyl reductase of SEQ ID NO: 13 is for reduction of a compound of Formula 3 or a compound of Formula 4 The designer cell according to 1 above, which has about 3 to 15 times higher activity per unit cell mass as compared to the designer cell expressed in the cytoplasm of the cell.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and further m = 1-8;</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">In which R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">2R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">2R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5; )</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">8. Non-naturally occurring CRS polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 and non-naturally occurring GDH polypeptide of a sequence selected from SEQ ID NO: 9 or 11 of the Sequence Listing A designer cell that simultaneously expresses on the surface and simultaneously expresses in the cytoplasm of the cell the corresponding CRS of SEQ ID NO: 13 or 15 or 17 or 19 of the sequence list and the corresponding GDH of SEQ ID NO: 21 or 23 of the sequence list Unit mass of CRS polypeptide for conversion of ethyl 4-chloro-3-oxobutyrate of formula 1 below to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 below as compared to designer cells The designer cell, wherein the designer cell has an activity that is 250 to 300 times higher per and an activity that is enhanced 200 to 250 times per unit mass of GDH polypeptide for the oxidation of glucose to gluconate.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">9. A non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9 are simultaneously expressed on the surface of the cell, and the corresponding CRS and SEQ ID NO: 13 of SEQ ID NO: 13 From ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro of formula 2 compared to designer cells co-expressing the corresponding GDH of list SEQ ID NO: 21 in the cytoplasm of the cell 8. The method has about 270 times higher activity per unit mass of CRS polypeptide for conversion to -3-hydroxybutyrate and about 225 times enhanced activity per unit mass of GDH polypeptide for glucose to gluconate oxidation. Designer cell described in.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">10. Non-naturally occurring CRS polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 and non-naturally occurring GDH polypeptide of a sequence selected from SEQ ID NO: 9, 11, 13 or 15 of the Sequence Listing The designer simultaneously expresses the peptide on the surface of the cell, and simultaneously expresses in the cytoplasm of the cell the corresponding CRS of SEQ ID NO: 13 or 15 or 17 or 19 of the sequence list and the corresponding GDH of SEQ ID NO: 21 or 23 of the sequence list About 11 to 24 times per unit cell mass for the conversion of ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 compared to cells The designer cell according to claim 8, having a twice as high activity and a 9 to 31 times enhanced activity per unit cell mass for the oxidation of glucose to gluconate.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">11. A non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9 are simultaneously expressed on the surface of the cell, and the corresponding CRS and SEQ ID NO: 13 of SEQ ID NO: 13 From ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro of formula 2 compared to designer cells co-expressing the corresponding GDH of list SEQ ID NO: 21 in the cytoplasm of the cell The designer cell according to claim 8, which has about 15 times higher activity per unit cell mass for conversion to -3-hydroxybutyrate and about 16 times enhanced activity per unit cell mass for oxidation of glucose to gluconate.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">12. A non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9 are simultaneously expressed on the surface of the cell, and the corresponding CRS and SEQ ID NO: 13 of SEQ ID NO: 13 Approximately 55-fold to 270-fold higher activity per unit mass of CRS polypeptide as compared to designer cells co-expressing the corresponding GDH of SEQ ID NO: 21 in the cytoplasm of the cell for reduction of the compound of formula 3 below The designer cell according to 8 above, which has</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">13. A non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9 are simultaneously expressed on the surface of the cell, and the corresponding CRS and SEQ ID NO: 13 of SEQ ID NO: 13 Approximately 40-fold to 156-fold higher activity per unit mass of CRS polypeptide compared to designer cells co-expressing the corresponding GDH of list SEQ ID NO: 21 in the cytoplasm of the cell for reduction of the compound of formula 4 The designer cell according to 8 above, which has</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5)</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">14. A non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9 are simultaneously expressed on the surface of the cell, and the corresponding CRS and SEQ ID NO: 13 of SEQ ID NO: 13 About 2 to 15 per unit cell mass, as compared to designer cells that simultaneously express the corresponding GDH of SEQ ID NO: 21 in the cell cytoplasm for reduction of the compound of Formula 3 or the compound of Formula 4 The designer cell according to 8 above, having twice as high activity.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5)</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">15. The designer cell according to any one of the above 1 to 14, wherein the designer cell is recombinant Escherichia coli BL21 (DE3), or recombinant Escherichia coli C41 (DE3), or recombinant Escherichia coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">16. A recombinant expression vector comprising a polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO: 1 or 3 or 5 or 7 which exhibits carbonyl reductase activity.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">17. Recombinant expression comprising a polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO: 1 or 3 or 5 or 7 showing carbonyl reductase activity, and a polypeptide having the amino acid sequence of SEQ ID NO: 9 or 11 showing GDH activity vector.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">18. Use of a designer cell according to the above 1 for the production of about 100% enantiomeric excess of ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 below.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">19. Use of a designer cell according to the above 8 for the production of about 100% enantiomeric excess of ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">20. Use of a designer cell according to the above 1 for the production of a compound of formula 5 below.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">21. Use of a designer cell according to the above 8 for the production of a compound of formula 5 below.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">22. Use of a designer cell according to the above 1 for the production of a compound of formula 6 below.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5)</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">23. Use of a designer cell described in the above 8 for the production of a compound of the following formula 6.</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5)</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">24. A process for producing ethyl (S) -4-chloro-3-hydroxybutyrate of the following formula 2 in about 100% enantiomeric excess,</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">The above method is</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">f. Providing ethyl 4-chloro-3-oxobutyrate of formula 1</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">g. The ethyl 4-chloro-3-oxobutyrate is prepared by using the designer cell described in 1 above and 0.005 to 0.02 mol% of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase and pH 5. Contacting with 0 to 9.0 buffer solution,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">h. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">i. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">j. Extracting the product obtained in step (d) in ethyl acetate followed by isolating the product ethyl (S) -4-chloro-3-hydroxybutyrate.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">25. A method according to claim 24, wherein the pH is preferably 6.5.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">26. A method according to claim 24, wherein the temperature is preferably 30 ° C.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">27. A process according to claim 24, wherein the organic solvent is preferably di-n-butyl ether.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">28. 24. The method according to 24 above, wherein the designer cell is a recombinant E. coli strain selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">29. A method according to claim 24, wherein the designer cell is preferably recombinant E. coli C41 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">30. A process for producing ethyl (S) -4-chloro-3-hydroxybutyrate of the following formula 2 in about 100% enantiomeric excess,</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">The above method is</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">a. Providing ethyl 4-chloro-3-oxobutyrate of formula 1</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">b. Contacting the ethyl 4-chloro-3-oxobutyrate with the designer cells described in 8 above and 0.005 to 0.02 mol% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and a buffer solution of pH 5.0 to 9.0 Process of</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">c. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">e. Extracting the product obtained in step (d) in ethyl acetate followed by isolating the product ethyl (S) -4-chloro-3-hydroxybutyrate.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">31. A method according to claim 30, wherein the pH is preferably 6.5.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">32. A method according to claim 30, wherein the temperature is preferably 30 ° C.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">33. A method according to claim 30, wherein the organic solvent is preferably di-n-butyl ether.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">34. The method according to the above 30, wherein the designer cell is a recombinant E. coli strain selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">35. The method according to the above 30, wherein the designer cell is recombinant E. coli BL21 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">36. The method according to claim 30, wherein the designer cells are preferably recombinant E. coli C41 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">37. A process for producing an optically concentrated aliphatic alcohol of the following formula 5,</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8),</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">The above method is</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">f. Providing a ketone of formula 3</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">g. The ketone of formula 3 provided in step (a), the designer cell described in 1 above and 0.005 to 0.02 mole% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase and pH 5 Contacting with a buffer solution of 0 to 9.0 to form a reaction mixture,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">h. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">i. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">j. Extracting the product obtained in step (d) in ethyl acetate, followed by isolating the compound of formula 5 as described above.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">38. A method according to claim 37, wherein the pH is preferably 6.5.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">39. A method according to claim 37, wherein the temperature is preferably 30 ° C.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">40. A method according to claim 37, wherein the organic solvent is preferably di-n-butyl ether.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">41. The method according to 37, wherein the designer cell is a recombinant E. coli strain selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">42. A method according to claim 37, wherein the designer cell is preferably recombinant E. coli C41 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">43. A process for producing an optically enriched aryl alcohol of the following formula 6,</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">where n = 1 to 5),</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">The above method is</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">f. Providing a ketone of formula 4</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, n = 1 to 5)</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">g. The ketone of formula 3 provided in step (a), the designer cell described in 1 above and 0.005 to 0.02 mole% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase and pH 5 Contacting with a buffer solution of 0 to 9.0 to form a reaction mixture,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">h. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">i. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">j. Extracting the product obtained in step (d) in ethyl acetate, followed by isolating the compound of formula 6 as described above.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">44. A method according to claim 43, wherein the pH is preferably 6.5.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">45. A method according to claim 43, wherein the temperature is preferably 30 ° C.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">46. A method according to claim 43, wherein the organic solvent is preferably di-n-butyl ether.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">47. A method according to item 43, wherein the designer cell is a recombinant E. coli strain selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">48. A method according to claim 43, wherein the designer cell is preferably recombinant E. coli C41 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">49. A process for producing an optically concentrated aliphatic alcohol of the following formula 5,</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8),</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">The above method is</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">a. Providing a ketone of formula 3</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">(Wherein, R 1 = CH 3, CH</u> </u> </sub> </u> </u> </sub> </u> 2 X, (CH 3) 2 CH, CF 3 <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <u class="style-scope patent-text"> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n,</u> </sub> and</u> <u class="style-scope patent-text">be</u> <u class="style-scope patent-text">R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">= H, X or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text"> <u class="style-scope patent-text">2)</u> </u> </sub> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">= an alkyl group such as CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">m</u> </sub> <u class="style-scope patent-text">, X = Cl or Br, n = 1-4, and m = 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">b. The ketone of formula 3 provided in step (a) is combined with the designer cells described in 8 above with 0.005 to 0.02 mol% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and a buffer solution of pH 5.0 to 9.0. Contacting to form a reaction mixture,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">c. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">e. Extracting the product obtained in step (d) in ethyl acetate, followed by isolating the compound of formula 5 as described above.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">50. A method according to claim 49, wherein the pH is preferably 6.5.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">51. A method according to claim 49, wherein the temperature is preferably 30 ° C.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">52. A method according to claim 49, wherein the organic solvent is preferably di-n-butyl ether.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">53. 48. The method according to 49, wherein the designer cell is a recombinant E. coli strain selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">54. A method according to claim 49, wherein the designer cell is preferably recombinant E. coli C41 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">55. A process for producing an optically enriched aryl alcohol of the following formula 6,</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">where n = 1 to 5),</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">The above method is</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">a. Providing a ketone of formula 4</u> <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> <u class="style-scope patent-text">(Wherein, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">1</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">4</u> </sub> <u class="style-scope patent-text">RR</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">5</u> </sub> <u class="style-scope patent-text">HH, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, F, Cl, Br, I, CF</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, NO</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">or OCH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">, R</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">6</u> </sub> <u class="style-scope patent-text">ア ル キ ル</u> <u class="style-scope patent-text">alkyl group, for example, CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">or CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">3</u> </sub> <u class="style-scope patent-text">(CH</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">)</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">n</u> </sub> <u class="style-scope patent-text">where n = 1 to 5),</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">b. The ketone of formula 3 provided in step (a) is combined with the designer cells described in 8 above with 0.005 to 0.02 mol% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and a buffer solution of pH 5.0 to 9.0. Contacting to form a reaction mixture,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">c. Adding an organic solvent (eg, ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether) to the reaction mixture obtained in step (b) in a ratio ranging from 10: 1 to 1: 1 ,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .;</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">e. Extracting the product obtained in step (d) in ethyl acetate, followed by isolating the compound of formula 6 as described above.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">56. A method according to the above 55, wherein the pH is preferably 6.5.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">57. A method according to claim 55, wherein the temperature is preferably 30 ° C.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">58. A method according to claim 55, wherein the organic solvent is preferably di-n-butyl ether.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">59. 56. The method according to 55, wherein the designer cell is a recombinant E. coli strain selected from recombinant E. coli BL21 (DE3), recombinant E. coli C41 (DE3), and recombinant E. coli C43 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">60. A method according to claim 55, wherein the designer cell is preferably recombinant E. coli C41 (DE3).</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">61. Designer cells with accession numbers MTCC No. 5806, MTCC No. 5807, MTCC No. 5808 and MTCC No. 5809.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">62. 61. The designer cell according to 61 above, wherein the designer cell having Accession No. MTCC 5806-5809 expresses an amino acid sequence having SEQ ID NO: 1, 3, 5 and 7.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">63. The designer cell according to the above 61-62, wherein the amino acid sequence having SEQ ID NO: 1, 3, 5 and 7 corresponds to the nucleotide sequence having SEQ ID NO: 2, 4, 6, 8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">64. The designer cell according to the above 61-63, wherein SEQ ID NO: 1-8 is a non-naturally occurring carbonyl reductase enzyme sequence.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">65. The designer cell according to the above 61-64, which is capable of expressing a highly active carbonyl reductase at the cell surface.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">66. A recombinant vector construct comprising and capable of expressing SEQ ID NO: 1-8.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">67. 66. A recombinant vector construct according to claim 66 which comprises a non-naturally occurring carbonyl reductase enzyme sequence.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">68. 66. The recombinant vector construct according to the above 66-67, which is capable of expressing high activity carbonyl reductase at the cell surface.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">69. Designer cells with accession numbers MTCC No. 5810, MTCC No. 5811, MTCC No. 5812, MTCC No. 5813, MTCC No. 5814, MTCC No. 5815, MTCC No. 5816 and MTCC No. 5817.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">70. Designer cells have an accession number of MTCC No. 5810 and express an amino acid sequence having SEQ ID NO: 1 and SEQ ID NO: 9; Designer cells have an accession number of MTCC No. 5811; And an amino acid sequence having an accession number of MTCC No. 5812, which expresses the amino acid sequence having SEQ ID NO: 11, and a designer cell which expresses an amino acid sequence having the SEQ ID NO: 3 and SEQ ID NO. The designer cell has an accession number of 5813 and expresses an amino acid sequence having SEQ ID NO: 3 and SEQ ID NO: 11, a designer cell has an accession number of MTCC No. 5814, SEQ ID NO: 5 and SEQ ID NO: The designer cell expresses the amino acid sequence having SEQ ID NO: 9, the designer cell has the accession number of MTCC No. 5815, and expresses the amino acid sequence having SEQ ID NO: 5 and SEQ ID NO: 11, the designer cell has the MTCC No. 5816 Designer cell having an accession number and expressing an amino acid sequence having SEQ ID NO: 7 and SEQ ID NO: 9, an amino acid sequence having an accession number of MTCC No. 5817 and having SEQ ID NO: 7 and SEQ ID NO: 11 69. The designer cell according to the above 69, which expresses</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">71. The designer according to the above 69-70, wherein the amino acid sequence having SEQ ID NO: 1, 3, 5, 7, 9 and 11 corresponds to the nucleotide sequence having SEQ ID NO: 2, 4, 6, 8, 10 and 12. cell.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">72. Designer cell according to clause 65-67, wherein the enzymes carbonyl reductase and gluconase dehydrogenase can be coexpressed together at the cell surface.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">73. A recombinant vector comprising the sequence described in the above 71 and capable of expressing the above.</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">74. 74. The recombinant vector of clause 73, wherein the enzymes carbonyl reductase and gluconase dehydrogenase can be coexpressed together at the cell surface.</u> </span>
      </p>
    </embodiments-example>
  </description-of-embodiments>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(22)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM130387880" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列リストの配列番号:1、3、5又は7から選択される配列の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現するデザイナー細胞であって、配列リストの配列番号:13又は15又は17又は19の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して、下記式1のエチル4-クロロ-3-オキソブチレートから下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換についてCRSポリペプチドの単位質量当たり250倍から300倍高い活性を有する、前記デザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
</span>A designer cell that expresses on the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 of SEQ ID NO: 1, comprising SEQ ID NO: 13 or 15 of SEQ ID NO: From ethyl 4-chloro-3-oxobutyrate of formula 1 below, ethyl (S) -4-chloro- of formula 2 below, compared with designer cells expressing the corresponding carbonyl reductase of 17 or 19 in the cytoplasm of the cell The designer cell, wherein the designer cell has 250-fold to 300-fold higher activity per unit mass of CRS polypeptide for conversion to 3-hydroxybutyrate. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列リストの配列番号:1、3、5又は7から選択される配列の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現するデザイナー細胞であって、配列リストの配列番号:13又は15又は17又は19の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換について単位細胞質量当たり15倍から26倍高い活性を有する、請求項１に記載のデザイナー細胞。
</span>
&nbsp;&nbsp;A designer cell that expresses on the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 of SEQ ID NO: 1, comprising SEQ ID NO: 13 or 15 of SEQ ID NO: From ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3- of formula 2 in comparison with designer cells expressing the corresponding carbonyl reductase of 17 or 19 in the cytoplasm of the cell. The designer cell according to claim 1, having a 15 to 26 times higher activity per unit cell mass for conversion to hydroxybutyrate.
</span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現するデザイナー細胞であって、配列リストの配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して、下記式3の化合物の還元についてCRSポリペプチドの単位質量当たり50倍から275倍高い活性を有する、請求項１に記載のデザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）
</span>A designer cell expressing on the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 in the sequence listing, wherein the designer cell expresses the corresponding carbonyl reductase of SEQ ID NO: 13 in the cytoplasm of the cell The designer cell according to claim 1, which has 50 to 275 times higher activity per unit mass of CRS polypeptide for reduction of a compound of the following formula 3 in comparison with <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">3</sub> = alkyl group, XXCl or Br, n = 1-4 and m = 1-8.)</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現するデザイナー細胞であって、配列リストの配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して、下記式4の化合物の還元についてCRSポリペプチドの単位質量当たり50倍から180倍高い活性を有する、請求項１に記載のデザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）
</span>A designer cell expressing on the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 in the sequence listing, wherein the designer cell expresses the corresponding carbonyl reductase of SEQ ID NO: 13 in the cytoplasm of the cell The designer cell according to claim 1, which has 50-fold to 180-fold higher activity per unit mass of CRS polypeptide for reduction of a compound of the following formula 4 in comparison with. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5.)</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列リストの配列番号:1の天然に存在しないカルボニルレダクターゼポリペプチドを細胞の表面で発現するデザイナー細胞であって、配列番号:13の対応するカルボニルレダクターゼを細胞の細胞質で発現するデザイナー細胞と比較して、下記式3の化合物又は下記式4の化合物の還元について単位細胞質量当たり約3倍から15倍高い活性を有する、請求項１に記載のデザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）
</span>A designer cell expressing on the surface of the cell a non-naturally occurring carbonyl reductase polypeptide of SEQ ID NO: 1 of the sequence listing and comparing with the designer cell expressing the corresponding carbonyl reductase of SEQ ID NO: 13 in the cytoplasm of the cell The designer cell according to claim 1, which has about 3 to 15 times higher activity per unit cell mass for the reduction of the compound of the following formula 3 or the compound of the following formula 4. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">3</sub> = alkyl group, XXCl or Br, n = 1-4 and m = 1-8.) <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5.)</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号:1、3、5又は7から選択される配列の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9又は11から選択される配列の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現するデザイナー細胞であって、配列リストの配列番号:13又は15又は17又は19の対応するCRS及び配列リストの配列番号:21又は23の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、下記式1のエチル4-クロロ-3-オキソブチレートから下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換についてCRSポリペプチドの単位質量当たり250倍から300倍高い活性、及びグルコースからグルコネートへの酸化についてGDHポリペプチドの単位質量当たり200倍から250倍強化された活性を有する、前記デザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
</span>Non-naturally occurring CRS polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 and non-naturally occurring GDH polypeptide of a sequence selected from SEQ ID NO: 9 or 11 of the Sequence Listing A designer cell that simultaneously expresses on the surface and simultaneously expresses in the cytoplasm of the cell the corresponding CRS of SEQ ID NO: 13 or 15 or 17 or 19 of the sequence list and the corresponding GDH of SEQ ID NO: 21 or 23 of the sequence list Unit mass of CRS polypeptide for conversion of ethyl 4-chloro-3-oxobutyrate of formula 1 below to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 below as compared to designer cells The designer cell, wherein the designer cell has an activity that is 250 to 300 times higher per and an activity that is enhanced 200 to 250 times per unit mass of GDH polypeptide for the oxidation of glucose to gluconate. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号:1、3、5又は7から選択される配列の天然に存在しないCRSポリペプチド、及び配列リストの配列番号:9又は11から選択される配列の天然に存在しないGDHポリペプチドを細胞の表面で同時に発現するデザイナー細胞であって、配列リストの配列番号:13又は15又は17又は19の対応するCRS及び配列リストの配列番号:21又は23の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、式1のエチル4-クロロ-3-オキソブチレートから式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートへの変換について単位細胞質量当たり11倍から24倍強化された活性、及びグルコースからグルコネートへの酸化について単位細胞質量当たり9倍から31倍強化された活性を有する、請求項６に記載のデザイナー細胞。
</span>
&nbsp;&nbsp;Non-naturally occurring CRS polypeptide of a sequence selected from SEQ ID NO: 1, 3, 5 or 7 and non-naturally occurring GDH polypeptide of a sequence selected from SEQ ID NO: 9 or 11 of the Sequence Listing A designer cell that simultaneously expresses on the surface and simultaneously expresses in the cytoplasm of the cell the corresponding CRS of SEQ ID NO: 13 or 15 or 17 or 19 of the sequence list and the corresponding GDH of SEQ ID NO: 21 or 23 of the sequence list 11 to 24 per unit cell mass for the conversion of ethyl 4-chloro-3-oxobutyrate of formula 1 to ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 compared to designer cells 7. The designer cell according to claim 6, having an enhanced activity and an enhanced activity from 9 to 31 times per unit cell mass for the oxidation of glucose to gluconate.
</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現するデザイナー細胞であって、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、下記式3の化合物の還元についてCRSポリペプチドの単位質量当たり約55倍から270倍高い活性を有する、請求項６に記載のデザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）
</span>A designer cell simultaneously expressing on the surface of the cell a non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9, Approximately 55-fold to 270-fold per unit mass of CRS polypeptide for reduction of the compound of Formula 3 below as compared to designer cells that simultaneously express the corresponding CRS and the corresponding GDH of SEQ ID NO: 21 in the cell list 7. The designer cell of claim 6, having twice as high activity. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">3</sub> = alkyl group, XXCl or Br, n = 1-4 and m = 1-8.)</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現するデザイナー細胞であって、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、下記式4の化合物の還元についてCRSポリペプチドの単位質量当たり約40倍から156倍高い活性を有する、請求項６に記載のデザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）
</span>A designer cell simultaneously expressing on the surface of the cell a non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9, Approximately 40-fold to 156-fold per unit mass of CRS polypeptide for reduction of the compound of Formula 4 below as compared to designer cells that simultaneously express the corresponding CRS and the corresponding GDH of SEQ ID NO: 21 in the sequence listing in the cytoplasm of the cell 7. The designer cell of claim 6, having twice as high activity. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5.)</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号:1の天然に存在しないCRSポリペプチド及び配列リストの配列番号:9の天然に存在しないGDHポリペプチドを細胞の表面に同時に発現するデザイナー細胞であって、配列リストの配列番号:13の対応するCRS及び配列リストの配列番号:21の対応するGDHを細胞の細胞質で同時に発現するデザイナー細胞と比較して、下記式3の化合物又は下記式4の化合物の還元について単位細胞質量当たり約３倍から２４倍高い活性を有する、請求項６に記載のデザイナー細胞。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）
</span>A designer cell simultaneously expressing on the surface of the cell a non-naturally occurring CRS polypeptide of SEQ ID NO: 1 and a non-naturally occurring GDH polypeptide of SEQ ID NO: 9 of SEQ ID NO: 9, Approximately 3 per unit cell mass for reduction of the compound of formula 3 or the compound of formula 4 below as compared to the designer cell co-expressing the corresponding CRS and the corresponding GDH of SEQ ID NO: 21 in the sequence listing in the cytoplasm of the cell 7. The designer cell according to claim 6, which has twice to 24 times higher activity. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">3</sub> = alkyl group, XXCl or Br, n = 1-4 and m = 1-8.) <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5.)</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  組換え大腸菌（Escherichia coli）BL21(DE3)、又は組換え大腸菌C41(DE3)、又は組換<br class="style-scope patent-text">
え大腸菌C43(DE3)から調製される、請求項１又は６に記載のデザイナー細胞。
</span>The designer cell according to claim 1 or 6, which is prepared from recombinant Escherichia coli BL21 (DE3), or recombinant Escherichia coli C41 (DE3), or recombinant Escherichia coli C43 (DE3).</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  カルボニルレダクターゼ活性を示す、配列番号:1又は3又は5又は7のアミノ酸配列を有<br class="style-scope patent-text">
するポリペプチドをコードするポリヌクレオチドを含む組換え発現ベクター。
</span>A recombinant expression vector comprising a polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO: 1 or 3 or 5 or 7 which exhibits carbonyl reductase activity.</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  カルボニルレダクターゼ活性を示す配列番号:1又は3又は5又は7のアミノ酸配列を有す<br class="style-scope patent-text">
るポリペプチド、及びGDH活性を示す配列番号:9又は11のアミノ酸配列を有するポリペプ<br class="style-scope patent-text">
チドをコードするポリヌクレオチドを含む組換え発現ベクター。
</span>A recombinant comprising a polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO: 1 or 3 or 5 or 7 showing carbonyl reductase activity, and a polypeptide having the amino acid sequence of SEQ ID NO: 9 or 11 showing GDH activity Expression vector.</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  約100％鏡像体過剰の下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートの製造の<br class="style-scope patent-text">
ための請求項1又は６に記載のデザイナー細胞の使用。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
</span>The use of the designer cell according to claim 1 or 6 for the production of ethyl (S) -4-chloro-3-hydroxybutyrate of the following formula 2 with about 100% enantiomeric excess. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  下記式5の化合物の製造のための請求項１又は６に記載のデザイナー細胞の使用。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）
</span>Use of a designer cell according to claim 1 or 6 for the production of a compound of formula 5 below. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">3</sub> = alkyl group, XXCl or Br, n = 1-4 and m = 1-8.)</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  下記式６の化合物の製造のための請求項１又は６に記載のデザイナー細胞の使用。<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）
</span>Use of a designer cell according to claim 1 or 6 for the production of a compound of formula 6 below. <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5.)</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  約100％鏡像体過剰で下記式2のエチル(S)-4-クロロ-3-ヒドロキシブチレートを製造する方法であって、<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
  前記方法が、<br class="style-scope patent-text">
ａ．下記式1のエチル4-クロロ-3-オキソブチレートを提供する工程、<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
ｂ．該エチル4-クロロ-3-オキソブチレートを、請求項１又は６に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させる工程、<br class="style-scope patent-text">
ｃ．工程（b）で得られる反応混合物に、酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテルから成る群から選択される有機溶媒を10：1から1：1の範囲の比率で添加する工程、<br class="style-scope patent-text">
ｄ．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、<br class="style-scope patent-text">
ｅ．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて当該生成物エチル(S)-4-クロロ-3-ヒドロキシブチレートを単離する工程を含む、前記方法。
</span>A process for producing ethyl (S) -4-chloro-3-hydroxybutyrate of formula 2 below with about 100% enantiomeric excess, <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> The above method is <br class="style-scope patent-text"> a. Providing ethyl 4-chloro-3-oxobutyrate of formula 1 <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> b. A designer cell according to claim 1 or 6, and 0.005 to 0.02 mol% of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose dehydrogenase, wherein said ethyl 4-chloro-3-oxobutyrate is used. And contacting with a buffer solution of pH 5.0 to 9.0, <br class="style-scope patent-text"> c. In the reaction mixture obtained in step (b), an organic solvent selected from the group consisting of ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether is in the range of 10: 1 to 1: 1. Adding in proportions, <br class="style-scope patent-text"> d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .; <br class="style-scope patent-text"> e. Extracting the product obtained in step (d) in ethyl acetate followed by isolating the product ethyl (S) -4-chloro-3-hydroxybutyrate.</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  光学的に濃縮された下記式5の脂肪族アルコールを製造する方法であって、<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）、<br class="style-scope patent-text">
  前記方法が、<br class="style-scope patent-text">
ａ．下記式3のケトンを提供する工程、<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝CH<sub class="style-scope patent-text">3</sub>、CH<sub class="style-scope patent-text">2</sub>X、(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>CH、CF<sub class="style-scope patent-text">3</sub>又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">2</sub>＝H、X又はCH<sub class="style-scope patent-text">3</sub>(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>であり、R<sub class="style-scope patent-text">3</sub>＝アルキル基であり、X＝Cl又はBrであり、n＝1−4であり、及びm＝1−8である。）<br class="style-scope patent-text">
ｂ．工程（a）で提供される式3のケトンを、請求項３又は８に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程、<br class="style-scope patent-text">
ｃ．工程（b）で得られる反応混合物に、酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテルから成る群から選択される有機溶媒を10：1から1：1の範囲の比率で添加する工程、<br class="style-scope patent-text">
ｄ．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、<br class="style-scope patent-text">
ｅ．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式5の化合物を単離する工程を含む、前記方法。
</span>A process for producing an optically concentrated aliphatic alcohol of the following formula 5, <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> , R <sub class="style-scope patent-text">3</sub>ア ル キ ル alkyl group, XClCl or Br, n = 1-4, and m = 1-8.), <br class="style-scope patent-text"> The above method is <br class="style-scope patent-text"> a. Providing a ketone of formula 3 <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> CHCH <sub class="style-scope patent-text">3</sub> , CH <sub class="style-scope patent-text">2</sub> X, (CH <sub class="style-scope patent-text">3</sub> ) <sub class="style-scope patent-text">2</sub> CH, CF <sub class="style-scope patent-text">3</sub> or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> and R <sub class="style-scope patent-text">2</sub> HH, X or CH <sub class="style-scope patent-text">3</sub> (CH <sub class="style-scope patent-text">2</sub> ) <sub class="style-scope patent-text">n</sub> R <sub class="style-scope patent-text">3</sub> = alkyl group, XXCl or Br, n = 1-4 and m = 1-8.) <br class="style-scope patent-text"> b. The ketone of formula 3 provided in step (a), the designer cell according to claim 3 or 8, and 0.005 to 0.02 mole% of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and 100 to 500 units of glucose Contacting with dehydrogenase and a buffer solution of pH 5.0 to 9.0 to form a reaction mixture, <br class="style-scope patent-text"> c. In the reaction mixture obtained in step (b), an organic solvent selected from the group consisting of ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether is in the range of 10: 1 to 1: 1. Adding in proportions, <br class="style-scope patent-text"> d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .; <br class="style-scope patent-text"> e. Extracting the product obtained in step (d) in ethyl acetate, followed by isolating the compound of formula 5 as described above.</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  光学的に濃縮された下記式6のアリールアルコールを製造する方法であって、<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）、<br class="style-scope patent-text">
  前記方法が、<br class="style-scope patent-text">
ａ．下記式４のケトンを提供する工程、<br class="style-scope patent-text">
<br class="style-scope patent-text">
<span class="patent-image-not-available style-scope patent-text"></span>
（式中、R<sub class="style-scope patent-text">1</sub>＝R<sub class="style-scope patent-text">2</sub>＝R<sub class="style-scope patent-text">3</sub>＝R<sub class="style-scope patent-text">4</sub>＝R<sub class="style-scope patent-text">5</sub>＝H、CH<sub class="style-scope patent-text">3</sub>、F、Cl、Br、I、CF<sub class="style-scope patent-text">3</sub>、NO<sub class="style-scope patent-text">2</sub>又はOCH<sub class="style-scope patent-text">3</sub>であり、R<sub class="style-scope patent-text">6</sub>＝アルキル基であり、及びn＝1から5である。）<br class="style-scope patent-text">
ｂ．工程（a）で提供される式４のケトンを、請求項４又は９に記載のデザイナー細胞並びに0.005から0.02モル％のニコチンアミドアデニンジヌクレオチドリン酸還元型（NADPH）及び100から500単位のグルコースデヒドロゲナーゼ及びpH5.0から9.0の緩衝溶液と接触させて反応混合物を形成する工程、<br class="style-scope patent-text">
ｃ．工程（b）で得られる反応混合物に、酢酸エチル、酢酸ブチル、ジエチルエーテル、メチルn-ブチルエーテル又はジ-n-ブチルエーテルから成る群から選択される有機溶媒を10：1から1：1の範囲の比率で添加する工程、<br class="style-scope patent-text">
ｄ．該反応混合物を磁気攪拌装置上で活発に20から40℃の一定の温度で混合する工程、<br class="style-scope patent-text">
ｅ．工程（d）で得られる生成物を酢酸エチル中で抽出し、続いて式6の化合物を単離する工程を含む、前記方法。
</span>A process for producing an optically enriched aryl alcohol of the following formula 6, <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5), <br class="style-scope patent-text"> The above method is <br class="style-scope patent-text"> a. Providing a ketone of formula 4 <br class="style-scope patent-text"> <br class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> (Wherein, R <sub class="style-scope patent-text">1</sub> RR <sub class="style-scope patent-text">2</sub> RR <sub class="style-scope patent-text">3</sub> RR <sub class="style-scope patent-text">4</sub> RR <sub class="style-scope patent-text">5</sub> HH, CH <sub class="style-scope patent-text">3</sub> , F, Cl, Br, I, CF <sub class="style-scope patent-text">3</sub> , NO <sub class="style-scope patent-text">2</sub> or OCH <sub class="style-scope patent-text">3</sub> and R <sub class="style-scope patent-text">6</sub>ア ル キ ル alkyl group, , And n = 1 to 5.) <br class="style-scope patent-text"> b. 10. A designer cell according to claim 4 or 9 and a 0.005 to 0.02 mole% nicotinamide adenine dinucleotide phosphate reduced form (NADPH) and a glucose of 100 to 500 units provided in step (a) Contacting with dehydrogenase and a buffer solution of pH 5.0 to 9.0 to form a reaction mixture, <br class="style-scope patent-text"> c. In the reaction mixture obtained in step (b), an organic solvent selected from the group consisting of ethyl acetate, butyl acetate, diethyl ether, methyl n-butyl ether or di-n-butyl ether is in the range of 10: 1 to 1: 1. Adding in proportions, <br class="style-scope patent-text"> d. Vigorously mixing the reaction mixture on a magnetic stirrer at a constant temperature of 20 to 40 ° C .; <br class="style-scope patent-text"> e. Extracting the product obtained in step (d) in ethyl acetate, followed by isolating the compound of formula 6 as described above.</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アクセッション番号MTCC No.5806、MTCC No.5807、MTCC No.5808、MTCC No.5809、MTCC No.5810、MTCC No.5811、MTCC No.5812、MTCC No.5813、MTCC No.5814、MTCC No.5815、MTCC No.5816及びMTCC No.5817のいずれかを有する、請求項１又は６に記載のデザイナー細胞。
</span>
&nbsp;&nbsp;Accession numbers MTCC No. 5806, MTCC No. 5807, MTCC No. 5808, MTCC No. 5809, MTCC No. 5810, MTCC No. 5811, MTCC No. 5812, MTCC No. 5813, MTCC No. 5814, MTCC No. 5814 The designer cell according to claim 1 or 6, which has any of .5815, MTCC No. 5816 and MTCC No. 5817.
</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">配</u>列番号１、３、５又は７のポリペプチド配列をコードするポリヌクレオチドを含む組換えベクター構築物であって、カルボニルレダクターゼ酵素の天然に存在しない配列を含みかつ細胞表面上で高活性のカルボニルレダクターゼを発現できることを特徴とする組換えベクター構築物。
</span>A recombinant vector construct comprising a polynucleotide encoding the polypeptide sequence of <u class="style-scope patent-text">SEQ</u> ID NO 1, 3, 5 or 7, comprising a sequence that is not naturally occurring in the carbonyl reductase enzyme and carbonyl reductase highly active on the cell surface A recombinant vector construct characterized in that it is capable of expressing</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">配</u>列番号１、３、５又は７及び配列番号９又は１１のポリペプチド配列をコードするポリヌクレオチド<u class="style-scope patent-text">を含む組換えベクター構築物であって、</u>酵素カルボニルレダクターゼ及びグル<u class="style-scope patent-text">コース</u>デヒドロゲナーゼを細胞表面で一緒に共同発現することができる組換えベクター<u class="style-scope patent-text">構築物</u>。
</span> <u class="style-scope patent-text">A recombinant vector construct comprising a</u> polynucleotide encoding the polypeptide sequence of <u class="style-scope patent-text">SEQ</u> ID NO 1, 3, 5 or 7 and SEQ ID NO: 9 or <u class="style-scope patent-text">11,</u> co-expresses the enzyme carbonyl reductase and <u class="style-scope patent-text">glucose</u> dehydrogenase together at the cell surface Can be a recombinant vector <u class="style-scope patent-text">construct</u> .</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (11)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4710468A/en"><a id="link" href="#" class="style-scope state-modifier">US4710468A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-10-24</span>
                    <span class="td style-scope patent-result">1987-12-01</span>
                    <span class="td style-scope patent-result">Sigma-Tau Industrie Pharmaceutiche Riunite S.P.A.</span>
                    <span class="td style-scope patent-result">Process for preparing L-carnitine and chemical intermediates employed therein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS62126997A/en"><a id="link" href="#" class="style-scope state-modifier">JPS62126997A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-11-28</span>
                    <span class="td style-scope patent-result">1987-06-09</span>
                    <span class="td style-scope patent-result">Nippon Synthetic Chem Ind Co Ltd:The</span>
                    <span class="td style-scope patent-result">Production of optically active gamma-halo-beta hydroxybutyric ester 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5413921A/en"><a id="link" href="#" class="style-scope state-modifier">US5413921A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-05-28</span>
                    <span class="td style-scope patent-result">1995-05-09</span>
                    <span class="td style-scope patent-result">Ajinomoto Co., Ltd.</span>
                    <span class="td style-scope patent-result">Method of the production of (s)-gamma-halogenated-γ-hydroxybutyric acid esters 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3155107B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3155107B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-01-12</span>
                    <span class="td style-scope patent-result">2001-04-09</span>
                    <span class="td style-scope patent-result">ダイセル化学工業株式会社</span>
                    <span class="td style-scope patent-result">
  Method for producing optically active 4-halo-3-hydroxybutyrate
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH08336393A/en"><a id="link" href="#" class="style-scope state-modifier">JPH08336393A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-04-13</span>
                    <span class="td style-scope patent-result">1996-12-24</span>
                    <span class="td style-scope patent-result">Mitsubishi Chem Corp</span>
                    <span class="td style-scope patent-result">Production of optically active gamma-substituted-beta-hydroxybutyric ester 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5891685A/en"><a id="link" href="#" class="style-scope state-modifier">US5891685A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-06-03</span>
                    <span class="td style-scope patent-result">1999-04-06</span>
                    <span class="td style-scope patent-result">Mitsubishi Chemical Corporation</span>
                    <span class="td style-scope patent-result">Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005017135A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005017135A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-08-11</span>
                    <span class="td style-scope patent-result">2005-02-24</span>
                    <span class="td style-scope patent-result">Codexis, Inc.</span>
                    <span class="td style-scope patent-result">Improved ketoreductase polypeptides and related polynucleotides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1660648B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1660648B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-08-11</span>
                    <span class="td style-scope patent-result">2013-10-09</span>
                    <span class="td style-scope patent-result">Codexis, Inc.</span>
                    <span class="td style-scope patent-result">Improved glucose dehydrogenase polypeptides and related polynucleotides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100743973B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100743973B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-04-27</span>
                    <span class="td style-scope patent-result">2007-07-30</span>
                    <span class="td style-scope patent-result">한국과학기술원</span>
                    <span class="td style-scope patent-result">Method for simultaneous display of target protein and cofactor regenerating enzyme on cell surface 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090004720A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090004720A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-06-26</span>
                    <span class="td style-scope patent-result">2009-01-01</span>
                    <span class="td style-scope patent-result">Ling Hua</span>
                    <span class="td style-scope patent-result">Smart Biocatalysts For Organic Synthesis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20120270285A1/en"><a id="link" href="#" class="style-scope state-modifier">US20120270285A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-06-23</span>
                    <span class="td style-scope patent-result">2012-10-25</span>
                    <span class="td style-scope patent-result">Montelione Gaetano T</span>
                    <span class="td style-scope patent-result">Stereospecific carbonyl reductases 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (6)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107326049A/en"><a id="link" href="#" class="style-scope state-modifier">CN107326049A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-04-28</span>
                    <span class="td style-scope patent-result">2017-11-07</span>
                    <span class="td style-scope patent-result">尚科生物医药（上海）有限公司</span>
                    <span class="td style-scope patent-result">Recombinate ketoreductase and prepare (R) -3,5- two（Trifluoromethyl）Application in benzyl carbinol 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN106279374A/en"><a id="link" href="#" class="style-scope state-modifier">CN106279374A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-08-26</span>
                    <span class="td style-scope patent-result">2017-01-04</span>
                    <span class="td style-scope patent-result">深圳市职业病防治院</span>
                    <span class="td style-scope patent-result">A kind of polypeptide being combined with lead ion and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN106399398A/en"><a id="link" href="#" class="style-scope state-modifier">CN106399398A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-11-16</span>
                    <span class="td style-scope patent-result">2017-02-15</span>
                    <span class="td style-scope patent-result">上海医药工业研究院</span>
                    <span class="td style-scope patent-result">Bio-preparation method for (R)-3,5-bis(trifluoromethyl) phenyl ethanol 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107794282B/en"><a id="link" href="#" class="style-scope state-modifier">CN107794282B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-11-20</span>
                    <span class="td style-scope patent-result">2020-12-25</span>
                    <span class="td style-scope patent-result">浙江工业大学</span>
                    <span class="td style-scope patent-result">Preparation method and strain of crizotinib chiral intermediate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN112941124B/en"><a id="link" href="#" class="style-scope state-modifier">CN112941124B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-02-09</span>
                    <span class="td style-scope patent-result">2023-12-29</span>
                    <span class="td style-scope patent-result">江苏阿尔法药业股份有限公司</span>
                    <span class="td style-scope patent-result">Method for preparing irinotecan intermediate by whole cell catalysis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113789353B/en"><a id="link" href="#" class="style-scope state-modifier">CN113789353B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-09-25</span>
                    <span class="td style-scope patent-result">2024-03-08</span>
                    <span class="td style-scope patent-result">复旦大学</span>
                    <span class="td style-scope patent-result">Preparation method of (2S, 3S) -2-chloro-3-hydroxy ester compound 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6330028B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6330028B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-23</span>
                    <span class="td style-scope patent-result">
  Designer cells for enantioselective reduction of ketones and their use in the efficient preparation of enantioenriched alcohols
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10597685B2/en"><a id="link" href="#" class="style-scope state-modifier">US10597685B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-03-24</span>
                    <span class="td style-scope patent-result">Host cells and methods for oxidizing aromatic amino acids 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7202069B2/en"><a id="link" href="#" class="style-scope state-modifier">US7202069B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-04-10</span>
                    <span class="td style-scope patent-result">(R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2011244829A/en"><a id="link" href="#" class="style-scope state-modifier">JP2011244829A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-12-08</span>
                    <span class="td style-scope patent-result">Oxidoreductase derived from pichia capsulata 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2007523617A6/en"><a id="link" href="#" class="style-scope state-modifier">JP2007523617A6</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-08</span>
                    <span class="td style-scope patent-result">
  Pichia capsulata-derived oxidoreductase
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109825538A/en"><a id="link" href="#" class="style-scope state-modifier">CN109825538A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-31</span>
                    <span class="td style-scope patent-result">A kind of synthetic method of Chiral 2-amino-1-butanol 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2651723C/en"><a id="link" href="#" class="style-scope state-modifier">CA2651723C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-11-08</span>
                    <span class="td style-scope patent-result">A novel group of esterases for the enantioselective production of fine and speciality chemicals 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW200305645A/en"><a id="link" href="#" class="style-scope state-modifier">TW200305645A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-11-01</span>
                    <span class="td style-scope patent-result">Novel carbonyl reductase, gene encoding the same and process for producing optically active alcohols using the same 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8945887B2/en"><a id="link" href="#" class="style-scope state-modifier">US8945887B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-02-03</span>
                    <span class="td style-scope patent-result">Whole cell biocatalyst 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5553354B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5553354B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-07-16</span>
                    <span class="td style-scope patent-result">
  Preparation of esterase
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2562253B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2562253B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-08-02</span>
                    <span class="td style-scope patent-result">Modified carbonyl reductase, gene thereof, and method of producing optically active alcohols using these 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113817693A/en"><a id="link" href="#" class="style-scope state-modifier">CN113817693A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-12-21</span>
                    <span class="td style-scope patent-result">Short-chain carbonyl reductase PpYSDR mutant, encoding gene, recombinant expression vector, genetic engineering bacterium and application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004357639A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004357639A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-12-24</span>
                    <span class="td style-scope patent-result">(2s,3s)-2,3-butanediol dehydrogenase 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2009213392A/en"><a id="link" href="#" class="style-scope state-modifier">JP2009213392A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-09-24</span>
                    <span class="td style-scope patent-result">Improved gallic acid synthase and method for producing gallic acid 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2365092A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2365092A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-21</span>
                    <span class="td style-scope patent-result">Sorbitol dehydrogenase, gene encoding the same and use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/12678925335108707112"><a id="link" href="#" class="style-scope state-modifier">Liu et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010</span>
                    <span class="td style-scope patent-result">Environmentally safe production of 7-ACA by recombinant Acremonium chrysogenum</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5789366B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5789366B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-07</span>
                    <span class="td style-scope patent-result">
  Novel styrene monooxygenase, method for producing the same, and method for producing optically active styrene oxide using the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5119166B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5119166B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-01-16</span>
                    <span class="td style-scope patent-result">
  Novel polypeptides having esterase activity and recombinant esterases and their use
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2008502334A/en"><a id="link" href="#" class="style-scope state-modifier">JP2008502334A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-01-31</span>
                    <span class="td style-scope patent-result">
  Production method of optically active alcohol using whole cell catalyst
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11807873B2/en"><a id="link" href="#" class="style-scope state-modifier">US11807873B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-11-07</span>
                    <span class="td style-scope patent-result">Conversion of S-lignin compounds to useful intermediates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3676370B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3676370B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-12-20</span>
                    <span class="td style-scope patent-result">Compositions and methods using methanotrophic s-layer proteins for expression of heterologous proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2010512733A/en"><a id="link" href="#" class="style-scope state-modifier">JP2010512733A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-30</span>
                    <span class="td style-scope patent-result">
  Method for preparing pravastatin
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2009521239A5/en"><a id="link" href="#" class="style-scope state-modifier">JP2009521239A5</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-26</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4601049B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4601049B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-12-22</span>
                    <span class="td style-scope patent-result">
  Microorganism expressing epoxide hydrolase derived from Bacillus subtilis and method for producing epoxide hydrolase using the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/11522871157923918828"><a id="link" href="#" class="style-scope state-modifier">Viña-González</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019</span>
                    <span class="td style-scope patent-result">Biotechnological platforms for aryl-alcohol oxidases by directed evolution</span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        IN1146/DEL/2013<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-04-17</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        IN1146DE2013<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-04-17</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014170917A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/IN2014/000247</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Designer cells for enantioselective reduction of ketones and use thereof in efficient production of enantioenriched alcohols 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-09-28</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20160928</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-09-28</span>
                    <span class="td nowrap style-scope patent-result">A621</span>
                    <span class="td nowrap style-scope patent-result">Written request for application examination</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A621</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20160928</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-10-10</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171010</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-01-10</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180110</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-01-29</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180129</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-03-22</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180322</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-04-03</span>
                    <span class="td nowrap style-scope patent-result">TRDD</span>
                    <span class="td nowrap style-scope patent-result">Decision of grant or rejection written</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-04-09</span>
                    <span class="td nowrap style-scope patent-result">A01</span>
                    <span class="td nowrap style-scope patent-result">Written decision to grant a patent or to grant a registration (utility model)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A01</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180409</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-04-26</span>
                    <span class="td nowrap style-scope patent-result">A61</span>
                    <span class="td nowrap style-scope patent-result">First payment of annual fees (during grant procedure)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A61</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180423</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-04-27</span>
                    <span class="td nowrap style-scope patent-result">R150</span>
                    <span class="td nowrap style-scope patent-result">Certificate of patent or registration of utility model</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 6330028</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: JP</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R150</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-04-05</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2022-04-27</span>
                    <span class="td nowrap style-scope patent-result">LAPS</span>
                    <span class="td nowrap style-scope patent-result">Cancellation because of no payment of annual fees</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1776206804" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1776206804" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=824818084" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>